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A B S T R A C T
Background
Rapid and accurate detection of stroke by paramedics or other emergency clinicians at the time of first contact is crucial for timely
initiation of appropriate treatment. Several stroke recognition scales have been developed to support the initial triage. However, their
accuracy remains uncertain and there is no agreement which of the scales perform better.
Objectives
To systematically identify and review the evidence pertaining to the test accuracy of validated stroke recognition scales, as used in a
prehospital or emergency room (ER) setting to screen people suspected of having stroke.
Search methods
We searched CENTRAL, MEDLINE (Ovid), Embase (Ovid) and the Science Citation Index to 30 January 2018. We handsearched
the reference lists of all included studies and other relevant publications and contacted experts in the field to identify additional studies
or unpublished data.
Selection criteria
We included studies evaluating the accuracy of stroke recognition scales used in a prehospital or ER setting to identify stroke and
transient Ischemic attack (TIA) in people suspected of stroke. The scales had to be applied to actual people and the results compared to
a final diagnosis of stroke or TIA. We excluded studies that applied scales to patient records; enrolled only screen-positive participants
and without complete 2 × 2 data.
Data collection and analysis
Two review authors independently conducted a two-stage screening of all publications identified by the searches, extracted data and
assessed the methodologic quality of the included studies using a tailored version of QUADAS-2. A third review author acted as an
arbiter. We recalculated study-level sensitivity and specificity with 95% confidence intervals (CI), and presented them in forest plots and
in the receiver operating characteristics (ROC) space. When a sufficient number of studies reported the accuracy of the test in the same
setting (prehospital or ER) and the level of heterogeneity was relatively low, we pooled the results using the bivariate random-effects
model. We plotted the results in the summary ROC (SROC) space presenting an estimate point (mean sensitivity and specificity) with
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95% CI and prediction regions. Because of the small number of studies, we did not conduct meta-regression to investigate between-
study heterogeneity and the relative accuracy of the scales. Instead, we summarized the results in tables and diagrams, and presented
our findings narratively.
Main results
We selected 23 studies for inclusion (22 journal articles and one conference abstract). We evaluated the following scales: Cincinnati
Prehospital Stroke Scale (CPSS; 11 studies), Recognition of Stroke in the Emergency Room (ROSIER; eight studies), Face Arm Speech
Time (FAST; five studies), Los Angeles Prehospital Stroke Scale (LAPSS; five studies), Melbourne Ambulance Stroke Scale (MASS; three
studies), Ontario Prehospital Stroke Screening Tool (OPSST; one study), Medic Prehospital Assessment for Code Stroke (MedPACS;
one study) and PreHospital Ambulance Stroke Test (PreHAST; one study). Nine studies compared the accuracy of two or more scales.
We considered 12 studies at high risk of bias and one with applicability concerns in the patient selection domain; 14 at unclear risk
of bias and one with applicability concerns in the reference standard domain; and the risk of bias in the flow and timing domain was
high in one study and unclear in another 16.
We pooled the results from five studies evaluating ROSIER in the ER and five studies evaluating LAPSS in a prehospital setting. The
studies included in the meta-analysis of ROSIER were of relatively good methodologic quality and produced a summary sensitivity
of 0.88 (95% CI 0.84 to 0.91), with the prediction interval ranging from approximately 0.75 to 0.95. This means that the test will
miss on average 12% of people with stroke/TIA which, depending on the circumstances, could range from 5% to 25%. We could not
obtain a reliable summary estimate of specificity due to extreme heterogeneity in study-level results. The summary sensitivity of LAPSS
was 0.83 (95% CI 0.75 to 0.89) and summary specificity 0.93 (95% CI 0.88 to 0.96). However, we were uncertain in the validity of
these results as four of the studies were at high and one at uncertain risk of bias. We did not report summary estimates for the rest
of the scales, as the number of studies per test per setting was small, the risk of bias was high or uncertain, the results were highly
heterogenous, or a combination of these.
Studies comparing two or more scales in the same participants reported that ROSIER and FAST had similar accuracy when used in
the ER. In the field, CPSS was more sensitive than MedPACS and LAPSS, but had similar sensitivity to that of MASS; and MASS
was more sensitive than LAPSS. In contrast, MASS, ROSIER and MedPACS were more specific than CPSS; and the difference in the
specificities of MASS and LAPSS was not statistically significant.
Authors’ conclusions
In the field, CPSS had consistently the highest sensitivity and, therefore, should be preferred to other scales. Further evidence is needed
to determine its absolute accuracy and whether alternatives scales, such asMASS and ROSIER, whichmight have comparable sensitivity
but higher specificity, should be used instead, to achieve better overall accuracy. In the ER, ROSIER should be the test of choice, as it
was evaluated in more studies than FAST and showed consistently high sensitivity. In a cohort of 100 people of whom 62 have stroke/
TIA, the test will miss on average seven people with stroke/TIA (ranging from three to 16). We were unable to obtain an estimate
of its summary specificity. Because of the small number of studies per test per setting, high risk of bias, substantial differences in
study characteristics and large between-study heterogeneity, these findings should be treated as provisional hypotheses that need further
verification in better-designed studies.
P L A I N L A N G U A G E S U M M A R Y
Accuracy of prehospital stroke scales to identify people with stroke or transient ischemic attack (TIA)
Background
Stroke is a life-threatening medical condition in which brain tissue is damaged. This could be caused by a clot blocking the blood
supply to part of the brain or bleeding in the brain. If symptoms resolve within 24 hours without lasting consequences, the condition
is called TIA (mini stroke). Effective treatment depends on early identification of stroke and any delays may result in brain damage or
death.
Emergency medical services are the first point of contact for people experiencing symptoms suggestive of stroke. Medical responders
could identify people with stroke more accurately if they use checklists called stroke recognition scales. Such scales include symptoms
and other readily-available information. A positive result on the scale indicates high risk of stroke and the need of urgent specialist
assessment. The scales do not differentiate between stroke and TIA; this is done in hospital by a neurologist or stroke physician.
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Our objective was to review the research evidence on how accurately stroke recognition scales can detect stroke or TIA when used by
paramedics or other prehospital clinicians, who are the first point of contact for people suspected of stroke.
Study characteristics
The evidence is current to 30 January 2018. We included studies assessing the accuracy of stroke recognition scales when applied to
adults suspected of stroke out of hospital.
We included 23 studies evaluating the following scales: Cincinnati Prehospital Stroke Scale (CPSS; 11 studies), Recognition of Stroke
in the Emergency Room (ROSIER; eight studies), Face Arm Speech Time (FAST; five studies), Los Angeles Prehospital Stroke Scale
(LAPSS; five studies), Melbourne Ambulance Stroke Scale (MASS; three studies), Ontario Prehospital Stroke Screening Tool (OPSST;
one study), Medic Prehospital Assessment for Code Stroke (MedPACS; one study) and PreHospital Ambulance Stroke Test (PreHAST;
one study). Nine studies compared two or more scales in the same people. The results from five studies were combined to estimate
the accuracy of ROSIER in the emergency room (ER) and five studies to estimate the accuracy of LAPSS when used by ambulance
clinicians.
Quality of the evidence
Many of the studies were of poor or unclear quality and we could not be sure that their results were valid.
Key results of the accuracy of the evaluated prehospital stroke scales
Studies differed considerably in terms of included participants and other characteristics. As a consequence, studies evaluating the same
scale reported variable results.
We combined five studies evaluating ROSIER in the ER and obtained average sensitivity of 88% (88 out of 100 people with stroke/
TIA will test positive on ROSIER). We were unable to obtain an estimate of specificity (how many people without stroke/TIA will test
negative).
We also combined the results for LAPSS, but the included studies were of poor quality and the results may not be valid. The rest of
the scales were evaluated in a smaller number of studies or the results were too variable to be combined statistically.
A small number of studies compared two or more scales when applied to the same participants. Such studies are more likely to produce
valid results as the scales are used in the same circumstances. They reported that in the ER, ROSIER and FAST had similar accuracy,
but ROSIER was evaluated in more studies. When used by ambulance staff, CPSS identified more people with stroke/TIA in all studies,
but also more people without stroke/TIA tested positive.
Conclusion
Current evidence suggests that CPSS should be used by ambulance clinicians in the field. Further research is needed to estimate the
proportion of wrong results and whether alternatives scales, such as MASS and ROSIER, which might have comparable sensitivity
but higher specificity, should be used instead to achieve better overall accuracy. In the ER, ROSIER should be the test of choice. In
a group of 100 people of whom 62 have stroke/TIA, the test will miss on average seven people with stroke/TIA (ranging from three
to 16). Because of the small number of studies evaluating the tests in a specific setting, poor quality, substantial differences in study
characteristics and variability in results, these findings should be treated with caution and need further verification in better-designed
studies.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
OBJECTIVES AND METHODS
Review question: what is the absolute and relat ive (comparat ive) accuracy of stroke recognit ion scales used in a prehospital or ER sett ing to ident if y people with stroke and
TIA?
Inclusion criteria: primary studies evaluat ing the test accuracy of stroke recognit ion scales in a prehospital or ER sett ing. The scales were used to ident if y stroke and TIA in
people suspected of stroke, and the results were compared to a f inal diagnosis of stroke or TIA made by a neurologist or stroke physician (reference standard). Only studies
report ing suf f icient data to reconstruct the full 2 × 2 table were included. Studies in which the scales were applied to pat ient records, or including only scale-posit ive pat ients
were excluded
Databases searched: CENTRAL, MEDLINE, Embase, Science Citat ion Index, plus hand-searches of reference lists
Search date: f rom earliest date possible to 30 January 2018
Methodologic quality assessment: QUADAS-2
Statistical analysis: if appropriate, the bivariate random-ef fects model was used to pool results
RESULTS
Number of studies included: 23 studies including 9230 part icipants, range 31-1130 part icipants, median 312 (IQR 154 to 554)
Number of scales evaluated: 8 scales, CPSS (11 studies), ROSIER (8 studies), FAST (5 studies), LAPSS (5 studies), MASS (3 studies), OPSST (1 study), MedPACS (1 study),
PreHAST (1 study)
Setting: 6 studies evaluated the scales in the ER and 17 in a prehospital sett ing (16 evaluated the tests in the f ield and 1 in primary care)
Studies comparing scales in the same participants: 9 studies compared ≥ 2 scales in the same patients (3 studies each compared FAST vs ROSIER and CPSS vs MASS, 2
studies each compared ROSIER vs CPSS, LAPSS vs CPSS and LAPSS vs MASS, and 1 study each compared some of the remaining pairs)
Methodologic quality: 12 studies were at high risk of bias and 1 with applicability concerns in the pat ient select ion domain; 14 at unclear risk of bias and 1 with applicability
concerns in the reference standard domain; and 1 at high risk of bias and another 16 at unclear risk of bias in the f low and tim ing domain
CONCLUSIONS: CPSS should be preferred in the f ield as it had consistent ly high sensit ivity in direct comparisons; further evidence is needed to determ ine its absolute
accuracy and whether alternat ives scales, such as MASS and ROSIER, which might have comparable sensit ivity but higher specif icity, should be used instead to achieve better
overall accuracy. In the ER, ROSIER should be the test of choice. In a cohort of 100 people of whom 62 have stroke/ TIA, the test will m iss on average 7 people with stroke/
TIA (range 3-16). We were unable to obtain an est imate of its summary specif icity. Because of the small number of studies per test per sett ing, high risk of bias, substant ial
dif f erences in study characterist ics and large between-study heterogeneity, these f indings should be treated as provisional hypotheses that need further verif icat ion in better-
designed studies
RESULTS: relative (comparative) accuracy
Considering only the results for which the stat ist ical signif icance was reported or could be determined f rom the non-overlapping CIs of the accuracy est imates, the results of
the comparat ive studies could be summarized as follows
In the ER:
• ROSIER vs FAST: no stat ist ically signif icant dif f erence in sensit ivit ies and specif icit ies.
In the field:4
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• CPSS vs MASS: no stat ist ically signif icant dif f erence in sensit ivit ies, but MASS was more specif ic;
• CPSS vs ROSIER: the specif icity of ROSIER was higher (the result for sensit ivity was uncertain);
• CPSS vs LAPSS: the dif ference in sensit ivit ies was stat ist ically signif icant in favor of CPSS (the dif ference in specif icit ies was uncertain);
• CPSS vs MedPACS: both the dif ferences in sensit ivity and specif icity were stat ist ically signif icant, with CPSS being more sensit ive but less specif ic;
• MASS vs LAPSS: the dif ference in sensit ivit ies was stat ist ically signif icant in favor of MASS, but no stat ist ically signif icant dif f erence in specif icit ies was found.
Addit ional data f rom Purrucker 2015 (excluded f rom the main analysis) contradicted some of these results
RESULTS: absolute accuracy
Index test Number of studies Number of studies
at high risk of bias or
applicability concerns
Results Comments
ROSIER 8 (2 in the f ield, 1 in primary care
and 5 in ER)
2 (1 in pat ient select ion and 1 in
f low and tim ing)
Mean summary sensitivity 0.88
(95% CI 0.84 to 0.91), predict ion
region 0.75 to 0.95
Specif icity (study-level, range) 0.
18 to 0.93
We report only a mean summary
est imate for sensit ivity, based
on 5 studies of relat ively good
methodologic quality conducted
in the ER. It means that in this
sett ing the test will m iss on av-
erage 12/ 100 people with stroke/
TIA, but this could range f rom 5
to 25 people
Study-level specif icit ies were ex-
tremely heterogeneous and the
stat ist ical uncertainty in the sum-
mary est imate was too great to al-
low meaningful clinical interpreta-
t ion. Across the studies, between
7/ 100 and 82/ 100 people without
stroke/ TIA tested posit ive
CPSS 11 (9 in the f ield, 1 in primary care
and 1 in ER)
9 (8 in pat ient select ion and 1 in
the applicability of the reference
standard)
Sensit ivity 0.44 to 0.95
Specif icity 0.21 to 0.79
High level of heterogeneity even
when analysis restricted to use
of CPSS in a prehospital set-
t ing by paramedics (7 studies).
Across all studies, between 5/ 100
and 55/ 100 people with stroke/
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TIA were missed and between 21/
100 and 79/ 100 without stroke/
TIA tested posit ive
LAPSS 5 studies (prehospital) 4 (pat ient select ion) Summary sensit ivity 0.83 (95%CI
0.75 to 0.89)
Summary specif icity 0.93 (95%CI
0.88 to 0.96)
According to the obtained sum-
mary est imates, the test will m iss
17/ 100 people with stroke/ TIA
and 7/ 100 without stroke/ TIA will
test posit ive. However, these re-
sults should be treated with cau-
t ion as 4/ 5 studies were at high
risk of select ion bias and for most
the level of bias in the reference
standard and the f low and tim-
ing domain could not be fully as-
sessed
FAST 5 studies (3 in prehospital and 2
in ER)
3 (2 in pat ient select ion and 1 in
f low and tim ing)
Sensit ivity 0.64 to 0.97
Specif icity 0.13 to 0.92
Heterogeneous results even when
results analyzed separately by
sett ing. Across studies the test
m issed between 3/ 100 and 36/
100 people with stroke/ TIA and
between 8/ 100 and 87/ 100 peo-
ple without stroke/ TIA tested pos-
it ive
MASS 3 studies (prehospital) 3 (pat ient select ion) Sensit ivity 0.74 to 0.90
Specif icity 0.67 to 0.86
Heterogeneous results f rom stud-
ies at high risk of bias. Across
studies, the test m issed be-
tween 10/ 100 and 26/ 100 people
with stroke/ TIA and between 14/
100 and 33/ 100 people without
stroke/ TIA tested posit ive
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OPSST 1 study 1 (pat ient select ion) Sensit ivity 0.92
(95%CI 0.88 to 0.94)
Specif icity 0.86
(95%CI 0.80 to 0.90)
High risk of select ion bias; the fo-
cus was on the posit ive predict ive
value which was 0.90 (95% CI 0.
86 to 0.93). This means that 90/
100 people with a posit ive test
had stroke/ TIA
MedPACS 1 study 1 (pat ient select ion) Sensit ivity 0.74
(95%CI 0.67 to 0.80)
Specif icity 0.33
(95%CI 0.27 to 0.39)
Retrospect ive data collect ion.
The test m issed 26/ 100 people
with stroke/ TIA and 67/ 100 peo-
ple without stroke/ TIA tested pos-
it ive
PreHAST 1 study No quality issues Sensit ivity 1.00 (95%CI 0.87 to 1.
00)
Specif icity 0.40 (95%CI 0.25 to 0.
56)
PreHAST was designed for both
recognit ion and severity assess-
ment of stroke in the f ield; this
was a pilot study focusing mainly
on the accuracy of the scale
to ident if y people with stroke/
TIA. The test m issed 0 people
with stroke/ TIA, but 60/ 100 peo-
ple without stroke/ TIA tested pos-
it ive
CI: conf idence interval; CPSS: Cincinnat i Prehospital Stroke Scale; ER: emergency room; FAST: Face Arm Speech Time; IQR:
interquart ile range; LAPSS: Los Angeles Prehospital Stroke Scale; MASS: Melbourne Ambulance Stroke Scale; MedPACS:
Medic Prehospital Assessment for Code Stroke; OPSST: Ontario Prehospital Stroke Screening Tool; PreHAST: PreHospital
Ambulance Stroke Test; ROSIER: Recognit ion of Stroke in the Emergency Room; TIA: transient ischemic attack.
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B A C K G R O U N D
Worldwide, stroke is the leading cause of death. By 2020, 19 mil-
lion out of 25 million annual stroke deaths will occur in low- to
middle-income countries. Some 88% of these events are ischemic
strokes, with the remainder being hemorrhagic strokes. Stroke is
also the leading cause of disability with 30% of stroke survivors
requiring life-long assistance with their activities of daily living,
20% requiring assistance with ambulation and 16% requiring in-
stitutional levels of care (Daroff 2012). Ischemic stroke is caused
by blockage of blood flow by thrombi, which are blood clots made
of platelets, lipids, clotting factors and fibrin. Fibrin is the par-
ticular substrate of the thrombolytic, tissue plasminogen activator
(tPA), which is a standard of care treatment for certain people with
stroke. Failure to restore blood flow in a timely fashion results in
an ischemic stroke, and infarction of brain tissue.
A transient ischemic attack (TIA) is an episode of neurologic deficit
that reverses without any clinical evidence of neuronal damage.
TIAs are prognosticators for future strokes and also require rapid
identification, so that physicians can confirm whether or not the
symptoms have resolved and then work towards early risk stratifi-
cation, which has been shown to decrease recurrence (Amarenco
2008). The reference standard for diagnosis of stroke and TIA is
the evaluation by a neurologist or stroke physician upon review
of history, physical exam and a non-contrast brain computed to-
mography (CT) scan.
Intravenous tPAwas the only approved treatment of acute ischemic
stroke up until 2015. Utilization of intravenous tPA is limited by
its time sensitivity and thismedication can only be providedwithin
a window of 0 to 4.5 hours after onset of symptoms. Data from
multicenter randomized controlled trials (RCTs) of intravenous
tPA treatment in acute stroke have shown that the odds of a fa-
vorable outcome at three months increased as onset-to-treatment
time decreased (Hacke 2008; NINDS 1995; Sandercock 2012).
Pooled analysis supported these findings (Wardlaw 2009).
In an effort to deliver thrombolytics at the earliest time point pos-
sible, various streamlined ’stroke code’ systems have been devel-
oped to decrease the door-to-treatment time. The current Amer-
ican Heart Association guideline recommends that the target
door-to-treatment time be less than 60 minutes. However, this is
rarely achieved (Lyden 1994;Marler 2000;O’Connor 1999; Saver
2013). In addition to tPA, the American Heart and Stroke As-
sociation (Powers 2018), and the European Stroke Organisation
(ESO 2018), now recommend that for selected people with acute
ischemic stroke, mechanical thrombectomy be considered up to
24 hours of onset of symptoms.
An ideal system for rapid thrombolytic delivery and, now, consid-
eration for revascularization, begins with rapid and accurate stroke
detection at the time of first contact with medical personnel (in
most cases paramedics). Stroke pathways that include prehospital
notification have been demonstrated to reduce door-to-treatment
time and improve outcomes. Furthermore, hemorrhagic strokes
require rapid assessment and it is believed that early identification
and intervention is associated with signals toward decreased end
volume size of hemorrhage (Anderson 2008). Optimal time of
intervention and specific therapy including blood pressure agents
and targets (Butcher 2013; Hill 2013), and use of clotting factors
(Flaherty 2014), are currently under investigation.
Notably, all studies are focused on initiating therapies as soon as
possible. However, the diagnostic accuracy of paramedics’ diag-
nosis of stroke based on unstructured clinical assessment is poor
(Harbison 1999). Better results could be achieved if validated
stroke recognition tools are used to support the initial triage. Sev-
eral such instruments have been developed and implemented in
different countries worldwide, but the question about their abso-
lute and relative accuracy remains unanswered.
Target condition being diagnosed
We included all suspected acute strokes (ischemic, hemorrhagic
or TIAs) in people assessed by prehospital or emergency room
(ER) staff including paramedics, emergency medicine technicians
(EMTs), nurses, emergency physicians or general practitioners
(GPs). Trauma must not be a primary disease mechanism, but
we considered eligible studies including people with secondary
trauma (a fall due to stroke). In the case of TIA, it is impossible
to know if the neurologic deficit has resolved until the person has
been assessed by a neurologist or stroke physician and has had ad-
equate imaging. The presentation of TIA is analogous on a spec-
trum of disease that cannot be separated into categories at the time
of first contact by the responding healthcare staff.
We included TIA in the target condition as the scales are not in-
tended to differentiate between stroke and TIA. Therefore, if a
person with relevant symptoms at presentation and a final diag-
nosis of TIA tests positive on the scale, the result will be treated
as true positive rather than false positive. However, we appreci-
ate that a lack of clear guidance on whether or not to apply the
scales on people who are no longer symptomatic at the time of
first contact is likely to introduce variation in the spectrum of in-
cluded participants and, as a result, in test accuracy. We took this
into consideration when interpreting the results from the included
studies.
Index test(s)
The index tests are prehospital scales used to determine whether
the person is having stroke. They are based on the National In-
stitutes of Health Stroke Scale (NIHSS) and the first such tools,
Cincinnati Prehospital Stroke Scale (CPSS) and Los Angeles Pre-
hospital Stroke Scale (LAPSS), were developed and introduced in
the USA in the mid-1990s (Nor 2004). The use of prehospital
stroke scales by emergency medical responders is recommended
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by the American Heart and Stroke Association (Powers 2018),
the European Academy of Neurology and the European Stroke
Organisation (Kobayashi 2018). However, they make no recom-
mendations about the use of specific instruments. The scales are
in wide circulation worldwide and emergency medical responders
receive training on how to use them as part of their professional
education.
The scales are screening tools intended for use by prehospital and
ER staff, and are not meant for diagnosis of any neurologic con-
dition. Furthermore, they are not for determining the severity of
stroke (unless they have a dual purpose) or the type of stroke (is-
chemic versus hemorrhagic versus TIA, or any subtypes). Due to
the urgency to act on any type of stroke, the prehospital environ-
ment is not the appropriate setting in the decision tree to sepa-
rate ischemic from hemorrhagic stroke or stroke from TIA. This
is done by the attending neurologist or stroke physician.
The following stroke recognition scales were evaluated in the stud-
ies eligible for inclusion in the current review.
• Cincinnati Prehospital Stroke Scale (CPSS; Kothari 1999).
• Los Angeles Prehospital Stroke Scale (LAPSS; Kidwell
2000).
• Melbourne Ambulance Stroke Scale (MASS; Bray 2005a).
• Ontario Prehospital Stroke Screening Tool (OPSST;
Chenkin 2009).
• Face Arm Speech Time (FAST; Harbison 2003).
• Recognition of Stroke in the Emergency Room (ROSIER;
Nor 2005).
• Medic Prehospital Assessment for Code Stroke (MedPACS;
Studnek 2013).
• PreHospital Ambulance Stroke Test (PreHAST; Andsberg
2017).
We summarized the characteristics of the evaluated scales in Table
1. Each scale consists of a list of checkbox items from the patient’s
history of presenting illness, past medical history, physical exam
and basic laboratory values. The presence of any of the symptoms
listed on the scale indicates high probability of stroke and should
trigger an emergency stroke protocol. If none of the listed symp-
toms are present, diagnosis of stroke is less likely but not com-
pletely ruled out. Each symptom is scored ’+1’ when present and
’0’ when absent. Because the number of symptoms that could be
scored ’+1’ is different for different scales, the total score varies.
However, for all scales included in our review, a total score ’+1 or
greater’ indicates high probability of stroke and warrants a referral
for specialist assessment.
Some of the scales include additional criteria which determine
whether the person is eligible for assessment with the respective
scale. These criteria have been added to improve specificity by ex-
cluding people with common stroke mimics. However, the eligi-
bility criteria of OPSST aim not only to reduce unnecessary triage
of people with stroke mimics, but also of people who would be
ineligible for fibrinolysis, regardless of whether stroke is present or
not (e.g. people who could not be transported on time to an acute
stroke care center) (Chenkin 2009).
ROSIER and PreHAST use slightly different scoring systems.
ROSIER comprises five physical symptoms, each scored ’+1’ and
two additional items, seizure activity and abnormal blood sugar,
each scored ’-1’. The presence of any of these additional items
makes the diagnosis of stroke less likely even when some of the five
listed symptoms are present. The total score could range from ’-
2’ (none of the five physical symptoms and both additional items
are present) to ’+5’ (all physical symptoms are present and neither
of the two additional items). The positivity threshold is the same
as for the other scales ’+1 or greater’.
PreHAST is a tool “designed to screen for common stroke symp-
toms and grade severity, similarly to theNIHSS.” (p. 2) It includes
stroke symptoms that could predict main arterial vessel occlusion
in addition to recognizing peoplewith stroke in the field (Andsberg
2017). It comprises eight items that are scored differently (e.g. 0
or 1; 0, 1 or 2; 0 or 2), with 0 indicating absence of the symptom
and 1 and 2, different levels of severity of a present symptom.
The total score ranges from 0 to 19 points and ’+1 or greater’
is used as a positivity threshold to identify potential stroke. One
study eligible for inclusion in this review evaluated PreHAST as
the only prehospital stroke scale combining recognition of stroke
and assessment of severity.We identified studies evaluating similar
’dual purpose’ scales, but none of them met our inclusion crite-
ria, mainly because the scales were applied to patient records (e.g.
Purrucker 2015; Purrucker 2017).
Clinical pathway
The clinical pathway is very simple. When the paramedic, am-
bulance worker or medical attendant who is first on the scene is
suspicious that the person may be having stroke, they are to im-
plement a stroke scale in their evaluation of the person. Thus, the
point of first contact between emergency medical responders and
the person is where the index tests are to be implemented. The
people are then brought to an ER for further evaluation and clin-
ical workup. The triage of people who present directly to the ER
and are suspected of stroke could also involve a stroke recognition
scale.
Alternative test(s)
As discussed earlier, in addition to PreHAST we identified other
prehospital stroke scales that combine stroke identification and
severity assessment. Most of them were repurposed stroke sever-
ity scales (e.g. Kurashiki Prehospital Stroke Scale (KPSS), Los
Angeles Motor Scale (LAMS), eight-item National Institutes of
Health Stroke Scale (sNIHSS-8) and five-itemNational Institutes
of Health Stroke Scale (sNIHSS-5)) initially designed to identify
people with large vessel occlusion (LVO), who might be candi-
dates for thrombectomy. They were evaluated in a small number
of studies none of which met our inclusion criteria. In addition,
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one of the included studies compared CPSS to a panel of blood
biomarkers but, as far as we are aware, these are not routinely used
in clinical practice and have not been recommended for prehos-
pital triage of people suspected of stroke (Vanni 2011).
Rationale
Despite the fact that prehospital stroke recognition scales are
widely used in clinical practice, there has been little effort to sys-
tematically identify and review the evidence pertaining to their
accuracy. Two non-Cochrane systematic reviews with objectives
similar to ours have been published (Brandler 2014; Rudd 2016).
The first review, Brandler 2014, included only studies in which the
scales were used by paramedics, in agreement with the usual prac-
tice in the USA emergency medical services (EMS). The authors
noted the heterogeneity in test accuracy estimates and concluded
that “LAPSS and CPSS had similar diagnostic capabilities” (p. 1).
This was questioned by the authors of the second review, Rudd
2016, which had a broader scope and concluded that “Available
data do not allow a strong recommendation to be made about the
superiority of a stroke recognition instrument.” (p. 1). Given the
contradicting outcomes from these two investigations, we decided
to review the evidence pertaining to the absolute and relative ac-
curacy of prehospital stroke recognition scales using well-defined
inclusion criteria and established Cochrane Review methods, in
order to make recommendations for future research and, if appro-
priate, for clinical practice.
O B J E C T I V E S
To systematically identify and review the evidence pertaining to
the test accuracy of validated stroke recognition scales used in
a prehospital or emergency room (ER) setting to screen people
suspected of having stroke.
Secondary objectives
To investigate the effect of potential sources of heterogeneity on
test accuracy estimates.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered all primary test accuracy studies if they evaluated
a stroke recognition scale (index test) used in a prehospital or ER
setting, against a final diagnosis of stroke/TIA. We included only
those studies reporting sufficient data to determine test accuracy
parameters (2 × 2 table). We included retrospective studies us-
ing stroke and EMS registry data, if the scales had been applied
directly, face-to-face, to eligible patients. We excluded studies in
which the scales were applied to patient records rather than to ac-
tual patients. We also excluded studies that enrolled only screen-
positive patients.
Participants
We defined the target population as non-comatose, non-trauma
patients suspected of stroke, with symptom duration under 24
hours at the time of presentation. Participants had to be over 18
years of age as this is a criterion for thrombolytic use. We included
studies that had a subpopulation of people with previous history
of stroke. The stroke recognition scales had to be applied in a
prehospital or emergency setting.
We defined comatose patients as people who presented in the field
with a Glasgow Coma Scale (GCS) score less than 8 and, there-
fore, required intubation and life-saving airway management. We
included studies on people with a depressed level of conscious-
ness who were protecting their airway, as their exam was not con-
founded by medications used for the induction and maintenance
of an artificial airway.
Index tests
The Index tests were prehospital scales for the determination of
whether the person was having stroke or not. We included all such
scales if they were evaluated in eligible studies. The index tests
could have been administered by a paramedic, an emergencymed-
ical responder, a nurse, an emergency physician or a GP. There
were no limitations on the amount of training the scale adminis-
trator had received with the particular stroke scale. However, we
acknowledge that differences in knowledge, experience and train-
ing could contribute to heterogeneity in test accuracy results. Here
we used ’prehospital’ as an umbrella term referring to the use of
the scales in any prehospital setting including in the field (i.e.
people attended by the ambulance), the ER or primary care. We
specified setting (prehospital versus ER versus primary care) when
discussing the use of specific scales in the studies.
Target conditions
The target condition was stroke, regardless of its type or severity,
including ischemic stroke, hemorrhagic stroke or TIA.We defined
ischemic stroke as irreversible neurologic damage due to obstruc-
tion of a blood vessel, corresponding to the parenchymal territory
responsible for the neurologic function that was lost. We defined
intracerebral hemorrhage as a stroke due to a bleedwithin the brain
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parenchyma. TIA is, by definition, transient and the neurologic
deficit reverses without any clinical evidence of neuronal damage.
To be included, studies could have used either the tissue-based
definition of TIA (a negative diffusion-weighted imaging study) or
the time-based definition of TIA (resolution of symptoms in less
than 24 hours (but may be diffusion-weighted imaging positive).
Reference standards
There is no single, ’gold standard’ diagnostic test to determine
stroke. Therefore, we used the following criteria to define an ac-
ceptable reference standard.
• The initial inhospital diagnosis of stroke must have been
done by a physician (neurologist, stroke physician, internist,
emergency physician) who performed the history, physical exam
and interpretation of the non-contrast CT head scan and any
other imaging. It could alternatively be done by an internist,
family physician or an emergency physician with the assistance
of a consulting radiologist, neurologist, stroke physician, or a
combination of these, available in person or by telephone.
• The person must have a documented discharge diagnosis of
stroke or ’other’, where ’other’ could have been a neurologic or
non-neurologic diagnosis. ’Other’ could have been any medical
condition that was determined by a physician, where the
symptoms that mimicked stroke were accounted for.
• The person’s chart must have been reviewed by a neurologist
or stroke physician and the final diagnosis signed off by a
neurologist or stroke physician, once the evolution of the person’s
condition had occurred to the point where they were discharged.
For the purpose of the review, we considered a neurologist and a
stroke physician equivalent. Non-neurologic discharge diagnoses
made by non-neurologists were considered valid.
• Every participant who was assessed with the index test by
prehospital staff/emergency responders was then to be assessed
by a neurologist or stroke physician at some point prior to
having a neurologic discharge diagnosis. This applied even to
people with a ’negative’ score on the index test. The path at
which they arrived at a non-stroke diagnosis was beyond the
scope of this review.
Search methods for identification of studies
We searched relevant computerized databases (listed below) from
the earliest year possible to 30 January 2018. We applied no re-
strictions on language of publication.
Electronic searches
We searched the following electronic bibliographic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 1) in the Cochrane Library (searched
30 January 2018; Appendix 1);
• MEDLINE (Ovid) (1946 to 30 January 2018; Appendix 2);
• Embase (Ovid) (1974 to 30 January 2018; Appendix 3);
• Science Citation Index Cited Reference Search for forward
tracking of important articles (up to 13 February 2018).
We developed the MEDLINE search strategy with the help of the
Cochrane Stroke Group Information Specialist and adapted it for
the other databases (Appendix 2).
Searching other resources
We searched the reference lists of all included studies and other
relevant publications to identify additional studies. We contacted
authors of the known prehospital stroke scales and asked them to
provide information regarding unpublished studies.
Data collection and analysis
Selection of studies
Due to the large volume of initial titles produced by our database
searches, we divided the references into two groups. We screened
each title twice independently; ZZ and NH screened half of all
titles, and GW and JF the other half. We retrieved the full texts
of potentially relevant papers and JF and GW assessed their eligi-
bility against the inclusion criteria. We resolved discrepancies by
discussion or arbitration by a third review author (ZZ). We coded
the studies excluded at full-text screening with a particular reason
for exclusion.
Data extraction and management
To collect data from studies, we used a prespecified data extrac-
tion form, which included information on study characteristics,
participant population and relevant outcomes (Appendix 4). Two
review authors (NH and JF) independently extracted the data to
ensure adequate reliability and quality, and a third review author
(ZZ) adjudicated any disagreements. If reported in the paper, we
extracted 2 × 2 data directly (true positives, false positives, true
negatives and false negatives) for each index test. Alternatively, we
reconstructed 2 × 2 tables by entering data on sensitivity, speci-
ficity, total number of participants and the proportion of diseased
participants in the Review Manager 5 diagnostic accuracy calcu-
lator (Review Manager 2014). We sent data requests to study au-
thors before excluding a study due to insufficient data.
Assessment of methodological quality
We assessed the methodologic quality of each study using the
Quality Assessment of Diagnostic Accuracy Studies version 2
(QUADAS-2) tool (Whiting 2011). The tool consists of four do-
mains: patient selection, index test, reference standard, and flow
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and timing. The first three domains are assessed in terms of risk of
bias and concerns regarding applicability, and rated as ’high’, ’low’
or ’unclear’. The fourth domain, flow and timing, is assessed only
in terms of risk of bias using the same rating categories. The tai-
lored version of the tool including a set of operational definitions
is provided in Appendix 5.
We added to the patient selection domain an additional signaling
question to check if data were collected prospectively or retrieved
from EMS and stroke registries. Retrospective data are prone to
selective and incomplete recording, and matching patient records
across different databases is not always possible. Therefore, we
considered all studies using retrospective data collection to be at
high risk of bias. We included only studies that applied the scales
to actual patients and not to patient records, regardless of whether
the patients were enrolled prospectively (prospective design) or
data were retrieved from registries (retrospective design).
In the current review, the index tests were prehospital scales used
to screen people suspected of having stroke at the first point of
contact. The reference standard was a combination of tests per-
formed once the person had already been admitted to hospital.
Therefore, the question “Were the index test results interpreted
without knowledge of the results of the reference standard?” would
always be answered ’Yes’. This question was initially removed from
the checklist, but included again during the editorial process upon
advice from the Diagnostic Test Accuracy Editorial team.
It is unlikely that awareness of the index test results will affect the
final diagnosis of stroke, if made by a neurologist/stroke physician
using the results from imaging and other objective tests. However,
it is possible to affect the diagnosis of TIA, which is based on the
patient’s presenting symptoms and assessment of their resolution
within 24 hours. To capture this, we included in the reference
standard domain a signaling question askingwhether the clinicians
making the final diagnosis were blinded to the results from the
index test. However, the presenting symptoms were both part of
the index test and the reference standard for TIA and, therefore,
complete independence was not possible. Clinicians making the
final diagnosis of TIA will always have access to this information,
regardless of whether the results from the stroke scale are available
to themor not. Therefore, we acknowledge that there could be risk
of incorporation bias even in studies in which stroke adjudicators
were blinded to the index test results.
Two review authors (GW, SY) independently assessed themethod-
ologic quality of the studies and resolved any disagreements
through discussion or arbitration by a third review author (ZZ or
NH). If any of the signaling questions in the domain was rated
’high risk of bias’, the overall domain was also categorized as ’high
risk of bias’.
Statistical analysis and data synthesis
The index tests being reviewed are each made up of a set of criteria
that are individually assessed and then combined to assign each
participant a particular score. All scales use the same positivity
threshold, ’1 or greater’, which indicates that the person may have
been having a stroke. For each index test, we generated a diagnostic
2 × 2 table (true positives, false positives, true negatives and false
negatives) fromwhichwe calculated sensitivity and specificity with
95% confidence intervals (95% CI). We also created forest plots
and receiver operating characteristics (ROC) plots to show the
variation in test accuracy estimates across studies.
When at least four studies evaluating the same index test were con-
ducted in the same setting and reported consistent test accuracy
estimates, we pooled sensitivity and specificity using the bivariate
random-effects method. This method is recommended for studies
using the same positivity threshold; it preserves the two-dimen-
sional nature of the data; accounts for between-study variability
by using a random-effects approach, and allows for the possibility
of a negative correlation that may exist between sensitivity and
specificity across studies (Reitsma 2005). We presented the sum-
mary estimates with a 95% confidence ellipse (i.e. a bivariate CI)
and a 95% prediction region in the summary ROC space.
When only a small number of studies are included in a meta-
analysis, the prediction regions generated by the Review Manager
5 are excessively conservative (Review Manager 2014). They may
appear inconsistent with the estimated CIs, as they depend on
the number of included studies as well as on the standard errors
and the covariance of the estimated mean logit sensitivity and
specificity. To mitigate this, we followed the practice suggested in
Gurusamy 2015. It recommends that when fewer than 10 studies
are included in a meta-analysis, the number of studies entered into
the Review Manager’s analysis panel should be 10 (rather than
the actual number of pooled studies). According to the authors,
this provides a better approximation of the prediction region than
using the actual (smaller) number of studies.
We calculated positive and negative likelihood ratios from the
summary sensitivity and specificity, and plotted the results from
comparative studies in the ROC plane to illustrate the relative
accuracy of the tests. All statistical analyses were carried out using
the analysis functions of Review Manager 5 (Review Manager
2014) andSTATAstatistical software version15 (StataCorp 2011).
Investigations of heterogeneity
In the protocol, we listed the following variables as potential con-
tributors to between-study variation in test accuracy estimates:
• participant demographics (e.g. age, gender);
• proportion of different types of stroke (ischemic,
hemorrhagic or TIA);
• level of training;
• methodologic quality of included studies.
While working on the review, we identified additional potential
sources of variation, the most important of which were:
• different triggers for applying the tool (prespecified criteria
versus general suspicion of stroke);
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• different procedures to obtain test scores, when more than
one stroke scale was performed (e.g. consecutive application of
both scales versus deriving the score of the simpler scale from the
more complex scale);
• differences in the reference standard (e.g. hospital discharge
diagnosis versus independent panel of clinicians).
Statistical investigation of the influence of the above sources of
heterogeneity was not feasible, because of the small number of
studies per test conducted in the same setting. Instead, we con-
ducted a visual inspection of the ROC and forest plots, and pro-
vided a narrative description of the observed heterogeneity.
Sensitivity analyses
The small number of studies included in the meta-analyses pre-
cluded quantitative sensitivity analysis based on the methodologic
quality of included studies. However, when reporting the results,
we considered the methodologic quality of studies evaluating spe-
cific tests and highlighted the results reported by better-quality
studies.
Assessment of reporting bias
Following the recommendations of theCochraneHandbook for Sys-
tematic Reviews of Diagnostic Test Accuracy, we did not investigate
publication bias because of the low power of the recommended
test for funnel plot asymmetry, when there is heterogeneity in the
diagnostic odds ratios and, more generally, because of the limited
research in this area (Macaskill 2010). However, publication bias
might be present and might affect the results from the review. In
order to mitigate this, we conducted comprehensive searches of
the published literature and contacted experts in the field to iden-
tify any additional or unpublished studies. We also interpreted our
results with caution, acknowledging the possibility of publication
bias.
R E S U L T S
Results of the search
Figure 1 illustrates the selection process and Appendix 6 shows the
number of records per database. From the initial electronic searches
conducted in January 2015, we identified 8481 unique references.
After screening titles and abstracts, we selected 162publications for
full-text assessment. Of those, we excluded 71 conference abstracts
that did not report sufficient data and for which there were no full-
text articles or additional data. Two review authors (JF, GWor SY)
independently assessed the eligibility of the remaining 91 titles
and selected 19 studies for inclusion in the review.We last updated
the searches on 30 January 2018 and identified 3526 additional
unique references.We screened 33 at full-text level and considered
four of them to be inclusions. We also searched the reference lists
of all included studies and other relevant publications, but found
no additional inclusions. The final number of studies included in
the review was 23.
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Figure 1. Study flow diagram. ER: emergency room; LAPSS: Los Angeles Prehospital Stroke Scale;
ROSIER: Recognition of Stroke in the Emergency Room.
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Characteristics of the included studies
The characteristics of the included studies are summarized in
Table 2, Table 3, and Table 4. Twenty-two studies were journal
articles and one was a conference abstract (Kim 2017). They were
published between 2000 and 2017. Five studies were conducted
in China (Chen 2013; Ding 2009; Jiang 2014; Mingfeng 2012;
Mingfeng 2017); five in the USA (English 2018; Frendl 2009;
Kidwell 2000; Ramanujam 2008; Studnek 2013); four in the UK
(Fothergill 2013; Jackson 2008; Nor 2005; Whiteley 2011); two
each in Australia (Bray 2005a; Bray 2010); Sweden (Andsberg
2017; Berglund 2014); and the Republic of Korea (Kim 2017; Lee
2015); and one each in Belgium (Bergs 2010), Canada (Chenkin
2009), and Italy (Vanni 2011).
Twenty-one studies were published in English, one in Korean (Lee
2015), and one in Chinese (Ding 2009). The data extraction and
methodologic quality assessment of the two non-English language
studies were done by stroke neurologists fluent in the respective
language: the translation from Chinese was done by a member
of our team (SY); and the translation from Korean was done by
Dr Sang Min Sung from the Pusan National University Hospital
in South Korea. Additional data or answers to specific queries, or
both, were very kindly provided by the authors of the following
included papers: Berglund 2014, Jiang 2014, and Lee 2015.
The studies evaluated eight prehospital stroke scales:
• CPSS (11 studies; Bergs 2010; Bray 2005a; Bray 2010;
English 2018; Frendl 2009; Kim 2017; Mingfeng 2012;
Mingfeng 2017; Ramanujam 2008; Studnek 2013; Vanni 2011);
• ROSIER (eight studies; Fothergill 2013; Jackson 2008;
Jiang 2014; Lee 2015; Mingfeng 2012; Mingfeng 2017; Nor
2005; Whiteley 2011);
• FAST (five studies; Berglund 2014; Bergs 2010; Fothergill
2013; Lee 2015; Whiteley 2011);
• LAPSS (five studies; Bergs 2010; Bray 2005a; Chen 2013;
Ding 2009; Kidwell 2000);
• MASS (three studies; Bergs 2010; Bray 2005a; Bray 2010);
• OPSST (one study; Chenkin 2009);
• MedPACS (one study; Studnek 2013);
• PreHAST (one study; Andsberg 2017).
Nine of the included studies (39%) evaluated more than one
stroke scale in the same participants (Bergs 2010; Bray 2005a;
Bray 2010; Fothergill 2013;Mingfeng 2012; Mingfeng 2017; Lee
2015; Studnek 2013; Whiteley 2011), and one study compared
CPSS to a panel of blood biomarkers used to identify people with
stroke in the ER (Vanni 2011). All studies obtained the scores di-
rectly, by face-to-face application of the scales to people suspected
of stroke.
Nor 2005 also compared the accuracy of ROSIER with that of
FAST, CPSS and LAPSS, but the scores for the latter three scales
were derived post hoc from neurologist-recorded signs. An ad-
ditional analysis from the same study compared the accuracy of
ROSIER (completed by ER physicians) with that of FAST (com-
pleted by paramedics) in a subgroup of 49 participants. We in-
cluded the data for ROSIER, which was the main focus of the
study, but excluded the two comparative data sets: the first one
because the scores for FAST, CPSS and LAPSS were derived from
patient records, and the second one because it was a post-hoc anal-
ysis of a small convenience sample and the tests were performed
in different setting by different clinicians.
The total number of participants in the included studies was 9230
and ranged from 31 (Bergs 2010) to 1130 (Chen 2013), median
312 (interquartile range (IQR) 154 to 554). The prevalence of
the target condition (stroke and TIA) ranged from 16% (Ding
2009) to 92% (Jackson 2008), mean 54% (standard deviation
(SD) 20%). The index tests were used in an ER setting in six
studies (Jackson 2008; Jiang 2014; Lee 2015; Nor 2005; Vanni
2011; Whiteley 2011); in three of them they were applied by ER
physicians, in two by ER physicians or nurses, and by nurses in
one study. The rest of the studies were conducted in a prehospital
setting and the scales were applied by paramedics, with the ex-
ception of Ding 2009 and Mingfeng 2012 (ER physicians as part
of an ambulance crew), Andsberg 2017 and Bergs 2010 (nurses),
Berglund 2014 (nurses or paramedics), andMingfeng 2017 (GPs).
The amount of training and the trigger for applying the scales also
varied across studies. Some studies applied the stroke recognition
tool to all participants suspected of stroke by the attending clin-
ician (Fothergill 2013; Frendl 2009; Nor 2005; Studnek 2013).
Other studies required the participants to meet specific eligibility
criteria to be tested (Table 2). This most likely led to differences
between study cohorts and contributed to the observed between-
study heterogeneity.
Methodological quality of included studies
Themethodologic quality of the included studies is summarized in
Figure 2 and Figure 3.We considered 12 studies (52%) at high risk
of bias in the patient selection domain: seven because they were
retrospective analyses of stroke registry data (Bray 2010; Chenkin
2009; English 2018; Frendl 2009; Kim 2017; Ramanujam 2008;
Studnek 2013), and five prospective studies that failed to include
all eligible consecutive participants (Bergs 2010; Bray 2005a;Chen
2013; Fothergill 2013; Kidwell 2000). Retrospective studies de-
pend on routinely collected data, which are susceptible to selective
and incomplete recording. For instance, Bray 2010 and Studnek
2013 excluded over 10% of all eligible patient records because
they were missing relevant data. Therefore, we considered all ret-
rospective studies at high risk of selection bias.
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Figure 2. Risk of bias and applicability concerns graph: review authors’ judgments about each domain
presented as percentages across included studies.
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Figure 3. Risk of bias and applicability concerns summary: review authors’ judgments about each domain
for each included study.
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Another potential source of bias in this domain was the failure
to include all people with a negative screen. The reason was that
in some studies participants who tested positive on the scale were
transported to an acute stroke care center, while those with a neg-
ative screen were taken to other hospitals and could not always
be included in the study sample. Such non-consecutive selection
is likely to affect both sensitivity and specificity by missing false
negative and true negative cases. The authors of some papers ac-
knowledged this issue (Chenkin 2009; Ramanujam 2008), but it
is entirely possible that more studies were affected by such non-
consecutive selection.
The retrospective analysis conducted by English 2018 included
only participants identified by the EMS dispatchers as potential
stroke cases. Most likely, this led to a significant proportion of the
true stroke patients and those without stroke, but with relevant
clinical presentation, to be missed. The effect of such selection has
been demonstrated by Berglund and colleagues (Berglund 2014);
in their study, EMS dispatchers missed about 30% of the people
with stroke/TIA. In addition, we had applicability concerns about
the selection of participants in one study, as 41% of the included
participants were assessed more than 24 hours after the onset of
symptoms (Jiang 2014).
All studies used a prespecified positivity threshold for the index
tests and, as the stroke scales were always performed before the ref-
erence standard, the clinician administering the test was unaware
of the reference standard results. We could not determine the risk
of bias in the reference standard domain in 14 studies (61%), as
they failed to report sufficient detail. The reference standard was
hospital discharge diagnosis with no information on the actual
tests and procedures, and the blinding of the clinicians to the re-
sults from the index tests. We noted applicability concerns in the
reference standard domain for one study that excluded TIA from
the target condition (Vanni 2011).
For 16 studies (70%), we could not exclude the possibility of bias
in the flow and timing domain. Some of the studies failed to report
the time to diagnosis (within 14 days of presentation or longer),
whether all participants received (the same) reference standard, or
whether they included all participants in the analysis. Also, one
study excluded 7% of the participants and was rated as high risk
of bias (Lee 2015).
With regards to comparative accuracy, not included in the
Methodological Quality diagrams, we identified two main issues.
First, only a few studies reported the statistical significance of their
results; even when they did, they did not report whether the study
was adequately powered to detect clinically meaningful differences
in the accuracy of the compared tests. Second, in the index test
domain, one potential source of bias and applicability concerned
themethod by which the scores of individual tests were derived. In
the case of ’nested tests’, that is where one scale contained all items
of the other scales, such as CPSS and LAPSS nested in MedPACS,
the scores for the nested scales were derived from the more com-
plex one (Bray 2005a; Bray 2010; Fothergill 2013; Studnek 2013).
Other studies applied the tests individually, but by the same test
administrator and no random order of application was reported
(Lee 2015; Mingfeng 2012; Whiteley 2011). In the remaining
study, all compared tests (CPSS, FAST, LAPSS and MASS) were
combined in a 10-item questionnaire completed by the attending
EMS nurses (Bergs 2010). In theory, these different methods of
application could lead to biased results and variability in the per-
formance of the scales.
Findings
Face Arm Speech Test (FAST)
Five studies evaluated the FAST tool (Berglund 2014; Bergs 2010;
Fothergill 2013; Lee 2015; Whiteley 2011). The total number
of participants was 1894 and ranged from 31 to 900, median
312. The mean prevalence of stroke/TIA was 56% (SD 12%) and
ranged from 36% to 69%. The proportion of TIA in people with
the target condition was also variable and ranged from 5% (Bergs
2010) to 27% (Berglund 2014), suggesting different spectrum of
included participants. This could be explained, at least partly, with
differences in the inclusion criteria (e.g. Berglund 2014 included
people with symptom onset less than six hours; Bergs 2010 kept
the inclusion criteria broad to avoid missing cases).
All studies had prospective design, but we considered two of them
at high risk of selection bias (Bergs 2010; Fothergill 2013), as they
failed to include all eligible consecutive participants. We deter-
mined the risk of bias in the flow and timing domain to be high
for Lee 2015, as they excluded from the analysis 7% of all partic-
ipants due to incomplete records; and for Bergs 2010, we could
not fully assess the risk of bias in the reference standard, and flow
and timing domains.
Three studies evaluated the accuracy of FAST in a prehospital
setting with the test being performed by paramedics or nurses
(Berglund 2014; Bergs 2010; Fothergill 2013). The reported sen-
sitivities were 0.64 (Berglund 2014), 0.95 (Bergs 2010), and 0.97
(Fothergill 2013), and the reported specificities 0.75 (Berglund
2014), 0.33 (Bergs 2010), and 0.13 (Fothergill 2013). This sug-
gests potential presence of a threshold effect, which could be re-
lated to differences in selection criteria, as all three studies used
the same positivity threshold (’1 or greater’).
In the two studies conducted in the ER, the test was administered
by ERphysicians or ERphysicians and nurses (Lee 2015;Whiteley
2011). The reported sensitivities were 0.86 (Lee 2015) and 0.81
(Whiteley 2011), and the specificities were 0.92 (Lee 2015) and
0.39 (Whiteley 2011) (Figure 4; Figure 5). We could not find an
obvious explanation for the large difference in specificities, but
noted that the two cohorts differed in important aspects, such as
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prevalence of the target condition (36% (Lee 2015) versus 69%
(Whiteley 2011)) and mean age (60 years (Lee 2015) versus 72
years (Whiteley 2011)).
Figure 4. Forest plot of 2 Face Arm Speech Time (FAST).
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Figure 5. Summary receiver operating characteristics plot of 2 Face Arm Speech Time (FAST). ER:
emergency room.
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Los Angeles Prehospital Stroke Scale (LAPSS)
Five studies evaluated LAPSS (Bergs 2010; Bray 2005a; Chen
2013; Ding 2009; Kidwell 2000). The total number of included
participantswas 1794,withmedian206 and range 31 to1130.The
mean prevalence of stroke/TIA was 51% (SD 33%) and ranged
from 16% to 88%. All studies had prospective design but, with
the exception of Ding 2009, were at high risk of selection bias
because of non-consecutive sampling. We could not determine
the risk of bias in the reference standard domain for three studies
(Bergs 2010; Bray 2005a; Ding 2009), and considered all studies
at unclear risk of bias in the flow and timing domain.
All studies used the index test in a prehospital setting, performed
by paramedics in three studies (Bray 2005a; Chen 2013; Kidwell
2000), by emergency nurses in one (Bergs 2010), and by ER physi-
cians in one (Ding 2009). The sensitivity of LAPSS ranged from
0.74 to 0.92 and specificity from 0.83 to 0.97 (Figure 6; Figure
7). Kidwell 2000 and Ding 2009 reported much higher sensitiv-
ity and specificity compared to the other three studies (sensitivity:
0.91 to 0.92 (Ding 2009; Kidwell 2000) versus 0.74 to 0.78 (other
three studies), and specificity: 0.96 to 0.97 (Ding 2009; Kidwell
2000) versus 0.83 to 0.90 (other three studies)).
Figure 6. Forest plot of 3 Los Angeles Prehospital Stroke Scale (LAPSS).
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Figure 7. Summary receiver operating characteristics plot of 3 Los Angeles Prehospital Stroke Scale
(LAPSS).
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One possible explanation of these differences was the level of train-
ing and expertise in the two groups of studies. Ding 2009 did
not report training, but in this study ER physicians (as part of
an ambulance crew) used the test, so we can assume much higher
level of expertise compared to even trained paramedics. In Kidwell
2000, the paramedics received extensive training on stroke and
the use of LAPSS, including video vignettes of people with stroke
and stroke mimics. They also had to pass an exam which, if failed,
was followed by further training. The test administrators in the
other three studies included nurses and paramedics with far less
intensive training (Table 4).
The two groups of studies differed in other important ways, which
may also have contributed to the observed differences in the re-
ported accuracy estimates. The prevalence of stroke/TIA in Ding
2009 and Kidwell 2000 was much lower (16% to 17% (Ding
2009; Kidwell 2000) versus 61% to 88% (in other three studies)),
and the proportion of eligible participants out of all emergency
runs was much higher (16% to 34% (Ding 2009; Kidwell 2000)
versus 2.1% to 7.6% (in other three studies). Also, in comparison
to the other three studies, the cohorts in Ding 2009 and Kidwell
2000 were much younger (mean age: 58 to 63 years (Ding 2009;
Kidwell 2000) versus 72 to 77 years (other three studies)), and
the proportion of women was higher (48% (Ding 2009; Kidwell
2000) versus 39% (Bergs 2010; Chen 2013 (Bray 2005a did not
report sex distribution))).
The authors of Chen 2013 tried to explain the difference between
their study and that of Kidwell 2000 by pointing to differences
in study populations, level of training, and different EMS systems
in the USA and China. However, Ding 2009 was also conducted
in China, suggesting that the differences in the healthcare systems
might have had less impact than other factors, such as training and
selection of participants.
As the studies reported relatively consistent sensitivity and speci-
ficity estimates, we decided to pool the results of all five stud-
ies. They applied the same positivity threshold (’1 or greater’), so
we used the random-effects bivariate model (Reitsma 2005). This
produced amean summary sensitivity 0.83 (95% CI 0.75 to 0.89)
and a mean summary specificity 0.93 (95%CI 0.88 to 0.96), with
fairly wide prediction region reflecting the small number of studies
and the presence of between-study heterogeneity (Figure 7). The
respective mean positive likelihood ratio was 12 (95% CI 6 to 23)
and the mean negative likelihood ratio was 0.18 (95% CI 0.11
to 0.29). However, these estimates should be treated with caution
because of the methodologic limitations noted above.
Melbourne Ambulance Stroke Scale (MASS)
Three studies evaluated the MASS tool in a prehospital setting
(Bray 2005a; Bray 2010; Bergs 2010). The number of participants
included in the studies was 100 (Bray 2005a), 850 (Bray 2010),
and 31 (Bergs 2010); the prevalence of stroke/TIA was 73% (Bray
2005a), 23% (Bray 2010), and 61% (Bergs 2010), and the propor-
tion of eligible participants out of all EMS runs was 2.1% (Bray
2005a), 19.0% (Bray 2010), and 7.6% (Bergs 2010), suggesting
differences in the selection and composition of study cohorts.
The test was administered by nurses in Bergs 2010, and by
paramedics in Bray 2005a and Bray 2010. We considered all three
studies to be at high risk of selection bias and to have ’unclear’ risk
of bias in the reference standard, and flow and timing domains.
The sensitivity ofMASS was 0.90 (Bray 2005a), 0.83 (Bray 2010),
and 0.74 (Bergs 2010), and the specificity was 0.74 (Bray 2005a),
0.86 (Bray 2010), and 0.67 (Bergs 2010) (Figure 8; Figure 9).
Figure 8. Forest plot of 5 Melbourne Ambulance Stroke Scale (MASS).
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Figure 9. Summary receiver operating characteristics plot of 5 Melbourne Ambulance Stroke Scale (MASS;
prehospital setting)
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Cincinnati Prehospital Stroke Scale (CPSS)
Eleven studies evaluated CPSS (Bergs 2010; Bray 2005a; Bray
2010; English 2018; Frendl 2009; Kim 2017; Mingfeng 2012;
Mingfeng 2017; Ramanujam 2008; Studnek 2013; Vanni 2011).
The total number of participants was 4157 with median 268 and
range 31 to 1045. The mean prevalence of stroke/TIA was 56%
(SD 17%) and ranged from 23% to 74%.
We determined the risk of bias in the patient selection domain
to be high in eight studies, of which six had retrospective design
and two because of non-consecutive sampling (Bergs 2010; Bray
2005a). We could not assess the risk of bias in the reference stan-
dard domain in eight studies and in the flow and timing domain
in all but two studies (Mingfeng 2017; Vanni 2011). Also, Vanni
2011 excluded TIA from their definition of target condition and
was at high level of applicability concerns.
One study used the test in the ER and reported sensitivity and
specificity estimates 0.75 and 0.78, respectively (Vanni 2011). In
another study, the test was used by GPs to decide whether to trans-
fer people suspected of stroke from primary care to a hospital with
an acute stroke center (Mingfeng 2017). The reported sensitivity
and specificity of the test were 0.78 and 0.71, respectively.
The remaining nine studies used CPSS administered by ambu-
lance staff in the field: by paramedics in seven studies, nurses in
one study, and ER physicians in one study. However, professional
expertise and training could not explain the differences in study
estimates. The two studies in which the test was applied by nurses
(Bergs 2010), and ER physicians (Mingfeng 2012), reported rel-
atively high estimates of sensitivity (0.95 (Bergs 2010) and 0.89
(Mingfeng 2012)), but variable specificity (0.33 (Bergs 2010) and
0.69 (Mingfeng 2012)). Across studies, the level of between-study
heterogeneity was very high, with sensitivity ranging from 0.44 to
0.95 and specificity from 0.21 to 0.79 (Figure 10; Figure 11).
Figure 10. Forest plot of 1 Cincinnati Prehospital Stroke Scale (CPSS). ER: emergency room; GP: general
practitioner.
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Figure 11. Summary receiver operating characteristics plot of 1 Cincinnati Prehospital Stroke Scale. ER:
emergency room.
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Considering only the seven studies where paramedics performed
the test in a prehospital setting did not result in more consis-
tent study-level estimates (Figure 12). English 2018, Ramanujam
2008, and Studnek 2013 reported accuracy estimates lying very
close to the line of no-discrimination. This indicated that, in these
studies, the test performed no better than a random guess. In con-
trast, Bray 2005a, Bray 2010, and Kim 2017 reported very high
sensitivity (greater than 85%) and specificity higher than in the
other four studies (greater than 50%). We could not find an ob-
vious explanation of this extreme variation and assumed that the
most likely reasons were differences in the inclusion criteria and
the presence of selection bias.
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Figure 12. Summary receiver operating characteristics plot of 1 Cincinnati Prehospital Stroke Scale (CPSS)
including only studies evaluating the test when used by paramedics in a prehospital setting.
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Indeed, all studies conducted in a prehospital setting varied con-
siderably in terms of inclusion criteria and selection of partici-
pants (Table 2). For instance, English 2018 included only people
suspected of stroke by emergency dispatchers, while Frendl 2009
included all people transported by EMS and coded as having pos-
sible stroke or TIA (Table 2). As a consequence, the composition
of study cohorts was very different: the prevalence of stroke/TIA
in this group of studies ranged from 23% to 74%, median 57%
(IQR 41% to 72%); the proportion of TIA in people with the
target condition ranged from 3% to 23%; mean age ranged from
63 to 77 years; the proportion of women ranged from 32% to
56%; and the proportion of eligible participants out of all EMS
runs ranged from 1.3% to 34.5% (Table 3). Studies also differed
in terms of training and reference standard, and most of them
were at high risk of bias in at least one domain (especially selection
bias).
Given the high level of between-study heterogeneity, which could
not be reduced through stratification, and the high risk of bias in
most of the studies, we decided not to pool the results. We con-
sidered three of the studies at low risk of bias (Mingfeng 2012;
Mingfeng 2017; Vanni 2011), and, therefore, more likely to pro-
vide unbiased test accuracy estimates. They were conducted in dif-
ferent countries (China and Italy), different settings (ambulance,
primary care and the ER) and CPSS was used by emergency physi-
cians, GPs, and nurses (Figure 10). As expected, specificity was
higher relative to most of the CPSS studies in which paramedics
used the test in the field. Vanni 2011 andMingfeng 2017 reported
moderate sensitivities (0.75 (Vanni 2011) and 0.78 (Mingfeng
2017)), while the sensitivity in Mingfeng 2012 was relatively high
(0.89). Vanni 2011 excluded TIA from their definition of target
condition: people with positive CPSS screen diagnosed with TIA
were considered false positives rather than true positives, and peo-
ple with negative screen diagnosed with TIA were considered true
negatives instead of false negatives. However, the effect of TIA
exclusion on the reported accuracy estimates remains unclear.
Recognition Of Stroke In the Emergency Room tool
(ROSIER)
Eight studies evaluated theROSIER tool (Fothergill 2013; Jackson
2008; Jiang 2014; Lee 2015; Mingfeng 2012; Mingfeng 2017;
Nor 2005; Whiteley 2011). Across all studies, the total number of
participants was 2895 and ranged from 50 to 714, median 334.
The mean prevalence was 64% (SD 16%) and ranged from 36%
to 92%. Three studies used the test in a prehospital setting: it was
administered by paramedics in Fothergill 2013, by ER physicians
in Mingfeng 2012, and by GPs at a primary healthcare center in
Mingfeng 2017. In the remaining five studies, the setting was the
ER and the test was administered by ER physicians in three studies
and ER physicians or nurses in two studies.
The methodologic quality of the studies was better compared with
the studies evaluating the other tests: we considered Fothergill
2013 at high risk of selection bias because of non-consecutive
sampling; Lee 2015 at high risk of bias in the flow and timing
domain as they excluded 7% of the participants due to incomplete
records (data provided by the authors); we could not fully assess
the risk of bias in the reference standard domain in Jackson 2008;
and for Jiang 2014, there were applicability concerns in the patient
selection domain as 41%of the included participants were assessed
more than 24 hours after the onset of symptoms (Figure 3).
The sensitivity of ROSIER was consistently high and ranged from
0.83 to 0.97, while specificity was extremely heterogeneous and
ranged from 0.18 to 0.93 (Figure 13). This did not change even
when studies conducted in different settings were considered sep-
arately (Figure 14). In two of the five studies conducted in the
ER, the test was applied by ER physicians and nurses (versus ER
physicians only); these studies reported relatively low specificity
estimates. However, in Jackson 2008, ROSIER was used by ER
physicians only and the reported specificity was even lower (Figure
15).
Figure 13. Forest plot of 4 Recognition of Stroke in the Emergency Room (ROSIER). ER: emergency room;
GP: general practitioner.
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Figure 14. Summary receiver operating characteristics plot of 4 Recognition of Stroke in the Emergency
Room (ROSIER). ER: emergency room.
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Figure 15. Summary receiver operating characteristics plot of Recognition of Stroke in the Emergency
Room (ROSIER) including only studies conducted in the emergency room (ER).
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Also, there was some variability in study cohorts, even when analy-
sis was restricted to studies conducted in the ER. Thus, the preva-
lence ranged from 36% to 92%; the proportion of people with
ischemic stroke ranged from 57% to 81%, hemorrhagic stroke
from 5% to 31%, and TIA from 7% to 15%. However, we could
not find obvious determinants of the difference in specificities and
assumed that this was the cumulative effect of a range of factors,
including differences in populations, patient selection, test admin-
istrators and reference standard. In addition, we could not rule
out the presence of bias in some of the included studies.
Given the relatively consistent sensitivity estimates and better
methodologic quality, we decided to pool the results from the five
studies conducted in the ER. Since all studies applied the same
positivity threshold (’1 or greater’) we used the random-effects bi-
variate model (Reitsma 2005). The mean summary sensitivity was
0.88 (95% CI 0.84 to 0.91) and the mean summary specificity
was 0.66 (95% CI 0.37 to 0.86) (Figure 15). The corresponding
mean positive likelihood ratio was 2.58 (95% CI 1.18 to 5.66)
and the mean negative likelihood ratio was 0.18 (95% CI 0.10 to
0.32).
Figure 15 shows the extreme between-study heterogeneity and
the associated statistical uncertainty around the specificity esti-
mate. The between-study heterogeneity in sensitivity was less pro-
nounced but still substantial, with the prediction region (the outer
dashed line) indicating that the sensitivity of similar (interchange-
able) future studies could range approximately from 0.75 to 0.95.
Four of the five studies included in the meta-analysis reported
details about the type of stroke missed by the test (Appendix 8),
with the most frequent diagnosis, as reported by Nor 2005 and
Whiteley 2011, being posterior circulation stroke.
Ontario Prehospital Stroke Screening Tool (OPSST)
This tool should be considered separately from the other stroke
recognition scales, as the exclusion criteria in OPSST were added
“for reducing the unnecessary triage of patients with strokemimics
and patients who are ineligible for fibrinolysis” (Chenkin 2009,
p. 154). Therefore, the intended use of the scale was not only to
identify people with stroke/TIA, but also to assess their suitability
for treatment.
Only one included study evaluatedOPSST and provided diagnos-
tic accuracy data (Chenkin 2009). The study was a retrospective
analysis of consecutive participants with symptoms suggesting an
acute neurologic problem. Paramedics applied the tool in a pre-
hospital setting and the participants were transported to a single
stroke center. Data included 554 participants transported over a
one-year period and identified by reviewing the database of the
Registry of the Canadian Stroke Network.
The prevalence of stroke/TIA in the sample was 57%. Data were
unavailable for participants who were screened negative and were
not taken to the regional stroke center. Themain focus of the study
was the positive predictive value (PPV) of the tool which was 0.90
(95% CI 0.86 to 0.93). The paper reported full 2 × 2 data, but
the authors cautioned that the reported estimates of sensitivity,
specificity, and negative predictive value (NPV) might be biased.
Sensitivity was 0.92 (95% CI 0.88 to 0.94) and specificity 0.86
(95% CI 0.80 to 0.90) (Figure 16).
Figure 16. Forest plot of 6 Ontario Prehospital Stroke Screening Tool (OPSST).
Medic Prehospital Assessment for Code Stroke
(MedPACS)
Only one included study evaluated the MedPACS tool (Studnek
2013). The study was a retrospective analysis of patient records
and included 416 participants. Data were obtained from the EMS
electronic patient care reports and the local stroke registries. People
were included in the study if they received a prehospital MedPACS
screen andwere transported to one of the seven local hospitals. The
test was performed by paramedics and the prevalence of stroke/
TIA in the study sample was 45%. The reported sensitivity was
0.74 (95% CI 0.67 to 0.80) and specificity was 0.33 (95% CI
0.27 to 0.39) (Figure 17).
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Figure 17. Forest plot of 7 Medic Prehospital Assessment for Code Stroke (MedPACS).
PreHospital Ambulance Stroke Test (PreHAST)
One pilot study, with 69 participants, evaluated the accuracy of
PreHAST(Andsberg 2017). This prehospital stroke scale was de-
signed to combine stroke identification and severity assessment,
and to be used by ambulance staff in the field. The study was
of good methodologic quality. It had a prospective design and
included unselected participants (greater than 18 years old) sus-
pected of stroke. The test was performed by ambulance nurses who
received extensive training in using the tool. Two stroke neurol-
ogists, blinded to the PreHAST results, independently made the
final diagnosis, using all available information including history,
clinical and imaging results.
Of the 78 participants assessed with the PreHAST tool, nine were
excluded: five did not give informed consent; it was not possible
to perform PreHAST in two due to agitation and an ongoing
epileptic seizure, and two had no symptoms at ambulance arrival.
Using a cutoff of ’1 or greater’ to identify people with stroke/TIA
produced sensitivity estimate of 1.00 (95% CI 0.87 to 1.00) and
a specificity estimate of 0.40 (95% CI 0.25 to 0.56) (Figure 18).
Higher thresholds resulted in better specificity but lower sensitivity
(e.g. using “≥ 2” produced sensitivity 0.81).
Figure 18. Forest plot of 8 PreHospital Ambulance Stroke Test (PreHAST).
Paired test data
In this section, we report the results from studies comparing di-
rectly, in the same participants, two or more prehospital stroke
scales. The small number of studies comparing the same scales
precluded statistical comparison of the summary estimates of sen-
sitivity and specificity through meta-regression. Instead, we tried
to summarize the results by focusing on the statistical significance
of the differences in sensitivities and specificities, as reported in
the individual studies.
FAST versus ROSIER
Three studies compared directly, in the same cohort of partici-
pants, FAST and ROSIER: two in the ER (Lee 2015; Whiteley
2011), and one in a prehospital setting (Fothergill 2013). As Figure
19 shows, there was no obvious difference in the performance
of the two tools. The two studies conducted in the ER reported
the statistical significance of their results: Lee 2015 found no dif-
ference in the area under the curve of the two tools (0.918 for
ROSIER and 0.910 for FAST, P = 0.376), and Whiteley 2011 re-
ported that the differences in both sensitivities and specificities of
the tests were non-significant (sensitivity P = 0.39 and specificity
P = 0.30).
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Figure 19. Summary receiver operating characteristics plot of tests: 1 Face Arm Speech Time (FAST), 5
Recognition of Stroke in the Emergency Room (ROSIER), paired data.
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CPSS versus MASS
Three studies directly comparedMASS and CPSS in a prehospital
setting (Bergs 2010; Bray 2005a; Bray 2010) (Figure 20). In both
Bray 2005a and Bray 2010, the difference in sensitivities was not
statistically significant (P = 0.45 ( Bray 2005a) and P = 0.149 (Bray
2010)), but MASS was more specific than CPSS (P = 0.007 ( Bray
2005a) and P = 0.001 (Bray 2010)). In Bergs 2010, the differences
in sensitivities (0.95 versus 0.74 in favor of CPSS) and specificities
(0.67 versus 0.33 in favor of MASS) were considerable. However,
this was a small study (31 participants) at high risk of selection
bias and there was a significant overlap in the CIs.
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Figure 20. Summary receiver operating characteristics plot of tests: 3 Melbourne Ambulance Stroke Scale
(MASS), 4 Cincinnati Prehospital Stroke Scale (CPSS), paired data.
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CPSS versus LAPSS
Two studies directly compared CPSS and LAPSS (Bergs 2010;
Bray 2005a). Both studies were conducted in a prehospital setting
and in both studies CPSS was more sensitive but less specific than
LAPSS (Figure 21). Neither of the studies reported the statistical
significance of their results, but the CIs around the sensitivity
estimates reported by Bray 2005a were almost non-overlapping:
0.78 (95% CI 0.67 to 0.87) versus 0.95 (95% CI 0.87 to 0.98) in
favor of CPSS, suggesting statistical significance.
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Figure 21. Summary receiver operating characteristics plot of tests: 2 Los Angeles Prehospital Stroke Scale
(LAPSS), 4 Cincinnati Prehospital Stroke Scale (CPSS), paired data.
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FAST versus LAPSS
One small study directly compared FAST andLAPSS (Bergs 2010;
31 participants). It reported that FAST was more sensitive but less
specific than LAPSS (sensitivity: 0.95 (95% CI 0.74 to 1.00) with
FAST versus 0.74 (95% CI 0.49 to 0.91) with LAPSS; specificity:
0.33 (95% CI 0.10 to 0.65) with FAST versus 0.83 (95% CI 0.52
to 0.98) with LAPSS) (Figure 22). However, this was a small study
at high risk of bias and the reported estimates had overlapping
CIs.
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Figure 22. Summary receiver operating characteristics plot of tests: 1 Face Arm Speech Time (FAST), 2
Los Angeles Prehospital Stroke Scale (LAPSS), paired data.
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MASS versus LAPSS
Two studies, both conducted in a prehospital setting, compared
MASS and LAPSS (Bray 2005a; Bergs 2010). The smaller study,
Bergs 2010 (31 participants), reported equal sensitivities (0.74)
but LAPSS was more specific than MASS (0.83 (95% CI 0.52
to 0.98) with LAPSS versus 0.67 (95% CI 0.35 to 0.90) with
MASS). However, the CIs were very wide and almost completely
overlapping. In Bray 2005a (100 participants), MASS was more
sensitive than LAPSS (P = 0.008), but the difference in specificities
was not statistically significant (P = 0.25) (Figure 23).
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Figure 23. Summary receiver operating characteristics plot of tests: 2 Los Angeles Prehospital Stroke Scale
(LAPSS), 3 Melbourne Ambulance Stroke Scale (MASS), paired data.
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CPSS versus FAST
Only Bergs 2010 (31 participants) reported data on the compari-
son of FAST and CPSS. The estimates of sensitivity and specificity
for both tests were the same (sensitivity: 0.95; specificity: 0.33)
(Figure 24).
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Figure 24. Summary receiver operating characteristics plot of tests: 1 Face Arm Speech Time (FAST), 4
Cincinnati Prehospital Stroke Scale (CPSS), paired data.
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CPSS versus ROSIER
Two studies directly compared CPSS and ROSIER (Mingfeng
2012: 540 participants; Mingfeng 2017: 468 participants). The
studies were conducted in China by the same research team.
Mingfeng 2012 had emergency physicians in the field use the
scales, whereas Mingfeng 2017 had GPs in primary healthcare
centers use the scales to decide whether people suspected of stroke
should be transferred to a hospital with acute stroke care facilities.
In Mingfeng 2012, the sensitivity of the two scales was equiva-
lent, with almost completely overlapping CIs. In Mingfeng 2017,
ROSIER was more sensitive than CPSS, but the CIs overlapped
(0.83 (95% CI 0.79 to 0.87) with ROSIER versus 0.78 (95% CI
0.73 to 0.82) with CPSS). In terms of specificity, ROSIER was
more specific in both studies: in Mingfeng 2012 the difference
appeared to be significant as the CIs did not overlap (0.83 (95%
CI 0.77 to 0.89) with ROSIER versus 0.69 (95% CI 0.61 to 0.76)
with CPSS). In Mingfeng 2017, the difference in specificities was
less pronounced and the CIs overlapped (Figure 25).
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Figure 25. Summary receiver operating characteristics plot of tests: 1 Cincinnati Prehospital Stroke Scale
(CPSS), 4 Recognition of Stroke in the Emergency Room (ROSIER).
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The authors of the studies reported that ROSIER was superior to
CPSS both in terms of sensitivity and specificity, but that there
was no difference in the “positivity rate” of the two tests. However,
they did not report the statistical significance of these results and
we were unable to clarify what they meant by “positivity rate”.
CPSS versus MedPACS
The retrospective analysis performed by Studnek 2013 (416 par-
ticipants) reported slightly higher sensitivity, but lower specificity
for CPSS compared with MedPACS (sensitivity: 0.79 with CPSS
versus 0.74 with MedPACS; specificity: 0.24 with CPSS versus
0.33 with MedPACS) (Figure 26). Both differences, in sensitivi-
ties and specificities, were statistically significant when compared
using the McNemar’s test (sensitivity: 0.048 (95% CI 0.009 to
0.088), P = 0.011; specificity: 0.086 (95% CI 0.042 to 0.131), P
< 0.001).
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Figure 26. Summary receiver operating characteristics plot of tests: 1 Cincinnati Prehospital Stroke Scale
(CPSS), 7 Medic Prehospital Assessment for Code Stroke (MedPACS).
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Summary of results for which statistical significance could
be determined
We made the following observations considering only the results
for which the statistical significance was reported or could be de-
termined from the non-overlapping CIs of the accuracy estimates.
In the ER:
• ROSIER versus FAST: there was no statistically significant
difference in sensitivities and specificities (Lee 2015; Whiteley
2011).
In the field:
• CPSS versus MASS: there was no statistically significant
difference in sensitivities, but MASS was more specific (Bray
2005a; Bray 2010);
• CPSS versus ROSIER: the specificity of ROSIER was
higher (the result for sensitivity was uncertain) (Mingfeng 2012);
• CPSS versus LAPSS: the difference in sensitivities was
statistically significant in favor of CPSS (the difference in
specificities was uncertain) (Bray 2005a);
• CPSS versus MedPACS: both the differences in sensitivity
and specificity were statistically significant, with CPSS being
more sensitive but less specific (Studnek 2013);
• MASS versus LAPSS: the difference in sensitivities was
statistically significant in favor of MASS, but there was no
statistically significant difference in specificities (Bray 2005a).
We summarized the above results in Table 5 and Figure 27. These
results should be treated with caution as none of the studies re-
ported whether they had the statistical power to detect clini-
callymeaningful differences in sensitivity and specificity estimates.
Also, many of the studies were at high or unclear risk of bias in
at least one of the QUADAS-2 domains and the compared scales
were not applied independently with blinding to the results of the
comparator.
Figure 27. Summary diagram of the results of studies comparing directly (in the same cohort of
participants) two or more scales and reporting the statistical significance of their results. The number next to
the arrows indicates the number of studies comparing the tests. CPSS: Cincinnati Prehospital Stroke Scale;
FAST: Face Arm Speech Time; LAPSS: Los Angeles Prehospital Stroke Scale; MASS: Melbourne Ambulance
Stroke Scale; MedPACS: Medic Prehospital Assessment for Code Stroke; ROSIER: Recognition of Stroke in the
Emergency Room.
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Additional comparative data
In Appendix 9, we provide additional data on the comparative ac-
curacy of the scales extracted from Purrucker 2015. We excluded
this study from the main analysis as it did not meet our inclusion
criteria: the test scores were derived by applying the scales to pa-
tient records rather than to actual participants. However, consid-
ering the paucity of comparative data, this study provided unique
informationby comparingmultiple scales in the same participants.
Also, unlike most of the comparative studies discussed earlier, it
included a large cohort of 689 participants and, hence, was more
likely to have the statistical power to detect small differences in the
accuracy estimates. Besides, indirect data collection is less likely
to affect the relative accuracy of the tests, as all scores are derived
using the same method. Therefore, we decided to include these
data as additional evidence, but to report them separately.
The study included consecutive participants attended by EMS
paramedics and emergency physicians using a prospective database
(DATAPEC GmbH, Germany). All participants allocated to the
database category ’suspected central nervous system disorder’ were
included with the exception of 33 cases with missing discharge di-
agnosis. The reference standard was the hospital discharge diagno-
sis reviewed by two of the authors (neurologists), who had access
to all clinical information including imaging. Both neurologists
were blinded to the results of the individual scales.
The paper reported the method of sample size calculation: the
study was powered to ensure maximum marginal error of estimate
of 5% with 95% confidence level of the true value of sensitivity
(or specificity). The statistical significance of the differences in the
accuracy of the individual scales was not reported, but for some of
these comparisons they could be determined as the 95% CIs did
not overlap.
Briefly, CPSS, FAST and ROSIER were the most sensitive and
LAPSS, MASS and MedPACS were the most specific, with many
of the differences in sensitivity and specificity being statistically
significant (non-overlapping CIs) (Appendix 9). In Appendix 10,
we provide an amended version of the comparative accuracy table
including the results from Purrucker 2015. The main differences
between the results from the included studies and Purrucker 2015
could be summarized as follows:
• FAST versus ROSIER: Purrucker 2015 detected difference
in specificities, with ROSIER being more specific;
• CPSS versus MASS: Purrucker 2015 detected difference in
sensitivities, with CPSS being more sensitive;
• MASS versus LAPSS: Purrucker 2015 detected a trend
towards difference in specificities, with LAPSS being more
specific.
The rest of the results were in agreement with those reported in the
included studies. These results are consistent with the expectation
that simpler scales, such as CPSS and FAST, would be more sensi-
tive but less specific than more complex scales with eligibility cri-
teria intended to identify stroke mimics. One possible explanation
of the discrepancies in the results reported by the included studies
and Purrucker 2015 was that the latter had more statistical power
to detect small differences in sensitivity and specificity estimates
(of the included studies only Bray 2010 had a larger sample size,
850 participants). However, this could not explain the discrepan-
cies for CPSS versus MASS, as one of the included studies was
Bray 2010.
D I S C U S S I O N
Summary of main results
We systematically identified and reviewed studies reporting on the
accuracy of prehospital stroke recognition scales. The scales had to
be applied to actual people suspected of stroke, to identify those
with a final diagnosis of stroke or TIA. Twenty-three studies con-
ducted innine different countries and reporting on eight scalesmet
our inclusion criteria. Nine of them compared the accuracy of two
or more scales in the same participants. As an additional source of
evidence, we reported the results from one large study that com-
pared multiple scales by applying them to patient records (hence,
it was excluded from the main analysis; Appendix 9; Appendix
10) (Purrucker 2015). Six studies were conducted in the ER and
one in primary care; in the remaining studies the scales were used
in the field by ambulance crew clinicians. We pooled the results
from five studies evaluating ROSIER in the ER and five studies
evaluating LAPSS in the field.
Limitations of the available evidence
We could summarize the main limitations as follows:
• small number of studies per test (or comparison) conducted
in the same setting;
• high or unclear risk of bias in most studies;
• significant clinical and methodologic differences between
studies;
• large between-study heterogeneity in the reported estimates
of test accuracy.
Paucity of evidence
OnlyCPSS, ROSIER and LAPSSwere evaluated inmore than five
studies in the same setting: CPSS in nine (ambulance), ROSIER in
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five (the ER) and LAPSS in five (ambulance). The rest of the scales
were evaluated in fewer studies at high risk of bias, precluding
pooling of results or statistical investigation of heterogeneity. The
number of direct comparisons was also small: only ROSIER versus
FAST andCPSS versusMASSwere evaluated in three studies each.
All other test pairs were evaluated in one, two or none.
Methodologic quality of studies
Most of the studies had serious methodologic issues, which means
that the reported estimates could be biased and not reflect the
actual performance of the test in the study-specific conditions.
The most important of these limitations concerned the selection
of participants and the quality of the reference standard. More
than half of the studies (12/23) were at high risk of selection bias
because they failed to include all eligible consecutive participants.
The reasons included: retrospective data collection, failure to apply
the tool to all eligible participants and failure to include all people
with a negative screen.
With respect to the reference standard, some of the studies, espe-
cially those using inhospital discharge diagnosis, failed to provide
sufficient information on the tests and procedures, to allow full
assessment of the risk of bias. Also, in the diagnosis of TIA, the in-
dex test and the reference standard are not independent by default,
as the neurologist or stroke physician making the final diagnosis
usually relies on the initial assessment of presenting symptoms.
As Brandler 2014 pointed out, this is particularly the case where
the presenting symptoms have resolved by the time of neurologic
exam and the clinician had to rely on the patient’s record. Differ-
ences in the reference standard and the presence of incorporation
bias may explain, at least to some extent, the substantial variation
in the proportion of TIA (out of all stroke/TIA diagnoses) which,
across studies, ranged from 3% to 27%.
In addition, studies comparing two ormore scales were at high risk
of bias and applicability concerns specific to comparative studies.
The main issue was that the scales were not applied independently
of each other, by test administrators blinded to the results of the
alternative scale. Also, many of the studies failed to report the sta-
tistical and clinical significance of their results, and none reported
whether the study had the statistical power to detect such differ-
ences.
Sources of heterogeneity
As evident from the forest and ROC plots, there was considerable
between-study heterogeneity in test accuracy estimates, even when
studies conducted in different settings were considered separately.
Due to the small number of studies, we were unable to investigate
statistically the effect of these variables. Instead, we summarized
them in tables and suggested hypotheses based on visual inspection
of the forest and ROC plots. The most important between-study
differences that might have contributed to the observed variation
included differences in study cohorts, qualification and training
of test administrators, and differences in the reference standard.
All studies included people suspected of stroke, but the variation
in study cohorts was considerable:
• the mean age ranged from 58 to 77 years (19 studies);
• the proportion of women ranged from 31% to 59% (18
studies);
• the prevalence of stroke/TIA ranged from 16% (Ding
2009) to 92% (Jackson 2008), mean 54% (SD 20%);
• the proportion of people with ischemic stroke ranged from
44% to 89% (15 studies), hemorrhagic stroke ranged from 4%
to 41% (16 studies) and TIA ranged from 3% to 27% (14
studies) (Table 3); and
• the proportion of participants eligible for assessment with
the evaluated stroke scale, out of all EMS runs, ranged from
1.3% to 34.4% (based on eight studies that reported such data).
In theory, prevalence should not affect sensitivity and specificity if
the spectrum of diseased and non-diseased patients remains con-
sistent. However, large variation in prevalence may reflect under-
lying differences in populations and patient selection likely to af-
fect accuracy (Leeflang 2009). As the above summary shows, study
samples varied considerably not only in terms of prevalence, but
also in terms of important patient characteristics, suggesting dif-
ferences in the spectrum of included participants.
One particularly important source of variation was the eligibility
criteria for applying the scales. These included criteria incorpo-
rated into the scales and additional study-specific criteria. Differ-
ent scales had different eligibility criteria (Table 1), which would
inevitably affect the accuracy of the scale in identifying people
with stroke/TIA and ruling out stroke mimics. Eligibility crite-
ria have been added to scales, such as LAPSS, MASS, MedPACS
and OPSST, to increase specificity by excluding participants with
symptoms most likely to be caused by stroke mimics. Given the
inverse relation between sensitivity and specificity, we can expect
that increasing specificity in this way would result in lower sensi-
tivity, as some of the ineligible participants may in fact have stroke.
Even before making a decision whether or not to apply a stroke
scale, a medical responder needs to decide whether the suspected
condition is likely to be stroke. A range of factors may influence
this decision. We can assume that if stroke is suspected by the
EMS dispatchers, the ambulance crew will more readily consider
stroke in the differential diagnosis and apply the scale. Indeed, in
some studies (e.g. Berglund 2014; Ramanujam 2008), all partic-
ipants suspected of stroke by the EMS dispatchers were included
in the study. Variation in the definition of ’suspected stroke’ is also
likely to contribute to variation in study samples. In some of the
included studies (Table 2), ’suspicion of stroke’ was defined very
loosely and the decision was left to the clinical judgment of the
medical responder. We can assume that in this case, qualification,
training, experience and awareness that one participates in a study
are all likely to affect the decision and cause variation in sample
composition.
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In other studies, the initial eligibility criteria were defined more
tightly, acting as a prior screen that determined whether or not the
stroke scale should be applied. One example of such a criterion
was the time from onset of symptoms: in Berglund 2014 it was six
hours whereas Kidwell 2000 used a 24-hour threshold. Another
example is the rule for dealing with people who were no longer
symptomatic at the time of first contact. Several studies excluded
such people from their cohorts (Andsberg 2017; Bray 2005a;
Bray 2010; Jiang 2014; Kidwell 2000; Mingfeng 2012; Mingfeng
2017; Nor 2005; Vanni 2011; Whiteley 2011), but the rest did
not explicitly define the rule. Such cases might have been dealt
with differently by different responders, especially in studies with
retrospective data collection, thus contributing to the observed
variation in the proportion of people with TIA. Although the
available evidence did not allow us to investigate the impact of
these differences, we can assume that their cumulative effect on
the reported test accuracy estimates has been significant.
Even when used in the same setting, the stroke scales were ad-
ministered by clinicians with different qualifications and training.
For instance, in four of the 16 studies conducted in a prehospital
setting, nurses, nurses or paramedics, and ER physicians adminis-
tered the scales, while paramedics administered them in the rest of
the studies. Training also varied, from a two-hour continuing ed-
ucation lecture about neurologic emergencies (Studnek 2013), to
more intensive instrument-specific training followed by an exam
and additional training (Kidwell 2000). In the same way, there
was variation in the reference standard, with many of the studies
using inhospital discharge diagnosis, while in others an indepen-
dent review by blinded experts was performed (Andsberg 2017;
Chen 2013; Kidwell 2000;Mingfeng 2017; Vanni 2011;Whiteley
2011) (Table 4).
Summary of findings
Considering the above limitations, the results from the review
could be summarized as follows.
Accuracy of the scales in the emergency room
Of the six studies conducted in the ER, one evaluated the accuracy
of CPSS, five evaluated ROSIER, and two (out of the latter five)
compared ROSIER and FAST in the same participants (Figure
28). Across all studies and scales, sensitivity was relatively high,
ranging from0.75 (CPSS, Vanni 2011) to 0.96 (ROSIER, Jackson
2008). In contrast, specificity was extremely variable, ranging from
0.25 (ROSIER, Jackson 2008) to 0.93 (ROSIER, Lee 2015). The
methodologic quality of these studies was better compared with
the studies conducted in the field.
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Figure 28. Summary receiver operating characteristics plot of all studies conducted in the emergency room
(ER). CPSS: Cincinnati Prehospital Stroke Scale; FAST: Face Arm Speech Tim; ROSIER: Recognition of Stroke
in the Emergency Room.
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Pooling the results of the five studies evaluatingROSIERproduced
a mean summary sensitivity of 0.88 (95% CI 0.84 to 0.91) and
a mean summary specificity of 0.66 (95% CI 0.37 to 0.86). The
prediction interval for sensitivity ranged from approximately 0.75
to 0.95. This means that the test, when used in an ER setting,
will miss on average 12% of all people with stroke/TIA, although
this may range from 5% to 25%, depending on the specific con-
ditions. In a cohort of 100 participants of whom 62 have stroke/
TIA (62% mean prevalence across the five studies) the test will
miss on average seven participants with stroke/TIA (ranging from
three to 16). Due to the high level of between-study heterogeneity,
the statistical uncertainty in summary specificity was too extreme
to allow meaningful clinical interpretation. The fact that the test
was performed by ER physicians in three of the studies and ER
physicians or nurses in the other two did not seem to have bearing
on the accuracy of the test (based on visual inspection of the ROC
plot).
Although the study evaluating CPSS was of good methodologic
quality, it did not include TIA in the definition of the target condi-
tion (Vanni 2011) (Figure 3). Therefore, we were unable to com-
pare the accuracy of CPSS (sensitivity 0.75 and specificity 0.78)
to that of FAST and ROSIER. Both studies comparing FAST and
ROSIER in the same participants reported that there was no sta-
tistically significant difference in the area under the curve of the
two tests (Lee 2015), or between their sensitivities and specifici-
ties (Whiteley 2011) (Figure 28). The high sensitivity of ROSIER
could be explained by its scoring system. It contains five ’positive’
items aiming to capture a broad range of stroke/TIA presenta-
tions, and two items intended to increase specificity (“no seizure at
onset” and “blood glucose > 3.5 mmol/L”; both scored ’-1’). The
latter are subtracted from the total score, rather than making the
patient ineligible for assessment (as in the other complex scales).
However, these results should be treated with caution as Purrucker
2015, which was a much larger study, reported that ROSIER was
more specific than FAST (as the CIs of specificity estimates did
not overlap), but probably less sensitive (although the statistical
significance of this result was not reported). Purrucker 2015 ap-
plied the scales to patient records of a mixed prehospital popu-
lation (ambulance and the ER), so this hypothesis needs further
investigation.
Accuracy of the scales in primary care
Only one study, conducted in China, evaluated the accuracy of
ROSIER and CPSS when used by GPs in a primary healthcare
center (Mingfeng 2017). The test was used to decide whether
people suspected of stroke should be transferred to a hospital with
acute stroke care facilities. The study was of good methodologic
quality (Figure 3), and reported that ROSIER was both more
sensitive and more specific than CPSS (Figure 25). However, the
authors did not report the statistical significance of these results.
If we assume that the reported estimates were unbiased and the
prevalence of stroke/TIA was 71%, in the study-specific cohort of
100 patients suspected of stroke, ROSIER will miss 12 (95% CI
9 to 15) out of 71 people with stroke/TIA and will misclassify as
positive 6 (95% CI 4 to 8) out of 29 people without stroke/TIA.
Accuracy of the scales when used by ambulance staff in the
field
Althoughmost of the included studies (16) evaluated the accuracy
of the scales in the field, the evidence for this setting was least
reliable due to the small number of studies per test, high or unclear
risk of bias, and high level of between-study heterogeneity. In this
group, only the five studies evaluating LAPSS reported relatively
consistent accuracy estimates that allowed pooling of results. The
mean summary sensitivity was 0.83 (95% CI 0.75 to 0.89) and
the mean summary specificity was 0.93 (95% CI 0.88 to 0.96).
The prediction region extending down to 0.55 for sensitivity and
0.65 for specificity (Figure 7). This means that in a cohort of 100
people of whom 51 have stroke/TIA (51%mean prevalence across
the five studies), on average the test will miss 9 (and up to 23)
people with stroke/TIA and will misclassify as positive 3 (up to
17) people without stroke/TIA. We considered four of the five
studies at high risk of selection bias and could not establish the
risk of bias in the reference standard or flow and timing domain
(or both) for all five studies. Therefore, we could not be sure that
the summary estimates reflected the actual performance of LAPSS
in this patient population.
The nine studies evaluating CPSS in the field reported extremely
variable accuracy estimates, even after we stratified the results by
test administrator (Figure 12). Since the risk of bias was high or
unclear in most of these studies, we decided that pooling of results
would be inappropriate. However, even if we consider only the
better-quality studies reporting the highest accuracy estimates, the
proportion of people with stroke that will be missed by the scale
is still considerable. For instance, if we assume that the 0.89 (95%
CI 0.85 to 0.92) sensitivity of CPSS reported by Mingfeng 2012
was unbiased, this still means that in the specific study conditions
(China, prehospital, ER physicians) the test will miss between 8%
and 15% of people with stroke/TIA, in the same time misclassi-
fying as positive almost one third of the people without stroke.
The rest of the scales, FAST, MASS, OPSST, MedPACS and Pre-
HAST, were evaluated in a small number of heterogeneous stud-
ies, most of which were at high risk of bias. Therefore, we were
unable to report reliable estimates of their absolute accuracy or to
compare their accuracy indirectly (across studies).
The number of studies comparing the scales in the same partici-
pants was also small and most of them were at high risk of bias or
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had other methodologic issues. The latter included the fact that
only a few studies reported the statistical significance of their re-
sults and none reportedwhether the study had the statistical power
to detect clinically significant differences in sensitivity and speci-
ficity. In summary, CPSS was more sensitive than MedPACS and
LAPSS, but had similar sensitivity to that of MASS; and MASS
was more sensitive than LAPSS. In contrast, MASS, ROSIER and
MedPACSweremore specific thanCPSS; and the difference in the
specificities of MASS and LAPSS was not statistically significant
(Figure 28).
These findings should be considered with caution, as the data re-
ported by Purrucker 2015 question some of the results (Appendix
9; Appendix 10). In particular, this study found that CPSS was
more sensitive but less specific than MASS. This result could not
be explained by lack of statistical power in the initial comparison,
Bray 2010, as the latter study was much larger than Purrucker
2015 (sample size: 850 with Bray 2010 versus 689 with Purrucker
2015).
Despite the limitations of the available evidence, one consistent
finding across all studies conducted in this setting was that CPSS
was more or equally sensitive than the other scales, but has a lower
specificity. This has been demonstrated in studies conducted inde-
pendently from the development team, which provides further re-
assurance that the finding is robust. Theoretically, this makes sense
as the higher sensitivity and lower specificity of CPSS, relative to
the more complex scales, could be explained by the additional el-
igibility criteria in the latter, which increase specificity, but at the
expense of sensitivity (threshold effect). We can expect FAST to
have similar accuracy (high sensitivity and low specificity), as the
two tests are very similar (they only differ in the assessment of
speech, Purrucker 2015), but further evidence is needed to con-
firm (or reject) this hypothesis.
Strengths and weaknesses of the review
In conducting the review, we followed the recommendations of the
CochraneCollaboration.We published a review protocol detailing
the objectives, inclusion and exclusion criteria, and the methods
for conducting the review.We ran comprehensive searches with no
language or publication date restrictions. Our searches identified
all studies included in the previous two reviews (Brandler 2014;
Rudd 2016), plus two non-English language studies (published
in Korean and Chinese) that have not been previously reviewed.
When uncertain, we contacted study authors to clarify the eli-
gibility of a study, or to obtain non-published data for included
studies. Two review authors independently selected studies for in-
clusion, extracted data and assessed the methodologic quality of
the included studies using QUADAS-2, as recommended by the
Cochrane Diagnostic Test Accuracy Group.
However, we should also acknowledge some limitations of the
review. First, despite our efforts, we failed to ascertain the eligibility
of all studies published as conference abstracts only and to obtain
additional data for some of the included studies.
Second, the focus of our review was on the accuracy of the scales
and not their impact on patient outcomes. The main advantage
of early identification of stroke is the opportunity for treatment of
eligible patients with intravenous tPA, and now with thrombec-
tomy. Therefore, the impact of the scales will depend first on the
type of patients with stroke that are missed (false negatives) and,
second, on the proportion of false positives which, if too high,
could burden the emergency services and block resources needed
for patients who actually have stroke. Future studies should be
designed as end-to-end studies (studies that examine the impact
of accuracy on patient outcomes) and include an economic eval-
uation, as such a design is more likely to identify the instruments
that maximize the use of these interventions and lead to better
patient outcomes.
Third, we focused on prehospital stroke scales designed to iden-
tify people with stroke and not to assess its severity or the per-
son’s eligibility for specific interventions. With the advances in
thrombectomy, the assessment of stroke severity in a prehospital
setting is likely to becomemore relevant and instruments combin-
ing recognition and severity assessment will attract interest. We
included only one study that evaluated a ’dual purpose’ scale (Pre-
HAST), but the range of available tools is increasing. For instance,
Purrucker 2015 compared several such instruments and the re-
sults suggested that the repurposed stroke severity scales could be
as sensitive as CPSS and FAST in identifying stroke in the field,
with the added advantage of being able to assess its severity. Well-
designed end-to-end studies comparing alternative triage strate-
gies, including those that make use of the new communication
technologies, are needed to show which one is the most effective
and cost-effective in a specific context.
Our review compared to previous reviews
We identified two systematic reviews, Brandler 2014 and Rudd
2016, with similar objectives to ours.
Brandler 2014, included only studies in which the scales were used
by paramedics or EMTs because “physicians are not present in
most EMS systems in the United States” (p. 2). All but one of the
eight studies included in the review were also included in ours; we
excluded Wojner-Alexandrov 2005 because it did not meet our
inclusion criteria. Four of the included studies evaluated LAPSS;
three evaluated CPSS; two evaluated MASS; and one each evalu-
ated MedPACS, OPSST, ROSIER and FAST. The authors con-
cluded that LAPSS was superior to the other scales, despite the
fact that only a single study compared directly (within the same
patient cohort) LAPSS to other scales (Bray 2005a), and reported
that both CPSS and MASS had higher sensitivity than LAPSS
(0.95 (CPSS) and 0.90 (MASS) versus 0.78 (LAPSS)). Also, two
of the four studies evaluating LAPSS reported sensitivity of 0.78
(Bray 2005a; Chen 2013). The other two studies that reported
higher sensitivities had serious methodologic issues: Kidwell 2000
was at high risk of selection bias because in this study paramedics
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completed LAPSS in only approximately half of all eligible par-
ticipants; the accuracy estimates reported by Wojner-Alexandrov
2005 related to the paramedic’s diagnosis of stroke in unselected
ambulance patients, the majority of whom would not have been
suspected of stroke in the first place.
In our review, five studies evaluated LAPSS: in addition to Bray
2005a, Chen 2013, and Kidwell 2000, we included Bergs 2010,
in which the scales were completed by nurses, and Ding 2009,
in which test administrators were emergency physicians (we ex-
cluded Wojner-Alexandrov 2005 for the above reason). Although
we pooled the results from the five included studies, we could not
be certain that the reported summary estimates were unbiased.
The high risk of bias and between-study variation in test accuracy
means that indirect (between-study) comparison of the scales was
unlikely to produce valid results. Instead, we focused on direct
(within-study) comparisons which, as stated earlier, suggested that
LAPSS was less sensitive than CPSS and MASS, but more specific
thanCPSS, a conclusion very different from thatmade in Brandler
2014.
The second review conducted by Rudd and colleagues included
all studies in which the scales were administered face-to-face by
any prehospital or hospital clinicians to identify adults suspected
of stroke (Rudd 2016). In comparison to our review, they did
not include studies published in languages other than English or
German, but included studies without complete 2 × 2 data, such as
studies that included only screen-positive patients. They included
21 studies (18 papers and three abstracts) evaluating the same
stroke scales as in our review (with the exception of PreHAST).
The authors of the review discussed various sources of bias and
between-study heterogeneity, and concluded that: “Available data
do not allow a strong recommendation to be made about the
superiority of a stroke recognition instrument.” (Rudd 2016, p.1).
While we agree with this general conclusion, we feel that we could
be more specific. We included six studies (two published in Chi-
nese and Korean, and four published in 2017) that were not in-
cluded in Rudd 2016. We pooled the results for two scales: we
obtained setting-specific summary sensitivity for ROSIER based
on five studies of better methodologic quality; and summary sensi-
tivity and specificity for LAPSS which, unfortunately, were based
on studies at high risk of bias. In addition, by focusing on com-
parative studies, we were able to arrive at more specific conclu-
sions about the relative accuracy of the scales that agree with what
would be theoretically expected, considering the tradeoff between
sensitivity and specificity.
Applicability of findings to the review question
Our findings were relevant to the review question we tried to
answer.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The primary goal of a prehospital stroke scale is to identify all
people with stroke or transient ischemic attack (TIA), so they
can be transported to hospital and undergo diagnostic assessment
without delay. Some of these people will experience irreversible
brain damage if they do not receive treatment in the first few hours
of the onset of symptoms. We do not want to miss any people
with stroke, even at the expense of some reasonable overcapturing
of stroke mimickers. Therefore, in terms of accuracy, we consider
sensitivity the prime metric for determining a ’superior’ stroke
scale.
Our findings suggest that in the fieldCincinnati Prehospital Stroke
Scale (CPSS) had consistently the highest sensitivity, but was less
specific than most of the scales. Unfortunately, the high risk of
bias and extreme between-study heterogeneity did not allow us to
obtain summary estimates of the absolute accuracy of CPSS. Also,
further evidence is needed to determine whether alternative scales
that might have comparable sensitivity but higher specificity, such
as Melbourne Ambulance Stroke Scale (MASS) and Recognition
of Stroke in the Emergency Room (ROSIER), should be used
instead, to achieve better overall accuracy.
The reviewed evidence suggests that in the emergency room (ER),
ROSIER should be the test of choice, as it was evaluated in the
largest number of studies, its sensitivity was consistently high and
had similar accuracy to Face Arm Speech Time (FAST), the only
alternative scale it was directly compared against in this setting.
When used in the ER, ROSIER will miss on average 12% (range
5% to 25%) of all people with stroke/TIA. This means that in a
cohort of 100 people of whom 62 have stroke/TIA the test will
miss on average seven people with stroke/TIA (range three to 16).
We are unable to provide an estimate of the summary specificity,
as the study-level results were too heterogeneous.
Because of the small number of studies per test per setting, high
risk of bias, substantial differences in study characteristics and large
between-study heterogeneity in the reported accuracy estimates,
these findings should be treated with caution. They are only provi-
sional hypotheses that need further verification in better-designed
studies.
Implications for research
Future studies should try to address some of the methodologic is-
sues identified here. Given the significant variation in clinical prac-
tice and populations, indirect comparisons are unlikely to produce
valid results. Also, the narrow focus on test accuracy does not al-
low more important questions to be answered, such as the impact
of alternative triage strategies on patient outcomes and their cost
effectiveness. Scales that have the same accuracy may have very
different clinical effectiveness if they identify a different propor-
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tion of the patients that would benefit from early treatment (as
opposed to those who would not, e.g. people with TIA).
Unfortunately, the impact of different triage protocols on patient
outcomes is not a simple question: first, because it is difficult to
predict who will benefit from early identification; and, second, be-
cause subsequent clinical decisions, such as diagnostic assessment
and treatment, will also contribute to the final outcome. Such
questions could not be answered by diagnostic accuracy studies
and, therefore, future research should be designed as end-to-end
studies. They should incorporate health economic evaluations and
compare directly alternative triage strategies, including alternative
stroke scales intended for the same use in a specific setting; stroke
recognition scales and repurposed stroke severity scales; or the use
of new communication technologies, to determine which one is
the most effective and cost-effective in a specific context.
Researchers should try to maximize the external validity of such
studies, bearing in mind that the introduction of extra elements
(e.g. intensive training) that will not be implemented in practice,
may jeopardize the applicability of results. Care should be taken
to include all consecutive patients suspected of stroke, including
those with a negative screen. The trigger for applying the test (e.g.
clinical suspicion versus prespecified criteria) is also likely to affect
the estimated accuracy of the scales and future studies should try
to investigate this in order to identify the most effective strategy.
It is unclear if using different methods to obtain scores when com-
paring two or more scales (as described earlier) has bearing on
the accuracy of the scales. If randomizing people to assessment
with alternative instruments is not feasible, the impact of using
one or another method should be considered when collecting data
(e.g. through a qualitative investigation) and in interpreting the
results. Using the hospital discharge diagnosis as a reference stan-
dard could introduce bias and contribute to heterogeneity. There-
fore, a chart review by independent neurologists/stroke physicians
using all available information should be preferred.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andsberg 2017
Study characteristics
Patient sampling Pilot study conducted in an ambulance district staffed by 43 ambulance nurses for 24-hour service
for the community hospital of Hässleholm, Sweden
Sampling: during the study period (9 January to 23 May 2014) neurologic assessment with Pre-
HAST was done if stroke was suspected in conscious people > 18 years of age
Patient characteristics and set-
ting
Inclusion and exclusion criteria: neurologic assessment with PreHAST was done if stroke was
suspected, defined as sudden onset of focal neurologic symptoms/signs, in conscious people > 18
years of age
Participant characteristics: not reported
Index tests Index test: PreHAST (score > 0 considered positive)
Test administrator: ambulance nurses
Training: before the study period all ambulance nurses received a 4-hour education program, cover-
ing basic stroke knowledge and assessment and grading of stroke symptoms according to PreHAST.
The education program included practical PreHAST training in pairs, where each ambulance nurse
performed the PreHAST items under supervision and proper execution. During the study an in-
struction video for PreHAST was available on YouTube
Target condition and reference
standard(s)
Target condition: stroke/TIA (people with TIA included in the study were required to have ongoing
symptoms when evaluated by the ambulance staff; used time-based definition of TIA)
Reference standard: 2 stroke physicians, blinded to the PreHAST scores, independently reviewed
the medical records of the participants, including evaluation of history, and clinical and radiologic
findings. In case of disagreement, a third evaluator adjudicated the final diagnosis
Flow and timing 78 participants were assessed with PreHAST; 9 were excluded (5 informed consent not obtained;
2 PreHAST was not possible to perform due to agitation and ongoing epileptic seizure; 2 did not
have symptoms at ambulance arrival)
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 26/69 (37.7%) participants had stroke/TIA
PreHAST: TP = 26, FP = 26, FN = 0, TN = 17
Notes Non-stroke diagnoses: 8 epilepsy, 7 late effect after stroke, 5 migraine, 3 Bell’s palsy, 3 fatigue,
1 SDH, 1 dementia, 5 vertigo, 3 syncope, 2 infection, 2 delirium, 1 transitory global amnesia, 1
opsoclonus syndrome
Ease of use and time: in the poststudy survey, the ambulance staff reported PreHAST easy to
execute and estimated the test time to be 2-3 minutes
Funding: financed by departmental funds
Methodological quality
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Andsberg 2017 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Andsberg 2017 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Low
Berglund 2014
Study characteristics
Patient sampling Sweden, Stockholm county, for 6 months in 2008
Sampling: people calling the Swedish equivalent of 911 in Sweden, Stockholm county were sampled
(EMCC procedure prior to ambulance assessment: when the nurse at the EMCC suspected stroke
with onset within 6 hours the inclusion criteria were checked. If the criteria were met, the nurse
opened a sealed envelope of the priority level. The FAST test was then an optional tool for the
nurse at the EMCC to use for identifying symptoms of stroke. The nurse was free to include the
participant on her/his own suspicion of stroke. As the study aimed to analyze priority code and
delay, the FAST test was not mandatory for the EMCC as it might have caused a delay)
Almost one-third of the participants in the study were identified and included from the ambulance,
when missed from the EMCC. The ambulance contacted the EMCC to have a code for random-
ization and the priority level. All participants included in the study were tested for FAST by the
ambulance personnel (hence, the sampling considered consecutive; this was confirmed by authors)
Patient characteristics and set-
ting
Inclusion and exclusion criteria: suspected stroke with symptom onset within 6 hours; ages 18-
85 years; previous independence in activities of daily living; and no other acute condition requiring
a priority level 1 (see HASTA study)
Participant characteristics: ages 22-93 years; 55.5% men
Index tests Index test: FAST (prespecified threshold, positive if ≥ 1)
Test administrator: registered specialist nurse and a registered general nurse or an ambulance
educated staff, a paramedic
Training: all personnel at the ambulance companies supplying the Stockholm area with ambulance
transport participated in 1 lecture about stroke and the FAST test, prior to start of the study. The
personnel at the EMCC were also given education of stroke and FAST, adjusted for testing FAST
by telephone, prior to study start. All emergency calls concerning medical issues were connected to
and evaluated by a registered nurse
Target condition and reference
standard(s)
Target condition: stroke or TIA
Reference standard: CT brain scan and in some cases CTA or MRI, neurologic exam, if necessary,
EEG (differential diagnosis), laboratory tests. People with obvious signs of other conditions than
stroke, such as diabetes or alcohol intoxication might not have been evaluated by a CT scan. All
participants received a final diagnosis by a neurologist or stroke specialist
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Berglund 2014 (Continued)
Flow and timing Withdrawals: 39 (4.3%) left at home or deviated from the ER before seeing a doctor, considered as
non-stroke diagnoses
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 472/900 (52%)
FAST: TP = 387; FP = 255; FN = 85; TN = 173
Combined data from EMCC (nurse) and ambulance (paramedic)
Notes Categorization of alternate diagnoses: 472 (52%) stroke/TIA, 166 (18%) neurology, 223 (25%)
non-neurology; 39 (4%) unknown
Funding: declared, provided by the authors as supplementary data.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Berglund 2014 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Low
Bergs 2010
Study characteristics
Patient sampling EMS of University Hospitals Leuven, Belgium, 11 December 2005 to 30 April 2006
Sampling: prospective but not consecutive (only 31/124 eligible patients were included in the
study). Inclusion criteria kept broad to avoid missing cases; nurses asked to complete a questionnaire
(combining all evaluated scales) for every patient transported with relevant neurologic complaints
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: all patients transported with relevant neurologic complaints: an acute neurologic event
without clear origin, altered LOC, convulsions, syncope, headache, symptoms of weakness, dizziness
or decreased well-being, aphasia, visual impairment, weakness in arms and or legs and facial paralysis
Exclusion: ages < 18 years, GCS < 9, transported to alternate hospital, trauma
Participant characteristics: mean age 77 years; 61% men; seizure history not reported
Index tests Index tests: FAST (prespecified threshold, positive if ≥ 1), CPSS (prespecified threshold ≥ 1),
LAPSS, MASS
Test administrator: emergency nurses
Training: all nurses were briefed on purpose of study, stroke scales and guidelines
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: unspecified, diagnosis at ER discharge
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Bergs 2010 (Continued)
Flow and timing Of 132 eligible participants, 70 were transported to the study hospital, but the ambulance nurses
completed the questionnaire only in 31 (39 participants did not have a completed questionnaire by
EMS despite meeting study criteria)
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 19/31 (61.3%)
LAPSS: TP = 14; FP = 2; FN = 5; TN = 10
MASS: TP = 14; FP = 4; FN = 5; TN = 8
FAST: TP = 18; FP = 8; FN = 1; TN = 4
CPSS: TP = 18; FP = 8; FN = 1; TN = 4
Notes Categorization of alternate diagnosis for people who did not have an ischemic stroke: not
reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Prospective design Yes
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
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Bergs 2010 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Bray 2005a
Study characteristics
Patient sampling Box Hill Hospital, Melbourne, Australia, September 2002 to September 2003
Sampling: prospective but not consecutive sampling: 3327/5957 consecutive calls attended by the
study paramedics were transported to the regional university teaching hospital (a single research site)
; 19 patients were excluded due to incomplete diagnosis prior to discharge; only 100/127 eligible
transports had completed MASS forms; of the 27 cases with incomplete forms 10 (37%) were
strokes and 17 (63%) were ’stroke mimics’
Patient characteristics and set-
ting
Inclusion and exclusion criteria: possible stroke based on triage (advanced MPDS) or focal neu-
rologic deficit on initial assessment. Specific inclusion and exclusion criteria not reported
Participant characteristics: not reported
Index tests Index test: LAPSS, CPSS, MASS
Test administrator: paramedics
Training: 1-hour educational session on pathogenesis and management of acute stroke, and in-
struction in assessment and documentation of items used in a prehospital stroke scale
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Bray 2005a (Continued)
Target condition and reference
standard(s)
Target condition: stroke and TIA
Reference standard: standard criteria for diagnosis of stroke or TIA (Warlow 2001); review of
discharge diagnosis
Flow and timing 27 incomplete/no documentation
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 73/100 (73%)
MASS: TP = 66; FP = 7; FN = 7; TN = 20
LAPSS: TP = 57; FP = 4; FN = 16; TN = 23
CPSS: TP = 69; FP = 12; FN = 4; TN = 15
Data recalculated from sensitivity, specificity and likelihood ratio in Table 3 in the paper
Notes Categorization of alternate diagnosis for people who did not have an ischemic stroke:
27 total: 7 cardiac, 5 seizure, 3 hypoglycemia, 3 SDH, 3 fracture, 2 tumor, 1 sepsis, 1 migraine, 1
vertigo, 1 Parkinson disease
Exclusions: 19 people excluded due to incomplete diagnosis; 27 eligible cases were excluded due
to incomplete MASS sheets: 10 (37%) were strokes and 17 (63%) were ’stroke mimics’
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Bray 2005a (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Bray 2010
Study characteristics
Patient sampling Box Hill Hospital, Melbourne, Australia, January to May 2008
Sampling: retrospective, consecutive; 2 groups of people admitted to the study hospital were used
in this study: 1. people transported by EMS with documented MASS assessments of hand grip,
speech and facial weakness; and 2. people with a discharge diagnosis of stroke or TIA included in
the stroke/TIA registry
Patient characteristics and set-
ting
Inclusion and exclusion criteria: conscious but neurologically compromised patients of no obvious
cause such as drug overdose or trauma. If these assessments were positive for stroke, they obtained
the remaining MASS history items and performed a blood sugar level to rule out stroke mimics and
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Bray 2010 (Continued)
suitability for thrombolysis. People whowere unconscious or asymptomatic at the time of paramedic
assessment were excluded
Participant characteristics: not reported
Index tests Index test: MASS, CPSS
Test administrator: paramedics
Training: 1-hour stroke education program and instruction on use of the MASS
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: data were cross-referenced against the hospital stroke/TIA registry (name, date,
gender and age) to determine if the discharge diagnosis was stroke or TIA. For 8 people with stroke
and TIA with no MASS documentation, MASS and CPSS were retrospectively applied based on
the paramedic assessment
Flow and timing 154 participants did not have completed questionnaire; in 8 cases, based on final discharge diagnosis
MASS was calculated retrospectively based on EMS report (not included in our analysis)
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 199/850 (23.4%)
MASS: TP = 166; FP = 92; FN = 33; TN = 559
CPSS: TP = 176; FP = 138; FN = 23; TN = 513
Data recalculated from sensitivity, specificity and likelihood ratio in Table 3
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
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Bray 2010 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Chen 2013
Study characteristics
Patient sampling Beijing Tiantan Hospital, China
Sampling: prospective but non-consecutive as 400/1550 “target stroke” runs did not complete
LAPSS
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Chen 2013 (Continued)
Patient characteristics and set-
ting
Inclusion and exclusion criteria: ages > 18 years, absence of trauma, absence of coma, neurologically
relevant complaint (altered LOC, local neurologic signs, seizure syncope, head pain, weak + dizzy
+ sick)
Participant characteristics: age range 20-101 years, median 72 years; 60.5% men; seizure history
included
Index tests Index test: LAPSS
Test administrator: paramedics
Training: 3 hours’ LAPSS-based stroke training session with 3 experts from study team
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: 2 blinded neurologists reviewed the ER charts, recorded final ER discharge
diagnoses, and verified absence or presence of potential stroke symptoms. The medical documents
and neuroimaging records were reviewed before the final diagnoses were verified
Flow and timing 420 participants did not have questionnaire completed.
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 997/1130 (88.2%)
LAPSS: TP = 782; FP = 13; FN = 215; TN = 120
Notes Categorization of alternate diagnosis for participants who did not have stroke: not reported
Funding:Ministry of Science and Technology and the Ministry of Health of the People’s Republic
of China
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
High Low
DOMAIN 2: Index Test Index tests
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Chen 2013 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
Chenkin 2009
Study characteristics
Patient sampling Sunnybrook Health Sciences Centre, Toronto, Canada; 1 March 2005 to 28 February 2006
Sampling: retrospective analysis of consecutive participants. Consecutive participants transported to
the stroke center by ambulance under the acute stroke protocol over a 1-year period. Participantswere
identified by reviewing the database of the Registry of the Canadian Stroke Network. Paramedics
applied this tool in the field to any person with symptoms suggesting an acute neurologic problem
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Chenkin 2009 (Continued)
Patient characteristics and set-
ting
Inclusion and exclusion criteria: consecutive patients with symptoms suggesting an acute neuro-
logic problem transported to the stroke center by ambulance under the acute stroke protocol over
1-year period
Participant characteristics: mean age 73.7 (SD 13.5) years; 69.1% men; positive screen only
Index tests Index test: OPSST
Test administrator: paramedics
Training: 90-minute training session on stroke screening tool prior to implementation
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: final inhospital diagnosis of acute stroke defined as either ischemic stroke,
ICH or TIA according to the consulting neurologist. No other details provided
Flow and timing Interval between index test and final diagnosis not reported
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 214/554 (39%)
OPSST: TP = 187; FP = 138; FN = 27; TN = 202
Notes Categorization of alternate diagnosis for participants who did not have stroke: not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Chenkin 2009 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Ding 2009
Study characteristics
Patient sampling 3 local hospitals, Yantian District, Shenzhen, China; June 2007 to June 2008
Sampling: prospective consecutive sample; 2035 people with non-traumatic, non-comatose, non-
obstetrics presentation and 327 had acute neurologic symptoms and were included in the study
Patient characteristics and set-
ting
Inclusion and exclusion criteria: non-traumatic, non-comatose, non-obstetrics people with acute
neurologic symptoms (no further details)
Participant characteristics: mean age 58 years; 48% women
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Ding 2009 (Continued)
Index tests Index test: LAPSS
Test administrator: emergency physicians applied LAPSS in a prehospital setting
Training: not reported
Target condition and reference
standard(s)
Target condition: stroke or TIA
Reference standard: final diagnosis made by a specialist group including 1 neurologist, 1 radiologist
and 1 hospital doctor
Flow and timing Unclear if diagnosis was done within 14 days of presentation
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: ischemic stroke = 44.1%, hemorrhagic stroke = 35.6%, TIA = 20.3%
LAPSS: TP = 47, FP = 12, FN = 4, TN = 264
Notes Categorization of alternate diagnosis for participants who did not have stroke: not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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Ding 2009 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
English 2018
Study characteristics
Patient sampling Mayo Clinic Hospital, St. Mary’s Campus Emergency Department, Rochester, MI, USA
Sampling: people identified with potential stroke by emergency dispatchers; 1 January 2014 to 31
December 2015
Patient characteristics and set-
ting
Inclusion criteria: any 1 of: positive CPSS in field; EMS impression of cerebrovascular accident or
TIA; acute stroke pager activation in the ER; or discharge diagnosis of cerebrovascular accident or
TIA
Exclusion criteria: any 1 of: hospital arrival via helicopter; outside hospital transfer; direct admission
without ER evaluation or last known well time > 6 hours
Participant characteristics: mean age: stroke 76.6 (SD 13.5), no stroke 72.1 (SD 14.6); 50% men
Index tests Index test: CPSS
Test administrator: paramedics
Training: 1-hour online module annually on stroke recognition and assessment in the field as part
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English 2018 (Continued)
of their required job training
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: final diagnosis at discharge documented following a review of hospital admis-
sion note and discharge summary
Flow and timing 377 people identified by EMS dispatchers with possible stroke were transported to the clinic; of
these, 185 met inclusion criteria; of the 185 people, 55 were excluded according to the prespecified
exclusion criteria and 5 did not have CPSS documentation; the latter 5 people were included in the
analysis but it was unclear how the CPSS scores for these people were determined
Comparative
Diagnostic test accuracy data Prevalence of stroke: 96/130 (73.8%); 64.5% were ischemic strokes, 20.8% were TIA and 14.6%
were ICH
CPSS: TP = 72, FP = 27, FN = 24, TN = 7
Notes Discharge diagnosis of participants falsely identified as stroke by EMS in the field, number:
9 (26.5%) seizure, 7 (20.6%) infection, 6 (17.6%) encephalopathy, 3 (8.8%) syncope, 2 (5.9%)
migraine, 2 (5.9%) peripheral nerve injury, 2 (5.9%) electrolyte disturbance, 3 (8.8%) other
Funding: none declared
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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English 2018 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
Fothergill 2013
Study characteristics
Patient sampling Royal London Hospital, UK
Sampling: prospective but not consecutive as only people assessed with ROSIER and conveyed
to the Royal London Hospital were included (32 people did not receive ROSIER and were not
included in the study)
Patient characteristics and set-
ting
Inclusion criteria: ages > 18 years presenting with symptoms of stroke
Exclusion criteria: ages < 18 years, not assessed using the ROSIER or transferred to another hospital
Participant characteristics: mean age 65 years, range 20-95 years; 53% men; people with seizure
history included
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Fothergill 2013 (Continued)
Index tests Index test: FAST, ROSIER
Test administrator: paramedics
Training: 1-hour stroke educational program, scenario-based demonstration of ROSIER, 15-
minute educational DVD
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: final diagnosis made by a stroke consultant or other senior medical physician
caring for the person within 72 hours of the person’s admission to hospital. Routine tests used,
including CT and MRI scans, undertaken by the clinical team to confirm whether the person had
a stroke. Final diagnosis was confirmed by a senior stroke consultant
Flow and timing 32 people not assessed by index tests; 17 without reference standard results
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 177/295 (60%)
ROSIER: TP = 171; FP = 97; FN = 6; TN = 21
FAST: TP = 171; FP = 103; FN = 6; TN = 15
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
No
Prospective design Yes
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Fothergill 2013 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Low
Frendl 2009
Study characteristics
Patient sampling Duke University Medical Center, USA
Sampling: retrospective chart review
Patient characteristics and set-
ting
Inclusion and exclusion criteria: all participants transported by EMS and coded as having possible
stroke or TIA. Any people identified by EMS as “unresponsive” were excluded
Participant characteristics: mean age 67 (SD 16) years; 44% men
Index tests Index test: CPSS
Test administrator: paramedics
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Frendl 2009 (Continued)
Training: 1-hour interactive educational presentation on stroke recognition and use of the CPSS
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: participants’ final diagnosis in the hospital stroke registry, which reflects the
results of routine clinical, laboratory and radiographic evaluations
Flow and timing 30 people were excluded from study as they were noted to be “unresponsive”
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 61/154 (40%)
CPSS: TP = 43; FP = 45; FN = 18; TN = 48
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: supported by an American Stroke Association student scholarship award
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
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Frendl 2009 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Jackson 2008
Study characteristics
Patient sampling St James’s Hospital, Newcastle-upon-Tyne, UK
Sampling: prospective, consecutive
Patient characteristics and set-
ting
Inclusion and exclusion criteria: suspected stroke on routine triage
Participant characteristics: mean age 73 years, range 29-41 years; 48% men
Index tests Index test: ROSIER
Test administrator: emergency physicians
Training: none reported
Target condition and reference
standard(s)
Target condition: stroke (TIA not mentioned in the paper)
Reference standard: participants’ records were later followed up to determine accuracy of initial
diagnosis; stroke confirmed on investigation (no further details reported)
Flow and timing Time interval between index test and discharge diagnosis not reported
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Jackson 2008 (Continued)
Comparative
Diagnostic test accuracy data Prevalence of stroke: 46/50 (92%)
ROSIER: TP = 44; FP = 3; FN = 2, TN = 1
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
Unclear
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Jackson 2008 (Continued)
of the results of the index tests?
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Jiang 2014
Study characteristics
Patient sampling Prince of Wales hospital, Chinese University of Hong Kong; 1 June 2011 to 31 December 2011
Sampling: prospective cohort, consecutive participants presenting to ER
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: > 18 years old, presenting to ER with symptoms/signs suggestive of stroke/TIA
Exclusion: trauma brain injury with an external cause, incomplete medical records, direct admission
to ward, SAH, SDH, TIA without symptoms/signs during the assessment
Participant characteristics: mean age in stroke/TIA group 72 (SD 13) years, mean age in stroke
mimics group 69 (SD 14) years; 53.4% men; seizure history: 11 people with seizure history; 295/
715 (41%) participants had an onset time > 24 hours prior to assessment, hence the high concerns
regarding the applicability of results
Index tests Index test: ROSIER
Test administrator: specialist stroke nurses or consultant in emergency medicine
Training: research staff received the specific training by stroke nurse and by a test provided by the
NIHSS website. All the criteria for the scale followed the rules of the NIHSS
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: stroke defined as a focal or global neurologic deficit with symptoms lasting
for 24 hours, or resulting in death within 24 hours, which after investigation was thought to be
due to a vascular cause; TIAs were defined as clinical syndromes characterized by an acute loss of
focal cerebral or monocular function with symptoms lasting < 24 hours and thought to be caused
by inadequate blood supply as a result of thrombosis or embolism. All people suspected of stroke
were reviewed by the stroke team which included 4 stroke nurses and 2 specialist doctors. The final
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diagnoses were made after their assessment and after review of clinical symptoms and the acute
neuroimaging (CT and MRI), and this was used as the reference standard for diagnosis in the study
Flow and timing Cases excluded from analysis: 51 in total of which: 4 incomplete records, 2 not accessible, 45 did
not meet original ROSIER scale criteria (people with SAH, SDH, TIA). Time interval between the
use of the scales and the final diagnosis, mean: 4.96 (SD 0.23) days
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 371/715 (52%)
ROSIER: TP = 323; FP = 202; FN = 48; TN = 142
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
34 spinal neuropathy, 27 dementia, 27 labyrinthitis, 27 sepsis, 24 musculoskeletal, 24 syncope,
21 hypertension, 20 somatization, 18 metabolic, 17 uncertain, 16 brain tumor, 16 peripheral
neuropathy, 14 encephalopathy, 14 numbness, 13 TGA
Additional outcomes: provided by the authors
Funding: Direct Grant for research of the Chinese University of Hong Kong
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low High
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
Kidwell 2000
Study characteristics
Patient sampling UCLA Medical Center, USA
Sampling: prospective but not consecutive as the paramedics completed LAPSS forms on 206/446
people with neurologically relevant symptoms (analysis based on all runs, including those without
completed forms, also reported but not included in the review)
Patient characteristics and set-
ting
Inclusion and exclusion criteria: sole inclusion criterion was transport by a paramedic vehicle
involved in the study during the enrolment period. Target stroke population was non-comatose,
non-trauma people with symptom duration < 24 hours with suspected ischemic stroke, ICH or
TIA if person was still symptomatic at the time of initial paramedic examination. 2-stage LAPSS
screening process:
• stage 1: paramedics were asked to identify all non-comatose, non-trauma people having
neurologic complaints, i.e. people with potential stroke or stroke mimic:
◦ altered LOC,
◦ local neurologic signs,
◦ seizure,
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◦ syncope,
◦ head pain, and
◦ cluster category of weak/dizzy/sick.
Examples of categories that were not neurologically relevant included chest pain, allergic reaction,
abdominal pain, and shortness of breath;
• stage 2: criteria for LAPSS form completion were:
◦ age ≥ 18 years,
◦ neurologically relevant complaint,
◦ absence of coma, and
◦ non-traumatic presentation.
Participant characteristics: mean age 67 years; 52% men
Index tests Index test: LAPSS
Test administrator: paramedics
Training: a brief certification tape was used that consisted of 5 video vignettes of paramedics
performing the LAPSS examination on 3 people with stroke, 1 stroke mimic (alcohol intoxication)
and 1 healthy person. After the LAPSS-based education session, trainees watched the certification
tape and completed the LAPSS exam on each vignette. Certification for use of the LAPSS required
correct completion of the LAPSS exam on all 5 people. If certification was not achieved on the
first trial, paramedics underwent further education in a small group setting focused on typical
exam errors and then repeated the certification exam until all 5 people were correctly identified.
To both reinforce and determine the impact of the training sessions, a 19-item stroke knowledge
test was administered before and after the education session. The test included 8 items regarding
stroke symptoms and diagnosis, 7 questions regarding acute stroke care and 4 items regarding stroke
pathophysiology
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: for all runs, 1 blinded author (KW) reviewed ER charts, recorded final ER dis-
charge diagnoses and confirmed absence or presence of potential stroke symptoms. On all potential
target stroke runs (people meeting LAPSS form completion criteria), 1 blinded author (CSK) addi-
tionally examined all inpatient medical records to confirm hospital discharge diagnoses of ischemic
stroke, ICH and TIA by review of reports from imaging studies and attending physician notes. For
people with the diagnosis of TIA, a consensus on final diagnosis was reached after complete medical
record review and case discussion with a second stroke neurologist. In all people with cerebral infarct
and ICH, the diagnosis of the blinded reviewer agreed with the charted diagnosis of the attending
neurologist
Flow and timing 446 people had neurologically relevant symptoms, of these paramedics applied LAPSS on 206
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 34/206 (16.5%)
LAPSS: TP = 31; FP = 5; FN = 3; TN = 167
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: Grant-in-aid from the American Heart Association, Greater Los Angeles Affiliate
Methodological quality
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
Kim 2017
Study characteristics
Patient sampling Study conducted in Busan, Republic of Korea
Sampling: people with suspected stroke transported to a single hospital by EMS paramedics and
people with true stroke without stroke recognition by EMS for 12 months; data extracted from
emergency care records including CPSS documented by EMS paramedics and hospital medical
records
Patient characteristics and set-
ting
Inclusion and exclusion criteria: people with suspected stroke referred by paramedics and people
with true stroke admitted during the same period (no further details)
Participant characteristics: not reported
Index tests Index test: CPSS
Test administrator: paramedics
Training: not reported
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: hospital medical records (no further details)
Flow and timing 268 people with suspected stroke referred, of whom 152 had confirmed stroke/TIA; time between
CPSS and final diagnosis not reported
Comparative
Diagnostic test accuracy data Prevalence: 152/268 (56.7%) participants had stroke/TIA
CPSS: TP = 142, FP = 31, FN = 10, TN = 85
Notes Proportion of stroke/TIA: stroke = 149, TIA = 3
Alternative diagnoses: not reported
Additional information: people with ischemic stroke with stroke recognition by EMS using CPSS
had a higher NIHSS score (10 with CPSS vs 6 with negative or no documented CPSS; P = 0.001)
and shorter on-scene to door time (22 with CPSS vs 25 minutes with negative or no documented
CPSS; P = 0.009) and were more likely to be treated with tissue plasminogen activator (49.7% with
CPSS vs 32.2% with negative or no documented CPSS; P = 0.007) than these with negative or no
documented CPSS
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Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Unclear
Did all patients receive a refer-
ence standard?
Unclear
Unclear
Lee 2015
Study characteristics
Patient sampling Dongguk University Ilsan Hospital, Korea, from August 2013 to February 2014
Sampling: prospective, consecutive sample (people who had come to the emergency care center
directly)
Patient characteristics and set-
ting
Inclusion criteria: age≥ 18 years; presentation symptoms: weakness of extremities, dysarthria, sen-
sory changes, alternation of consciousness, speech disturbance, visual disturbance, gait disturbance,
dizziness, severe headache, syncope; hospital arrival within 12 hours from symptom onset
Exclusion criteria: age < 18 years; symptoms caused by trauma; transfer from other hospitals
Participant characteristics: mean age 59.7 (SD 16.1) years in all included participants; 68.6 (SD
13.1) years in people with stroke/TIA; 54.6 (SD 15.5) years in people without stroke/TIA
45.2% men; 61.0% men in stroke or TIA group; 36.2% men in without stroke/TIA group
Index tests Index test: ROSIER, FAST (applied consecutively, information supplied by the authors), usual
cutoff ≥ 1 used for both scales
Test administrator: emergency physicians (including residents and ER consultants)
Training: 3 hours of training on theory of stroke and the acute stroke registration system from an
emergency medicine specialist
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: final diagnosis of stroke/TIA signed off by a neurologist after reviewing clinical
information and results MRI (confirmed by the authors). Classification of stroke was according to
Oxford Community Stroke Project
Flow and timing Interval between index test and reference standard < 14 days. 23 (7%) participants excluded from
analysis due to incomplete data (information supplied by the authors upon request)
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 113/312 (36.2%)
ROSIER: TP = 98; FP = 14; FN = 15; TN = 185
FAST: TP = 97; FP = 15; FN = 16; TN = 184
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Notes Proportion of ischemic, hemorrhagic and TIA
Ischemic 77/312 (24.7%)
Hemorrhage 21/312 (6.7%)
TIA 14/312 (4.5%)
Specific diagnosis in participants diagnosed with stroke or TIA: 32 (28.3%) lacunar stroke, 28
(24.8%) partial anterior circulation stroke, 14 (12.4%) primary ICH, 14 (12.4%) TIA, 13 (11.5%)
total anterior circulation stroke, 7 (6.2%) SAH, 4 (4.4%) posterior circulation stroke
Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
59/312 (18.9%) non-specific dizziness, 39/312 (12.5%) primary headache, 30/312 (9.6%) BPPV,
15/312 (4.8%) vestibular neuritis, 12/312 (3.8%) syncope, 8/312 (2.6%) migraine, 7/312 (2.2%)
drug intoxication, 6/312 (1.9%) facial palsy, 23/312 (7.4%) other
Comorbidities (% in patients with ischemic vs hemorrhagic vs TIA)
Hypertension 140 (44.9%) vs 74 (65.5%) vs 66 (33.2%); P < 0.001*
Diabetes mellitus 51 (16.3%) vs 26 (23.0%) vs 25 (12.6%); P < 0.025*
Previous stroke 33 (10.6%) vs 19 (16.8%) vs 14 (7.0%); P < 0.012*
Hyperlipidemia 33 (10.6%) vs 16 (14.2%) vs 17 (8.5%); P < 0.129*
Heart disease 21 (6.7%) vs 12 (10.6%) vs 9 (4.5%); P < 0.058*
Smoking 53 (17.0%) vs 30 (26.5%) vs 23 (11.6%); P < 0.001*
Current medication (% in patients with ischemic vs hemorrhagic vs TIA)
Aspirin 35 (11.2%) vs 20 (17.7%) vs 15 (7.5%); P < 0.009*
Plavix 15 (4.8%) vs 9 (8.0%) vs 6 (3.0%); P < 0.058*
Warfarin 2 (0.6%) vs 0 (0%) vs 2 (1.0%); P < 0.537
*Statistically significant.
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Yes
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dard?
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
Did all patients receive a refer-
ence standard?
Yes
High
Mingfeng 2012
Study characteristics
Patient sampling Guangzhou University of Traditional Chinese Medicine, China; April 2010 to November 2011
Sampling: prospective, consecutive sample
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: aged > 18 years with suspected stroke or TIA with symptoms or signs seen by emergency
physician in the prehospital setting
Exclusion: head trauma, did not accept medical treatment in prehospital setting, refused CT or
MRI; details of presenting symptoms/reason for query stroke: sudden weakness/numbness of face,
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arms, legs, sudden confusion, trouble speaking or understanding, sudden trouble seeing/walking,
dizziness, loss of balance/co-ordination, sudden severe headache
Participant characteristics: mean age 63 years, range 18-96 years; 67.6% men
Index tests Index test: ROSIER, CPSS
Test administrator: emergency physicians
Training: 6-hour course on ROSIER and CPSS
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard:CTorMRI; final discharge diagnosis of stroke or TIAmade by the neurologists
was used as the reference standard for diagnosis in this study
Flow and timing 42 people with suspected stroke did not meet the study criteria
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 380/540 (70.4%)
ROSIER: TP = 341; FP = 27; FN = 38; TN = 134
CPSS: TP = 340; FP = 49; FN = 43; TN = 108
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke: 40
vertigo, 27 seizure, 22 syncope, 20 cardiac, 15 sepsis, 10 hypoglycemia, 10 hysteria, 6 ethyl alcohol,
4 brain tumor, 3 demyelinating, 2 hypokalemia, 1 labyrinthitis
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Yes
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dard?
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Unclear
Mingfeng 2017
Study characteristics
Patient sampling Luocun Community Health Service Center (LCHSC) of Nanhai District affiliated with the Nanhai
Hi-Tech Industrial Zone Hospital (NHIZH) of Foshan, a Level-II hospital with the capability of
managing acute stroke, and Zhangcha Community Health Service Center (ZCHSC) of Chancheng
District, FoshanCity, affiliatedwith the FoshanHospital of Traditional ChineseMedicine (FSTCM)
, a tertiary care teaching hospital with acute stroke center, China
Sampling: all people presenting to the 2 health centers; August 2012 to January 2016; ages > 18
years with suspected stroke or TIA and with symptoms or signs observed by GPs in LCHSC and
ZCHSC were included in this study
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Patient characteristics and set-
ting
Inclusion criteria: suspected stroke or TIA based on the following clinical signs: numbness or
weakness in the face, arms or legs (especially on 1 side of the body); confusion, difficulty in speaking
or understanding speech; vision disturbance in 1 or both eyes; dizziness, walking difficulties, loss of
balance or co-ordination; severe headache without known cause
Exclusion criteria: head trauma or surgery in recent months; previous stroke with neurologic
deficits; incomplete medical testing was excluded from this study
Participant characteristics: mean age 67.54 (SD 12.66) years; 192 (41.03%) women
Index tests Index test: ROSIER, CPSS
Test administrator: 16 GPs
Training: GPs were trained by emergency physicians on the use of the ROSIER scale and CPSS for
10 hours before the study
Target condition and reference
standard(s)
Target condition: stroke/TIA (only people with observed symptoms/signs by the GPs were in-
cluded)
Reference standard: final discharge diagnosis of stroke or TIA made by neurologists reviewing all
diagnostic information including CT scan of the brain (immediately after transfer), blood tests and
12-lead ECG conducted in the ER; comprehensive neurologic assessment including additional tests,
such as continuous ECGmonitoring, 24-hour Holter ECG, duplex carotid and cardiac ultrasound,
TCD, MRI or MRA, and conventional cerebral angiography were performed as requested by the
neurologists once the participant was transferred to the neurology ward. The neurologists who made
the final diagnosis were blinded to the results from the ROSIER and CPSS
Flow and timing 512 people with suspected stroke assessed by GPs, of whom 468 met the study inclusion criteria;
the CT scan of the brain was done immediately after the participant was transferred to the ER
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 332/468 (70.94%) participants had final diagnosis stroke or TIA; 240
(72.29%) of the participants had ischemic stroke/TIA and 92 (27.71%) hemorrhagic stroke
ROSIER: TP = 276, FP = 26, FN = 56, TN = 110
CPSS: TP = 259, FP = 40, FN = 73, TN = 96
Notes Stroke mimics: 136 participants (45 syncope, 28 seizure, 26 vertigo, 10 hypoglycemia, 8 hy-
pokalemia, 5 sepsis, 4 brain tumor, 3 hysteria, 2 alcohol intoxication, 2 hepatic encephalopathy, 2
Meniere’s syndrome and 1 demyelination)
Funding: funding provided by the Internal Grants from Science and Technology Foundation of
Foshan City, China (no. 2014AB00328, no. 2014AG10002, and no. 2015AB00354), Guangdong
Province Science and Technology Foundation (no. 2014A020212002) and the Municipal Clin-
ical Key Specialty Construction Project Funds of Foshan City (no. Fspy2-2015004 and no. FS-
GSSPZD135025)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Did all patients receive a refer-
ence standard?
Yes
Low
Nor 2005
Study characteristics
Patient sampling Newcastle Hospital, UK; 1 November 2002 to 31 July 2003
Sampling: prospective, consecutive validation study
Patient characteristics and set-
ting
Inclusion and exclusion criteria: age > 18 years, suspected stroke or TIA
Participant characteristics: mean age: stroke 71 (SD 14) years, non-stroke 72 (SD 16) years; 41.
3% men
Index tests Index test: ROSIER (CPSS, LAPSS, FAST also calculated based on the neurologist-recorded signs
from the prospective validation cohort)
Test administrator: emergency physicians (ROSIER); retrospective calculation based on neurolo-
gist-recorded signs (CPSS, LAPSS, FAST)
Training: regular educational program on how to use the instrument with twice monthly updates
given to small groups of ER staff
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: final diagnosis made by the consultant stroke physician, after assessment and
review of clinical symptomatology and brain imaging findings, was used as the reference standard
Flow and timing Not reported
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 101/160 (63.1%)
ROSIER: TP = 94; FP = 10; FN = 7; TN = 49
FAST: TP = 83; FP = 10; FN = 18; TN = 49
LAPSS: TP = 60; FP = 9; FN = 41; TN = 50
CPSS: TP = 86; FP = 12; FN = 15; TN = 47
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
13 syncope, 8 seizure, 8 sepsis, 7 somatization, 4 brain tumor, 3 labyrinthitis, 3 SDH, 13 other
Funding: Stroke Association UK
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Did all patients receive a refer-
ence standard?
Yes
Unclear
Ramanujam 2008
Study characteristics
Patient sampling 6 hospitals in San Diego, USA; 1 January 2005 to 31 December 2005
Sampling: retrospective analysis of consecutive patient records
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: ages ≥ 18 years, identified as having stroke in the prehospital phase using MPDS stroke
protocol dispatchers
Exclusion: people taken to other acute care hospitals not participating in the study; people with a
dispatch determinant of stroke (card 28) who were not transported by City EMS agency (SDMSE)
to participating hospitals; people in the stroke registry not transported by SDMSE; or people with
no final outcome data
Participant characteristics: not reported
Index tests Index test: CPSS
Test administrator: paramedics
Training: annual 1-hour education session on recognizing stroke
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: discharge diagnosis for participants in stroke registry
Flow and timing Missing data for 16 participants
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 440/1045 (42.1%)
CPSS: TP = 193; FP = 284; FN = 247; TN = 321
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: Stroke Center, University of California San Diego Medical Center
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
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Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
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Unclear
Studnek 2013
Study characteristics
Patient sampling 7 hospitals under 2 healthcare systems, USA
Sampling: retrospective analysis of patient records; people were included in this study if they received
a prehospital MedPACS screen and were transported to 1 of the 7 local hospitals
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: signs or symptoms of acute stroke or TIA
Exclusion: no documented assessment, ages < 18 years, secondary transports
Participant characteristics: mean age 66.8 (SD 16.7) years; 45.7% men
Index tests Index test: CPSS, MedPACS
Test administrator: paramedics
Training: 2-hour continuing education lecture regarding neurologic emergencies
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: discharge diagnosis of stroke or TIA
Flow and timing 52 participants with no stroke screen performed or incomplete results
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 186/416 (44.7%)
MedPACS: TP = 138; FP = 155; FN = 48; TN = 75
CPSS: TP = 147; FP = 175; FN = 39; TN = 55
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
not reported
Funding: not reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
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Did the study avoid inappropri-
ate exclusions?
Unclear
Prospective design No
High Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Unclear
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Unclear
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Unclear
Unclear
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Vanni 2011
Study characteristics
Patient sampling ERs of 3 hospitals located in 3 towns of the northern (Florence), middle (Rome), and southern
(Pescara) regions of Italy; July 2006 to September 2006
Sampling: consecutive prospective sample
Patient characteristics and set-
ting
Inclusion and exclusion criteria:
Inclusion: presence at triage of acute focal neurologic deficit (including also signs of posterior
circulation ischemia: vertigo, double vision, visual field defects or disorders of perception, balance,
and co-ordination) or a local EMS dispatch of suspected stroke
Exclusion: major trauma and coma (GCS ≤ 8); people with terminal illnesses (life expectancy < 3
months)
Participant characteristics: age in all participants 72 (SD 14) years, in people with stroke 74 (SD
11) years, in people without stroke 69 (SD 16) years; P = 0.027; men in all participants 59%, in
people with stroke 61%, in people without stroke 56%; P = 0.622
Index tests Index test:CPSS (compared to TheTriage® Stroke Panel including quantitative measurement of B-
type natriuretic peptide, fibrin degradation products containing D-dimer, matrix metalloproteinase-
9 and S100β)
Test administrator: trained nurses (at triage)
Training: not reported
Target condition and reference
standard(s)
Target condition: stroke, defined according toWHO criteria of “a focal or global neurologic deficit
with symptoms lasting for 24 h or resulting in death before 24 hrs, which was considered to be due
to a vascular cause after investigation” (reference standard positive). All other patients, including
people with TIA (defined as clinical syndromes characterized by an acute loss of focal cerebral or
monocular function with symptoms lasting < 24 hours and thought to be caused by inadequate
blood supply as a result of thrombosis or embolism), were assigned to non-stroke diagnosis and
considered free of the target condition (reference standard negatives)
Reference standard: stroke diagnosis established by a consensus of 3 experts (1 emergency physician,
1 specialist in internal medicine and 1 neurologist), blinded to the index test results, after reviewing
all clinical data and brain imaging results. Stroke diagnosis established when at least 2 of the 3
expertsmatched. Non-contrast-enhanced CT scanning of the brain by a 12-channel CT scanner was
performed within 1 hour from emergency physician evaluation. MRI, MRA, CTA or conventional
angiography was performed when appropriate
Flow and timing The mean time from symptom onset to presentation was 7 hours (range 1-24 hours), and only 32%
of participants arrived at the hospital within 3 hours. Non-contrast-enhanced CT scanning of the
brain by a 12-channel CT scanner was performed within 1 hour from the emergency physician’s
evaluation
Comparative
Diagnostic test accuracy data Prevalence of stroke: 87/155 (56.1%)
Notes Specific diagnosis in participants diagnosed with stroke/TIA: not reported
Categorization of alternate diagnosis for participants who did not have stroke: 23/155 (15%)
had TIA; other diagnoses not reported
Comorbidities:
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Vanni 2011 (Continued)
Previous stroke or TIA: 21%
Diabetes mellitus: 16%
Atrial fibrillation: 12%
SBP: 156 (SD 22) mmHg
Funding: not declared
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low High
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Vanni 2011 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Low
Whiteley 2011
Study characteristics
Patient sampling Edinburgh Western General Hospital, UK; 21 March 2007 to 27 February 2009
Sampling: prospective consecutive people with suspected stroke, symptoms < 24 hours, symp-
tomatic at time of assessment, GP/paramedic/member of ER staff made a diagnosis of “suspected
stroke”
Patient characteristics and set-
ting
Inclusion and exclusion criteria: symptoms began < 24 hours before admission; still symptomatic
at the time of assessment; and in whom a GP, a paramedic or a member of the ER staff had made a
diagnosis of ’suspected stroke’
Participant characteristics: mean age 72 (SD 14) years; 51% women
Index tests Index test: FAST, ROSIER
Test administrator: emergency physician or nurse
Training: not reported
Target condition and reference
standard(s)
Target condition: stroke/TIA
Reference standard: panel of experts (which included stroke physicians, neurologists and neurora-
diologists), who had access to the clinical findings, imaging results and the participant’s subsequent
clinical course. Diagnostic criteria provided
Flow and timing 50 participants excluded from analysis due to incomplete assessment
Comparative
Diagnostic test accuracy data Prevalence of stroke/TIA: 246/356 (69.1%)
FAST: TP = 199; FP = 67; FN = 47; TN = 43
ROSIER: TP = 203; FP = 62; FN = 43; TN = 48
111Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Whiteley 2011 (Continued)
Notes Categorization of alternate diagnosis for participants who did not have an ischemic stroke:
TIA 37, ICH 10, SAH 2
Funding: none relevant
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Prospective design Yes
Low Low
DOMAIN 2: Index Test Index tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
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Whiteley 2011 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Did all patients receive a refer-
ence standard?
Yes
Low
BPPV: benign paroxysmal positional vertigo; CPSS: Cincinnati Prehospital Stroke Scale; CT: computed tomography; CTA: computed
tomography angiography; ECG: electrocardiogram; EEG: electroencephalogram; EMCC: Emergency Medical Communication
Center; EMS: emergency medical service; ER: emergency room; FAST: Face Arm Speech Time; FN: false negative; FP: false positive;
GCS: Glasgow Coma Scale; GP: general practitioner; ICH: intracerebral hemorrhage; LAPSS: Los Angeles Prehospital Stroke Scale;
LOC: level of consciousness; MASS:Melbourne Ambulance Stroke Scale;MedPACS:Medic Prehospital Assessment for Code Stroke;
MPDS: medical priority dispatch system; MRA: magnetic resonance angiography; MRI: magnetic resonance imaging; NIHSS:
National Institutes of Health Stroke Scale; OPSST: Ontario Prehospital Stroke Screening Tool; PreHAST: PreHospital Ambulance
Stroke Test; ROSIER: Recognition of Stroke in the EmergencyRoom; SAH: subarachnoid hemorrhage; SBP: systolic blood pressure;
SD: standard deviation; SDH: subdural hematoma; SDMSE: San Diego Medical Services Enterprise; TCD: transcranial Doppler;
TGA: transient global amnesia; TIA: transient ischemic attack; TN: true negative; TP: true positive; UCLA: University of California
at Los Angeles; WHO: World Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alhanati 2014 No stroke scale specified.
Asimos 2014 Did not meet gold standard of diagnosis of stroke/diagnosis not confirmed by stroke physician, just used
ICD 9/10 codes
Belvis 2005 No stroke scale specified.
Benjamin 2013 Diagnosis not confirmed by neurologist.
Birnbaum 2008 Not a scale specific to stroke/inappropriate scale.
Blomberg 2014 No stroke scale specified.
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(Continued)
Bray 2005b Did notmeet reference standard, author contacted requestingmore information, did not receive adequate
response
Brott 1989 Inappropriate scale.
Buck 2009 Study of dispatchers, no stroke scale specified.
Caceres 2013 No stroke scale specified.
Camerlingo 2002 Questionnaire over the telephone, no stroke scale specified.
Casolla 2013 No stroke scale specified.
De La Ossa 2014 Scale only assessed large artery occlusions.
Deakin 2009 Test administered by dispatcher.
Demeestere 2017 Evaluation of NIHSS-8 for LVO using retrospectively derived scores
Ellison 2004 No stroke scale specified.
Ferri 2005 Study protocol.
Ferro 1996 No stroke scale specified.
Ferro 1998 No stroke scale specified.
Fischer 2008 No stroke scale specified.
Garnett 2010 Protocol only, no scale.
Garrett 2013 Prognosis scale for ICH.
Govindarajan 2011 Protocol only.
Govindarajan 2012 Dispatchers only.
Gropen 2018 New stroke scale, EMSA, combining stroke recognition and severity assessment; paper described deriva-
tion and internal validation using patient records (inappropriate design)
Grossman 2011 Inappropriate scale.
Hand 2006 Not a prehospital stroke scale, scale administered by research fellow, neurologists and internists
Harbison 2003 Did not meet reference standard.
Hasegawa 2013 Did not meet reference standard.
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(Continued)
Henry-Morrow 2017 Evaluation of educational intervention for prehospital recognition of stroke (not an evaluation of a stroke
scale)
Herzberg 2014 Use of prehospital TCD, no stroke scale specified.
Heuer 2012 Did not evaluate stroke scale (evaluation of diagnostic accuracy of ER physicians)
Huang 1994 Allen score in clinical diagnosis of intracranial hemorrhage
Hurwitz 2005 Test administered by lay telephone caller.
Iguchi 2011 Evaluation of the Kurashiki prehospital severity scale in identifying thrombolytic candidates
Jang 2014 Evaluation of the Kurashiki prehospital severity scale in identifying thrombolytic candidates
Jia 2017 Accuracy of EMS diagnosis of stroke, no specific scale evaluated; retrospective data used
Josephson 2008 ABCD score calculated post-hoc.
Kidwell 1998 Scale tested retrospectively.
Kimura 2008 Scale of severity.
Kothari 1995 No stroke scale specified.
Kothari 1997 Creation of a new stroke scale from NIHSS.
Kothari 1999 Scale done postadmission, after diagnosis have been made.
Krebes 2012 Evaluation of dispatcher’s use.
Kwiatkowski 2006 Comment on another study.
Lange 2011 Only analyzed results of people who would be eligible for tPA, do not report data regarding accuracy of
stroke scale
Lavin 2014 Electronic triaging tool for family doctors.
Levine 2016 Review paper (not primary study).
Liferidge 2004 CPSS used by layperson.
Lin 2012 Prenotification study.
Llanes 2004 Scale of severity.
Malekzadeh 2015 CPSS used by dispatch nurses.
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(Continued)
Mao 2016 Recruited people with suspected stroke presenting to the ER with symptoms or signs within 7 days
Middleton 2016 Study protocol, general ER triage scale, not specific to stroke
Mohd 2004 Only FAST-positive cases, focus on agreement between paramedics and physicians
Mosley 2013 No stroke scale specified.
Nam 2014 Description of smart phone app, not accuracy study.
Nazliel 2008 Measure of stroke severity, indication of LVO.
Newman-Toker 2013 Only included people with vertigo/dizziness.
Noorian 2016 Stroke severity scale, target condition LVO.
Nor 2004 Objective of the study was an agreement between paramedics on the scene and by stroke physicians after
admission in determining acute stroke signs using FAST. Analysis was confined to acute stroke cases;
only FAST-positive participants identified as suspected stroke by paramedics were included. Nor 2005
reported on the same cohort of participants.
O’Brien 2012 Analysis of prehospital protocol, do not examine accuracy of FAST
Ollikainen 2018 New stroke scale, FPSS, which combines stroke recognition and LVO identification. Study reported
development and validation of scale using patient records (inappropriate design)
Oostema 2015 Focus on EMS accuracy to recognize stroke, not the accuracy of CPSS; also conference abstract, no full
text
Oostema 2016 Systematic review of the accuracy of emergency dispatchers stroke recognition when employing stroke
screening tools
Perez de la Ossa 2014 Predictor for LVO.
Purrucker 2015 Scales determined retrospectively from NIHSS; data collected from the ER neurological report
Purrucker 2017 Reports the development of “an NIH Stroke Scale (NIHSS) compatible, all-in-one scale for rapid and
comprehensive prehospital stroke assessment including stroke recognition, severity grading and progres-
sion monitoring as well as prediction of large vessel occlusion (LVO).” Validation using patient records
(same cohort as in Purrucker 2015) (inappropriate design).
Quenardelle 2016 FAST calculated a posteriori, data collection to produce a FAST score not described in detail but very
likely derived from the neurologist’s initial assessment
Qureshi 2016 Stroke severity scales evaluated; target condition LVO.
Richards 2016 Evaluated dichotomized CPSS to recognize people suitable for revascularization
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(Continued)
Robinson 2013 Public knowledge study.
Rodriguez-Pardo 2017 Evaluation of new criteria to identify people eligible for mechanical thrombectomy
Ross 2007 Protocol for workup of TIA.
Rudd 2015 Review paper of Rudd 2016.
Rudd 2016 Systematic review.
Schilling 2012 No stroke scale specified.
Schrock 2009 ABCD score as a predictor of positive work up for TIA.
Sequeira 2015 Retrospective analysis of the accuracy of several scales but the reference standard was the NIHSS; con-
ference abstract, no full data
Shapiro 2003 Evaluation of electronic stroke tool, not a purely diagnostic scale, no outcomes reported for accuracy
Sheppard 2015 Not a diagnostic accuracy study; only people with established stroke diagnosis included
Silva 2015 End-to-end study of the impact of LAPSS results upon clinical outcome (mRS < 3) at discharge; confer-
ence abstract, no diagnostic accuracy data reported
Smith 1998 No stroke scale specified.
Smith 1999 No stroke scale specified.
Soda 2016 “4iss” scale; probably a combined recognition/severity tool but only abstract available; “4iss” was used in
people who had a positive score on FAST, as decided by paramedics
Timerding 1989 No stroke scale specified.
Tirschwell 2002 NIHSS performed by a neurologist.
Tonomura 2015 Investigated the clinical characteristics of pseudonegative cases in prehospital triage for stroke/TIA by
EMS; only people with established stroke diagnosis included; conference abstract
Trivedi 2015 End-to-end retrospective analysis of a statewide database; only conference abstract with no sufficient test
accuracy data to recreate 2 × 2 table; authors did not reply to data request
Turc 2016 Target condition LVO.
Van Hooff 2013 Telemedicine, simulation.
Verma 2010 No stroke scale specified.
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Wennman 2012 No stroke scale specified.
Wesley 2016 Comment, no primary study.
Williams 2015 FAST score obtained retrospectively, evaluates accuracy of paramedics’ decision, not the instrument
Williams 2017 Evaluation of paramedics’ accuracy, not FAST (FAST was recorded only in half of the cases); ER dis-
charge diagnosis (not hospital) was used as a reference standard (inappropriate intervention and reference
standard)
Wojner-Alexandrov 2005 Evaluates accuracy of paramedics’ decision, not the instrument; all EMS runs rather than those with
neurologically relevant symptoms used to calculate false-negative rate
Yamashita 2011 Inappropriate scale; attempts to differentiate hemorrhage from ischemic stroke
Yilmaz 2014 Inappropriate reference standard, MRI only.
Yock-Corrales 2011 Participants were children.
You 2013 CPSS as a predictor of thrombolysis.
Zamora 2013 Awareness of scales in a population of medical doctors.
Ziegler 2008 No reference standard mentioned; unable to obtain additional information from authors
Zohrevandi 2015 Retrospective analysis based on ER records.
ABCD: age, blood pressure, clinical features, duration of TIA, and presence of diabetes; CPSS: Cincinnati Prehospital Stroke Scale;
ER: emergency room; EMS: emergency medical service; EMSA: Emergency Medical Stroke Assessment; FAST: Face Arm Speech
Time; ICD: International Classification of Disease; ICH: intracerebral hemorrhage; LAPSS: Los Angeles Prehospital Stroke Scale;
LVO: large vessel occlusion; MRI: magnetic resonance imaging; mRS: modified Rankin Scale; NIHSS: National Institutes of Health
Stroke Scale; TCD: transcranial Doppler; TIA: transient ischemic attack; tPA: tissue plasminogen activator.
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 CPSS 11 4157
2 FAST 5 1894
3 LAPSS 5 1794
4 ROSIER 8 2895
5 MASS 3 981
6 OPSST 1 554
7 MedPACS 1 416
8 PreHAST 1 69
Test 1. CPSS.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 1 CPSS
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bergs 2010 18 8 1 4 0.95 [ 0.74, 1.00 ] 0.33 [ 0.10, 0.65 ]
Bray 2005a 69 12 4 15 0.95 [ 0.87, 0.98 ] 0.56 [ 0.35, 0.75 ]
Bray 2010 176 138 23 513 0.88 [ 0.83, 0.93 ] 0.79 [ 0.75, 0.82 ]
English 2018 72 27 24 7 0.75 [ 0.65, 0.83 ] 0.21 [ 0.09, 0.38 ]
Frendl 2009 43 45 18 48 0.70 [ 0.57, 0.81 ] 0.52 [ 0.41, 0.62 ]
Kim 2017 142 31 10 85 0.93 [ 0.88, 0.97 ] 0.73 [ 0.64, 0.81 ]
Mingfeng 2012 340 49 43 108 0.89 [ 0.85, 0.92 ] 0.69 [ 0.61, 0.76 ]
Mingfeng 2017 259 40 73 96 0.78 [ 0.73, 0.82 ] 0.71 [ 0.62, 0.78 ]
Ramanujam 2008 193 284 247 321 0.44 [ 0.39, 0.49 ] 0.53 [ 0.49, 0.57 ]
Studnek 2013 147 175 39 55 0.79 [ 0.72, 0.85 ] 0.24 [ 0.19, 0.30 ]
Vanni 2011 65 15 22 53 0.75 [ 0.64, 0.83 ] 0.78 [ 0.66, 0.87 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. FAST.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 2 FAST
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Berglund 2014 301 107 171 321 0.64 [ 0.59, 0.68 ] 0.75 [ 0.71, 0.79 ]
Bergs 2010 18 8 1 4 0.95 [ 0.74, 1.00 ] 0.33 [ 0.10, 0.65 ]
Fothergill 2013 171 103 6 15 0.97 [ 0.93, 0.99 ] 0.13 [ 0.07, 0.20 ]
Lee 2015 97 15 16 184 0.86 [ 0.78, 0.92 ] 0.92 [ 0.88, 0.96 ]
Whiteley 2011 199 67 47 43 0.81 [ 0.75, 0.86 ] 0.39 [ 0.30, 0.49 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 3. LAPSS.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 3 LAPSS
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bergs 2010 14 2 5 10 0.74 [ 0.49, 0.91 ] 0.83 [ 0.52, 0.98 ]
Bray 2005a 57 4 16 23 0.78 [ 0.67, 0.87 ] 0.85 [ 0.66, 0.96 ]
Chen 2013 782 13 215 120 0.78 [ 0.76, 0.81 ] 0.90 [ 0.84, 0.95 ]
Ding 2009 47 12 4 264 0.92 [ 0.81, 0.98 ] 0.96 [ 0.93, 0.98 ]
Kidwell 2000 31 5 3 167 0.91 [ 0.76, 0.98 ] 0.97 [ 0.93, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 4. ROSIER.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 4 ROSIER
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Fothergill 2013 171 97 6 21 0.97 [ 0.93, 0.99 ] 0.18 [ 0.11, 0.26 ]
Jackson 2008 44 3 2 1 0.96 [ 0.85, 0.99 ] 0.25 [ 0.01, 0.81 ]
Jiang 2014 323 202 48 141 0.87 [ 0.83, 0.90 ] 0.41 [ 0.36, 0.47 ]
Lee 2015 98 14 15 185 0.87 [ 0.79, 0.92 ] 0.93 [ 0.88, 0.96 ]
Mingfeng 2012 341 27 38 134 0.90 [ 0.86, 0.93 ] 0.83 [ 0.77, 0.89 ]
Mingfeng 2017 276 26 56 110 0.83 [ 0.79, 0.87 ] 0.81 [ 0.73, 0.87 ]
Nor 2005 94 10 7 49 0.93 [ 0.86, 0.97 ] 0.83 [ 0.71, 0.92 ]
Whiteley 2011 203 62 43 48 0.83 [ 0.77, 0.87 ] 0.44 [ 0.34, 0.53 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. MASS.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 5 MASS
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bergs 2010 14 4 5 8 0.74 [ 0.49, 0.91 ] 0.67 [ 0.35, 0.90 ]
Bray 2005a 66 7 7 20 0.90 [ 0.81, 0.96 ] 0.74 [ 0.54, 0.89 ]
Bray 2010 166 92 33 559 0.83 [ 0.78, 0.88 ] 0.86 [ 0.83, 0.88 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 6. OPSST.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 6 OPSST
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Chenkin 2009 291 34 27 202 0.92 [ 0.88, 0.94 ] 0.86 [ 0.80, 0.90 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 7. MedPACS.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 7 MedPACS
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Studnek 2013 138 155 48 75 0.74 [ 0.67, 0.80 ] 0.33 [ 0.27, 0.39 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 8. PreHAST.
Review: Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
Test: 8 PreHAST
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Andsberg 2017 26 26 0 17 1.00 [ 0.87, 1.00 ] 0.40 [ 0.25, 0.56 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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A D D I T I O N A L T A B L E S
Table 1. Characteristics of the evaluated stroke identification scales
- CPSS FAST LAPSS MASS ROSIER MedPACS PreHAST OPSST
Eligibility criteria Exclusion cri-
teria
- - - Age > 45 years
His-
tory of seizures
or epilepsy ab-
sent
Symptom du-
ration < 24
hours
At baseline,
patient
not wheelchair
bound or
bedridden
Blood glucose
60-400 mg/dL
(3.3-22.2
mmol/L)
Age > 45 years
His-
tory of seizures
or epilepsy ab-
sent
At baseline,
patient
not wheelchair
bound or
bedridden
Blood glucose
2.8-22.2
mmol/L
- His-
tory of seizures
or epilepsy ab-
sent
Symptom dura-
tion ≤ 25 hours
Blood
glucose 60-400
mg/dL (3.3-22.
2 mmol/L)
Age > 18 years
Intended for use
only in
conscious peo-
ple, i.e. alert or
aroused by mi-
nor stimulation
CTAS level 1;
or uncorrected
airway, breath-
ing or circula-
tory problem
(or both)
Symptoms of
the stroke have
resolved
Blood sugar < 4
mmol/L
Seizure at on-
set of symptoms
or observed by
paramedic
GCS < 10
Terminally ill or
palliative care
patient
Could not ar-
rive to a stroke
center within 2
hours of
a clearly deter-
mined time of
symptom onset
or the time the
patients
was “last seen in
a usual state of
health”
Screen items
Facial palsy +1 +1 +1 +1 +1 +1 +1 +1
Gaze prefer-
ence
- - - - - +1 +2 -
Vision - - - - + 1 - + 2 -
Speech dis-
turbance
+1 +1 - +1 +1 +1 0-2 +1
123Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Characteristics of the evaluated stroke identification scales (Continued)
Hand grip - - +1 +1 - - - -
Arm drift/
weakness
+1 +1 +1 +1 +1 +1 0-2 +1
Leg drift/
weakness
- - - - +1 +1 0-2 +1
No seizure at
onset
- - - - -1 - - -
Blood
glucose > 3
5 mmol/L
- - - - -1 - - -
Other - - - - - - Verbal instruc-
tions +2
Sensory (pain)
0-2
-
Score range 0-3 0-3 0-3 0-4 -2 to 5 0-5 0-19 0-4
Positivity
threshold
≥ 1 ≥ 1 ≥ 1 ≥ 1 ≥ 1 ≥ 1 ≥ 1 ≥ 1
CPSS: Cincinnati Prehospital Stroke Scale; Kothari 1997 and Kothari 1999.
CTAS: Canadian Triage and Acuity Scale.
FAST: Face Arm Speech Time; Kleindorfer 2007.
GCS: Glasgow Coma Scale.
LAPSS: Los Angeles Prehospital Stroke Scale. This refers to the LAPSS criteria published in Kidwell 2000, which differ slightly from an
earlier version of the scale published in Kidwell 1998. In LAPSS 2000 an eligibility criterion is considered met even when the answer to
the question is unknown (e.g. the person will be considered > 45 years old when this information is not available). In LAPSS 1998 when
the answer to an eligibility question is unknown, the criterion is considered unmet and the person is not eligible for assessment with
LAPSS; in addition, in the earlier version the symptom duration was 12 (and not 24) hours. Only LAPSS 2000 criteria are presented
in the above table as no studies using LAPSS 1998 were included.
MASS: Melbourne Ambulance Stroke Scale; Bray 2005a.
MedPACS: Medic Prehospital Assessment for Code Stroke; Studnek 2013.
OPSST: Ontario Prehospital Stroke Screening Too; Chenkin 2009. The authors point out that “The addition of these exclusion criteria
may be helpful for reducing the unnecessary triage of patients with stroke mimics and patients who are ineligible for fibrinolysis” (p.
154).
PreHAST: PreHospital Ambulance Stroke Test. Designed to screen for common stroke symptoms and grade severity, similarly to the
National Institutes of Health Stroke Scale (NIHSS); simultaneous testing of right and left side for visual field and sensory items; only
verbal instructions allowed, so it tests indirectly for sensory (Wernicke’s) aphasia, Andsberg 2017.
ROSIER: Recognition of Stroke in the Emergency Room; Nor 2005.
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Table 2. Inclusion criteria of the studies included in the review
Study ID Country Inclusion criteria
Prehospital setting
Andsberg 2017 Sweden Suspected stroke defined as sudden onset of focal neurologic symptoms/signs, in conscious
people > 18 years of age
Berglund 2014 Sweden Suspected stroke with symptom onset within 6 hours; ages 18-85 years; previous indepen-
dence in activities of daily living; and no other acute condition requiring a priority level 1
Bergs 2010 Belgium Acute neurologic event without clear origin, altered level of consciousness, convulsions,
syncope, headache, and symptoms of weakness, dizziness or decreased well-being, aphasia,
visual impairment, weakness in arms or legs (or both) and facial paralysis. People age <
18 years, trauma, unconsciousness (GCS ≤ 8), and people transported to another hospital
were excluded
Bray 2005a Australia Paramedics were instructed to complete a MASS assessment sheet on all designated EMS
dispatches for ’stroke’ that were symptomatic, conscious and to be transported to Box Hill
Hospital. Paramedics were also asked to complete a MASS sheet for other people suspected
of stroke where a focal neurologic deficit (i.e. unilateral limb weakness, speech disturbance)
was noted during an initial exam
Bray 2010 Australia People transported by EMS with documented MASS assessments of hand grip, speech,
and facial weakness; and people with a discharge diagnosis of stroke or TIA included in
the stroke/TIA registry. People who were unconscious or asymptomatic at the time of
paramedic assessment were excluded
Chen 2013 China Baseline screen criteria for the ’target stroke’ population were referred from the original
LAPSS study including age ≥ 18 years; neurologically relevant complaints; absence of
coma and non-traumatic. The neurologically relevant complaints were identified with 6
categories, including altered level of consciousness; local neurologic signs; seizure; syncope;
head pain and the cluster category of weak/dizzy/sick
Chenkin 2009 Canada People screened as positive by paramedics using OPSST and transported directly to a
predesignated stroke center based on the person’s current geographic location. Also all
people with suspected stroke arriving by ambulance who did not have a positive screen
were examined
Ding 2009 China People with acute neurologic problems and non-traumatic, non-comatose, non-obstetrics
presentation transported to 3 local hospitals
English 2018 USA People identified by EMS dispatchers as potential stroke/TIA cases were included. Those
who met any of the following inclusion criteria were selected: positive CPSS in field; EMS
impression of cerebrovascular accident or TIA; acute stroke pager activation in the ER;
discharge diagnosis of cerebrovascular accident or TIA. People were excluded if theymet any
of the following: hospital arrival via helicopter, outside hospital transfer, direct admission
without ER evaluation or last known well time > 6 hours
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Table 2. Inclusion criteria of the studies included in the review (Continued)
Fothergill 2013 UK People aged > 18 years if they presented with symptoms of stroke, were assessed by par-
ticipating ambulance clinicians using the ROSIER, and conveyed to the Royal London
Hospital. Those who were ages < 18 years, not assessed using the ROSIER or transferred
to another hospital were excluded
Frendl 2009 USA All people transported to theDuke UniversityMedical Center and coded by EMS as having
a possible stroke or TIA were identified retrospectively by review of computerized and
paper-based paramedic records for the year before and after training, regardless of whether
or not an abnormality was noted for a CPSS item. These records were then compared with
the hospital’s prospective stroke registry for the same period. The stroke registry includes
all patients admitted to the study hospital with a discharge diagnosis of stroke or TIA
Kidwell 2000 USA A ’target stroke’ population was predefined as non-comatose, non-trauma patients with
symptom duration < 24 hours with ischemic stroke, intracerebral hemorrhage, or TIA if
the person was still symptomatic at the time of initial paramedic examination. These people
constituted the population the LAPSS was designed to identify
Kim 2017 Republic of Korea People suspected of stroke and transported to a single hospital by EMS paramedics and
people with true stroke without stroke recognition by EMS (retrospective sample), for a
period of 12 months (data extracted from EMS records, including CPSS score)
Mingfeng 2012 China All people > 18 years with suspected stroke or TIA with symptoms or signs seen by an
emergency physician in the prehospital setting were included. According to the ASA guide-
lines, people who got ≥ 1 of these suggestive clinical elements as follows were defined as
people with suspect acute stroke or TIA. The suggestive clinical elements included sudden
weakness or numbness of the face, arm or leg, especially on 1 side of the body; sudden con-
fusion, trouble speaking or understanding; sudden trouble seeing in 1 or both eyes; sudden
trouble walking, dizziness, loss of balance or co-ordination; or sudden severe headache with
unknown cause
Mingfeng 2017 China All people > 18 years with suspected stroke or TIA who presented to 2 primary care centers
during the recruitment period. The following clinical signs were considered suggestive of
stroke: numbness or weakness in the face, arms or legs (especially on 1 side of the body)
; confusion, difficulty in speaking or understanding speech; vision disturbance in 1 or
both eyes; dizziness, walking difficulties, loss of balance or co-ordination; severe headache
without known cause. Patients were excluded if they had head trauma or surgery in recent
months; previous stroke with neurologic deficits or incomplete medical testing
Ramanujam 2008 USA People age ≥ 18 years identified as having stroke in the prehospital phase using the MPDS
Stroke protocol by emergency medical dispatchers or by use of CPSS by paramedics.
People taken to other acute care hospitals not participating in the study, people with a
dispatch determinant of stroke who were not transported by City EMS agency (SDMSE) to
participating hospitals, people in the stroke registry not transported by SDMSE or people
with no final outcome data were excluded from the study
Studnek 2013 USA People were included if they received a prehospital MedPACS screen and were transported
to 1 of 7 local hospitals. The EMS agency protocols stipulated that a MedPACS screen be
performed on all people who had signs or symptoms of acute stroke or TIA. People with
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Table 2. Inclusion criteria of the studies included in the review (Continued)
no documented MedPACS screen, who nevertheless ended up with a hospital diagnosis of
stroke were excluded from the primary analysis. People were also excluded if they were <
18 years, if they were transported to any medical facility other than those in the inclusion
criteria or if they were secondary transports from a regional facility
ER setting
Jackson 2008 UK Consecutive participants admitted to a single ER identified on routine initial triage as
having possible or suspected stroke
Jiang 2014 China Consecutive participants ≥ 18 years old, presenting to the ER with symptoms or signs
suggestive of stroke orTIA.The followingpeoplewere excluded: traumatic brain injurywith
an external cause such asmotor vehicle crashes and falls; incompletemedical records; people
who did not present first to the ER (e.g. direct admission to a ward); and in accordance
with the criteria for the original ROSIER scale, people with subarachnoid hemorrhage,
subdural hematoma and TIA without symptoms and signs during this period
Lee 2015 Korea People with suspected acute stroke who were admitted to the ER
Nor 2005 UK People age > 18 years with suspected stroke or TIA with symptoms or signs seen by ER
physicians in the ER were included
Vanni 2011 Italy Consecutive adults with suspected stroke who presented to the ERs of 3 hospitals. Inclusion
criteria were the presence at triage of acute focal neurologic deficit (including also signs
of posterior circulation ischemia: vertigo, double vision, visual field defects or disorders of
perception, balance, and co-ordination) or a 118 (local EMS) dispatch of suspected stroke.
Exclusion criteria were major trauma and coma (GCS score ≤ 8). People with terminal
illnesses (life expectancy < 3 months) were also excluded
Whiteley 2011 UK Consecutive participants with suspected acute stroke who presented to the ER of the
Western General Hospital, Edinburgh, while the study neurologist was available. Acute
stroke was suspected in people: whose symptoms began < 24 hours before admission; who
were still symptomatic at the time of assessment; and in whom a general practitioner, a
paramedic or a member of the emergency-room staff had made a diagnosis of ’suspected
stroke’
ASA: American Stroke Association; CPSS: Cincinnati Prehospital Stroke Scale; EMS: emergency medical services; ER: emergency
room; GCS: Glasgow Coma Scale; LAPSS: Los Angeles Prehospital Stroke Scale; MASS: Melbourne Ambulance Stroke Scale;
MPDS: medical priority dispatch system; OPSST: Ontario Prehospital Stroke Screening Tool; ROSIER: Recognition of Stroke in
the Emergency Room; SDMSE: San Diego Medical Services Enterprise; TIA: transient ischemic attack.
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Table 3. Characteristics of study cohorts
Study ID Country Sample
size
Prevalence
(%)
Ischemic
stroke (%)
Hemor-
rhagic
stroke (%)
TIA (%) Mean age
(years)
Sex (%
women)
Eligi-
ble partic-
ipants out
of all EMS
runs
or
ER presen-
tations (%)
Prehospital setting
Andsberg
2017
Sweden 69 38 69 4 27 n/a n/a n/a
Berglund
2014
Sweden 900 52 64 9 27 71 44 n/a
Bergs 2010 Belgium 31 61 79 16 5 77 39 7.6
Bray
2005a
Australia 100 73 68 13 23 76 n/a 2.1
Bray 2010 Australia 850 23 n/a n/a n/a n/a n/a 19
Chen
2013
China 1130 88 61 25 3 72 39 3.1
Chenkin
2009
Canada 554 57 58 21 11 74 31 n/a
Ding 2009 China 327 16 44 36 20 58 48 16.1
English
2018
USA 130 74 64 15 21 72-77 50-52 34.5
Fothergill
2013
UK 295 60 71 23 6 64 47 n/a
Frendl
2009
USA 154 40 n/a n/a n/a 67 56 n/a
Kidwell
2000
USA 206 17 n/a n/a n/a 63 48 34.4
Kim 2017 Korea 268 57 n/a n/a 3 n/a n/a n/a
Mingfeng
2012
China 540 70 n/a 41 n/a 63 32 n/a
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Table 3. Characteristics of study cohorts (Continued)
Mingfeng
2017
China 468 71 n/a 28 n/a 71 51 n/a
Ramanu-
jam
2008
USA 1045 42 n/a n/a n/a n/a n/a 1.3
Studnek
2013
USA 416 45 82 n/a n/a 67 54 n/a
ER setting
Jackson
2008
UK 50 92 n/a n/a n/a 73 52 n/a
Jiang 2014 China 714 52 81 12 7 72 47 n/a
Lee 2015 Korea 312 36 57 31 12 60 55 n/a
Nor 2005 UK 160 63 76 14 10 70 59 n/a
Vanni
2011
Italy 155 56 89 11 n/a 72 41 6.8
Whiteley
2011
UK 356 69 80 5 15 72 51 n/a
EMS: emergency medical service; ER: emergency room; n/a: not applicable; TIA: transient ischemic attack.
Table 4. Index test and reference standard
Study ID Setting Index tests Test administrator Training Reference standard
Andsberg 2017 Prehospital PreHAST Nurse 4-hour
educational program,
covering basic stroke
knowledge and assess-
ment and grading of
stroke symptoms ac-
cording to PreHAST;
it included practi-
cal PreHAST training
in pairs, where each
ambulance nurse per-
formed the PreHAST
items under supervi-
sion and proper execu-
2 stroke physi-
cians, blinded to the
PreHAST scores, in-
dependently reviewed
the medical records of
the participants, in-
cluding evaluation of
history, clinical and ra-
diologic findings. In
case of disagreement, a
third evaluator adjudi-
cated the final diagno-
sis
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Table 4. Index test and reference standard (Continued)
tion. During the study
an instruction video
for PreHAST was
available on YouTube
Berglund 2014 Prehospital FAST Nurse or paramedic 1 lecture about stroke
and the FAST test,
prior to start of the
study
CT brain scan and in
some cases CTA or
MRI, neurologic ex-
amination, if neces-
sary, EEG (differential
diagnosis), laboratory
tests. All participants
received a final diagno-
sis by a neurologist or
stroke specialist
Bergs 2010 Prehospital CPSS, FAST, LAPSS,
MASS
Nurse All nurses were briefed
on purpose of
study, stroke scales and
guidelines
Diagnosis at ER dis-
charge (unspecified).
Bray 2005a Prehospital CPSS, LAPSS, MASS Paramedic 1-hour educational
session on stroke and
use of the prehospital
stroke scale
Standard criteria for
diagnosis of stroke or
TIA (Warlow 2001);
review of discharge di-
agnosis (no further de-
tails).
Bray 2010 Prehospital CPSS, MASS Paramedic 1-hour educa-
tional program and in-
struction on use of the
MASS
Discharge diag-
nosis based on hospital
stroke registry.
Chen 2013 Prehospital LAPSS Paramedic 3 hours’ LAPSS-based
stroke training session
with 3 experts from
study team
2 blinded neurologists
reviewed the
ER charts, recorded fi-
nal ER discharge diag-
noses, and verified ab-
sence
or presence of poten-
tial stroke symptoms.
The medical docu-
ments and neuroimag-
ing records were re-
viewed before the final
diagnoses were verified
Chenkin 2009 Prehospital OPSST Paramedic 90-minute training
session on the stroke
Hospital discharge di-
agnosis (no further de-
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Table 4. Index test and reference standard (Continued)
screening tool prior to
implementation
tails).
Ding 2009 Prehospital LAPSS Emergency physician Not reported. Hospital final diagno-
sis made by a special-
ist group including a
neurologist, a radiolo-
gist and a generalist
English 2018 Prehospital CPSS Paramedic 1-hour online mod-
ule annually on stroke
recognition and assess-
ment in the field as
part of their required
job training
Hospital discharge di-
agnosis (no further de-
tails).
Fothergill 2013 Prehospital FAST, ROSIER Paramedic 1-hour stroke educa-
tional program, sce-
nario based demon-
stration of ROSIER,
15-minute
educational DVD
Final diagnosis made
by a stroke consultant
or other senior medi-
cal physician caring for
the person within 72
hours of the person’s
admission to hospital,
based on CT andMRI
scans. The final diag-
nosiswas confirmedby
a senior stroke consul-
tant
Frendl 2009 Prehospital CPSS Paramedic 1-hour interactive ed-
ucational presentation
on stroke recognition
and use of the CPSS
Hospital discharge di-
agnosis based on the
results of routine clin-
ical, laboratory and ra-
diographic evaluations
Kidwell 2000 Prehospital LAPSS Paramedic Video vi-
gnettes of paramedics
performing the LAPSS
examination on 3 peo-
ple with stroke, 1
stroke mimic person,
and 1 healthy person.
Following a LAPSS-
focused education ses-
sion, trainees had to
pass an exam which, if
failed, was followed by
further training
For all runs, 1 blinded
author reviewed ER
charts, recorded final
ER discharge diag-
noses and confirmed
absence or presence of
potential stroke symp-
toms. On all poten-
tial target stroke runs,
1 blinded author addi-
tionally exam-
ined all inpatient med-
ical records to confirm
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Table 4. Index test and reference standard (Continued)
hospital discharge di-
agnoses of stroke/TIA
by review of reports
from imaging studies
and attending physi-
cian notes. For peo-
ple with the diagno-
sis of TIA, a consensus
on final diagnosis was
reached after complete
medical record review
and case discussion
with a second stroke
neurologist. In all peo-
ple with cerebral in-
farct and intracerebral
hemorrhage, the diag-
nosis of the blinded
reviewer agreed with
the charted diagnosis
of the attending neu-
rologist
Kim 2017 Prehospital CPSS Paramedic Not reported. Hospital medical
records.
Mingfeng 2012 Prehospital CPSS, ROSIER Emergency physician 6-hour course on
ROSIER and CPSS.
The final discharge di-
agnosis of stroke/TIA
made by neurologists
and based on CT or
MRI
Mingfeng 2017 Prehospital CPSS, ROSIER GP Trained by emergency
physicians on the use
of the ROSIER scale
and CPSS for 10 hours
before the study
Final discharge diag-
nosis of stroke or
TIA made by neurolo-
gists reviewing all diag-
nostic information in-
cluding CT scan of
the brain (immediately
after transfer), blood
tests and 12-lead ECG
conducted in the ER;
comprehensive neuro-
logic assessment in-
cluding additional
tests, such as continu-
ous ECG monitoring,
24-hour Holter ECG,
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Table 4. Index test and reference standard (Continued)
duplex carotid and car-
diac ultrasound,TCD,
MRI or MRA, and
conventional cerebral
angiography were per-
formed as requested by
the neurologists once
the person was trans-
ferred to the neurol-
ogy ward. The neurol-
ogists who made the
final diagnosis were
blinded to the results
from the ROSIER and
CPSS
Ramanujam 2008 Prehospital CPSS Paramedic Annual 1-hour educa-
tion session on recog-
nizing stroke.
Discharge
diagnosis for people in
stroke registry.
Studnek 2013 Prehospital CPSS, MedPACS Paramedic 2-hour continuing ed-
ucation lecture regard-
ing neurologic emer-
gencies
Discharge diagnosis of
stroke/TIA.
Jackson 2008 ER ROSIER Emergency physician No training reported. Patients’ records were
later followedup tode-
ter-
mine accuracy of ini-
tial diagnosis; stroke
confirmed on investi-
gation (no further de-
tails reported)
Jiang 2014 ER ROSIER Emergency physician
or nurse
The research staff re-
ceived the specific
training by a stroke
nurse and a module/
exam provided by the
NIHSS website
The final di-
agnoses were made af-
ter people suspected of
stroke were reviewed
by the stroke team
and after review of
clinical symptoms and
the acute neuroimag-
ing (CT and MRI)
Lee 2015 ER FAST, ROSIER Emergency physician 3 hours of training on
theory of stroke and
the acute stroke regis-
tration system from an
emergency medicine
Ischemic stroke and
bleeding were deter-
mined in accordance
with brain CT and
MRI results. The fi-
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Table 4. Index test and reference standard (Continued)
specialist nal diagnosis was con-
firmed at the time
through the electronic
medical record
Nor 2005 ER ROSIER Emergency physician Reg-
ular educational pro-
gram on the use of the
instrument with twice
monthly updates given
to small groups of ER
staff
Final diagnosis made
by the consultant
stroke physician, after
assessment and review
of clinical symptoma-
tology and brain imag-
ing findings
Vanni 2011 ER CPSS Nurse No training reported. TIA was ex-
cluded from the target
condition. Stroke di-
agnosis established by
a consensus of 3 ex-
perts, blinded to the
index test results, after
reviewing all clinical
data and brain imag-
ing results
Whiteley 2011 ER FAST, ROSIER Emergency physician
or nurse
No training reported. Diagnosis made by a
panel of experts, who
had access to the clin-
ical findings, imaging
results and the per-
son’s subsequent clini-
cal course
CPSS: Cincinnati Prehospital Stroke Scale; CT: computed tomography; CTA: computed tomography angiography; ECG: electrocar-
diogram; ER: emergency room; EEG: electroencephalogram; FAST: Face Arm Speech Time; LAPSS: Los Angeles Prehospital Stroke
Scale; MASS: Melbourne Ambulance Stroke Scale; MRA: magnetic resonance angiography; MRI: magnetic resonance imaging;
NIHSS: National Institutes of Health Stroke Scale; OPSST: Ontario Prehospital Stroke Screening Tool; PreHAST: PreHospital
Ambulance Stroke Test; ROSIER: Recognition of Stroke in the Emergency Room; TCD: transcranial Doppler; TIA: transient
ischemic attack.
Table 5. Comparative accuracy of the scales
Scales Sensitivity Specificity Studies
FAST vs ROSIER = = Lee 2015; Whiteley 2011
CPSS vs MASS = < Bray 2005a; Bray 2010
CPSS vs ROSIER ? < Mingfeng 2012
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Table 5. Comparative accuracy of the scales (Continued)
CPSS vs LAPSS > ? Bray 2005a
CPSS vs MedPACS > < Studnek 2013
MASS vs LAPSS > = Bray 2005a
The table summarizes the results from studies reporting the statistical significance of the differences in sensitivity and specificity estimates
of the scales and is equivalent to Figure 27. A version of the table including the results from Purrucker 2015 is given in Appendix
10.
A P P E N D I C E S
Appendix 1. Cochrane Library search strategy
The Cochrane Library databases
Cochrane Database of Systematic Reviews (CDSR)
Database of Reviews of Effects (DARE)
Cochrane Central Register of Controlled Trials (CENTRAL)
Health Technology Assessment database (HTA)
NHS Economic Evaluation Database (NHSEED)
#1 [mh ˆ“cerebrovascular disorders”] or [mh “basal ganglia cerebrovascular disease”] or [mh “brain ischemia”] or [mh “carotid artery
diseases”] or [mh “cerebrovascular trauma”] or [mh “intracranial arterial diseases”] or [mh “intracranial arteriovenous malformations”]
or [mh “intracranial embolism and thrombosis”] or [mh “intracranial hemorrhages”] or [mh ˆstroke] or [mh “brain infarction”] or [mh
ˆ“stroke, lacunar”] or [mh ˆ“vasospasm, intracranial”] or [mh ˆ“vertebral artery dissection”]
#2 (stroke* or apoplex* or cerebral next vasc* or cerebrovasc* or cva or SAH):ti,ab
#3 ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle next cerebr* or mca* or “anterior circulation” or “basilar artery” or “vertebral artery”) near/5 (isch*emi* or infarct* or thrombo*
or emboli* or occlus* or hypoxi*)):ti,ab
#4 ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal next gangli* or putaminal or putamen or “posterior fossa” or hemispher* or subarachnoid) near/5 (hemorrhag*
or haemorrhag* or hematoma* or hematoma* or bleed*)):ti,ab
#5 [mh ˆ“ischemic attack, transient”] or ((transient near/3 isch*emi*) or TIA or TIAs):ti,ab
#6 #1 or #2 or #3 or #4 or #5
#7 ((Cincinnati or “Los Angeles” or Ontario or Maria or Kurashiki) near/10 (scale* or screen*)):ti,ab
#8 ((“Melbourne Ambulance” near/5 (screen* or scale*)) or “face arm speech test”):ti,ab
#9 #7 or #8
#10 #6 and #9
#11 [mh ˆ“emergency medical services”]
#12 [mh ˆ“emergency medical service communication systems”]
#13 [mh ˆ“emergency service, hospital”] or [mh ˆ“emergency medicine”] or [mh ˆ“emergency treatment”]
#14 [mh âmbulances] or [mh ˆ“emergency responders”] or [mh ˆ“allied health personnel”]
#15 (prehospital* or pre-hospital* or pre hospital* or ambulance* or paramedic* or EMS):ti,ab
#16 (Emergency near/3 (medical or health) near/3 (service* or system* or worker* or personnel* or responder* or dispatcher* or unit
or units or technician* or vehicle*)):ti,ab
#17 (emergency near/5 (physician* or staff or room* or department*)):ti,ab
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#18 #11 or #12 or #13 or #14 or #15 or #16 or #17
#19 (stroke* near/5 (scale* or screen* or checklist* or assess* or identif* or recogni* or evaluat* or diagnos* or detect*)):ti,ab
#20 #18 and #19
#21 [mh ˆ“cerebrovascular disorders”/DI,CL] or [mh “basal ganglia cerebrovascular disease”/DI,CL] or [mh “brain ischemia”/DI,CL]
or [mh “carotid artery diseases”/DI,CL] or [mh “cerebrovascular trauma”/DI,CL] or [mh “intracranial arterial diseases”/DI,CL] or
[mh “intracranial arteriovenous malformations”/DI,CL] or [mh “intracranial embolism and thrombosis”/DI,CL] or [mh “intracranial
hemorrhages”/DI,CL] or [mh ˆstroke/DI,CL] or [mh “brain infarction”/DI,CL] or [mh ˆ“stroke, lacunar”/DI,CL] or [mh ˆ“vasospasm,
intracranial”/DI,CL] or [mh ˆ“vertebral artery dissection”/DI,CL]
#22 #18 and #21
#23 [mh ˆdiagnosis] or [mh ˆ“early diagnosis”]
#24 #6 and #18 and #23
#25 [mh “sensitivity and specificity”]
#26 (sensitiv* or specificity):ti,ab
#27 (predictive near/5 value*):ti,ab
#28 [mh “diagnostic errors”]
#29 ((false next positive*) or (false next negative*)):ti,ab
#30 (observer next variation*):ti,ab
#31 (roc next curve*):ti,ab
#32 (likelihood near/3 ratio*):ti,ab
#33 [mh ˆ“likelihood function”]
#34 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33
#35 #6 and #18 and #34
#36 #10 or #20 or #22 or #24 or #35
Appendix 2. MEDLINE search strategy
MEDLINE (Ovid)
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or
exp cerebrovascular trauma/ or exp intracranial arterial diseases/ or exp intracranial arteriovenous malformations/ or exp “intracranial
embolism and thrombosis”/ or exp intracranial hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm,
intracranial/ or vertebral artery dissection/
2. (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
middle cerebr$ or mca$ or anterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$
or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw
5. ischemic attack, transient/ or ((transient adj3 isch?emi$) or TIA or TIAs).tw.
6. 1 or 2 or 3 or 4 or 5
7. ((Cincinnati or Los Angeles or Ontario or Maria or Kurashiki) adj10 (scale$ or screen$)).tw.
8. (Melbourne Ambulance adj5 (screen$ or scale$)).tw.
9. 7 or 8
10. 6 and 9
11. emergency medical services/
12. emergency medical service communication systems/
13. emergency service, hospital/ or emergency medicine/ or emergency treatment/
14. ambulances/ or emergency responders/ or allied health personnel/
15. (prehospital$ or pre-hospital$ or pre hospital$ or ambulance$ or paramedic$ or EMS).tw.
16. (Emergency adj3 (medical or health) adj3 (service$ or system$ or worker$ or personnel$ or responder$ or dispatcher$ or unit or
units or technician$ or vehicle$)).tw.
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17. (emergency adj5 (physician$ or staff or room$ or department$)).tw.
18. 11 or 12 or 13 or 14 or 15 or 16 or 17
19. (stroke$ adj5 (scale$ or screen$ or checklist$ or assess$ or identif$ or recogni$ or evaluat$ or diagnos$ or detect$)).tw.
20. 18 and 19
21. cerebrovascular disorders/di, cl or basal ganglia cerebrovascular disease/di, cl or brain ischemia/di, cl or exp brain infarction/di, cl or
hypoxia-ischemia, brain/di, cl or carotid artery diseases/di, cl or carotid artery thrombosis/di, cl or carotid artery, internal, dissection/
di, cl or intracranial arterial diseases/di, cl or cerebral arterial diseases/di, cl or infarction, anterior cerebral artery/di, cl or infarction,
middle cerebral artery/di, cl or infarction, posterior cerebral artery/di, cl or exp “intracranial embolism and thrombosis”/di, cl or exp
stroke/di, cl or vertebral artery dissection/di, cl
22. 18 and 21
23. diagnosis/ or early diagnosis/
24. 6 and 18 and 23
25. exp “sensitivity and specificity”/
26. (sensitiv$ or specificity).tw.
27. (predictive adj5 value$).tw.
28. exp diagnostic errors/
29. ((false adj positive$) or (false adj negative$)).tw.
30. (observer adj variation$).tw.
31. (roc adj curve$).tw.
32. (likelihood adj3 ratio$).tw.
33. likelihood function/
34. 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
35. 6 and 18 and 34
36. 10 or 20 or 22 or 24 or 35
Appendix 3. Embase search strategy
1. cerebrovascular disease/ or exp basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarction/
or exp brain ischemia/ or exp carotid artery disease/ or cerebral artery disease/ or exp cerebrovascular accident/ or exp occlusive
cerebrovascular disease/ or stroke patient/
2. (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
middle cerebr$ or mca$ or anterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$
or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. ischemic attack, transient/ or ((transient adj3 isch?emi$) or TIA or TIAs).tw.
6. 1 or 2 or 3 or 4 or 5
7. ((Cincinnati or Los Angeles or Ontario or Maria or Kurashiki) adj10 (scale$ or screen$)).tw.
8. ((Melbourne Ambulance adj5 (screen$ or scale$)) or face arm speech test).tw.
9. 7 or 8
10. 6 and 9
11. emergency health service/
12. emergency/ or emergency call system/ or emergency care/ or emergency medicine/
13. emergency treatment/ or emergency patient/ or emergency nurse practitioner/ or emergency nursing/ or emergency physician/
14. ambulance/ or rescue personnel/ or rapid response team/ or paramedical personnel/ or paramedical profession/
15. (prehospital$ or pre-hospital$ or pre hospital$ or ambulance$ or paramedic$ or EMS).tw.
16. (Emergency adj3 (medical or health) adj3 (service$ or system$ or worker$ or personnel$ or responder$ or dispatcher$ or unit or
units or technician$ or vehicle$)).tw.
17. (emergency adj5 (physician$ or staff or room$ or department$)).tw.
18. 11 or 12 or 13 or 14 or 15 or 16 or 17
137Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
19. (stroke$ adj5 (scale$ or screen$ or checklist$ or assess$ or identif$ or recogni$ or evaluat$ or diagnos$ or detect$)).tw.
20. 18 and 19
21. cerebrovascular disease/di or exp basal ganglion hemorrhage/di or exp brain hematoma/di or exp brain hemorrhage/di or exp brain
infarction/di or exp brain ischemia/di or exp carotid artery disease/di or cerebral artery disease/di or exp cerebrovascular accident/di or
exp occlusive cerebrovascular disease/di or stroke patient/di
22. 18 and 21
23. neurologic examination/ or diagnosis/ or early diagnosis/ or diagnostic test/
24. 6 and 18 and 23
25. “sensitivity and specificity”/
26. receiver operating characteristic/
27. diagnostic accuracy/
28. exp diagnostic error/
29. observer variation/
30. “limit of detection”/
31. “diagnostic test accuracy study”.sh.
32. (sensitivity or specificity).tw.
33. (predictive adj3 value$).tw.
34. ((false adj positive$) or (false adj negative$)).tw.
35. observer variation$.tw.
36. (roc adj curve$).tw.
37. (likelihood adj3 ratio$).tw.
38. or/25-37
39. 6 and 18 and 38
40. 10 or 20 or 22 or 24 or 39
Appendix 4. Data extraction form
Review, reviewer and study Information
Title and ID of review
Reviewer ID
Date of form completion
Study ID (for Revman)
Study characteristics
Title
Authors
Journal Name
Publication date
Study design
Number of centres
Sample size
Funding
Country
Patient characteristics
Age
Sex
Seizure history
The study’s inclusion and exclusion criteria
Details of presenting symptoms/reason for query stroke
Index test
Test interventions- the prehospital stroke scale
Test name
Title of test administrator (Paramedic, Emergency physician)
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Details of test and stroke specific training regimen for test administrator
Reference standard
Tests on which the final diagnosis is based
Adjudication process
Outcomes
Diagnostic accuracy outcomes
Number of patients in study
Number of patients with a discharge diagnosis of stroke
Number of true positives (TP), false positives (FP), true negatives (TN) and false negatives (FN)
Sensitivity and specificity with 95% confidence intervals
Additional outcomes
Total mortality
Total morbidity
Modified Rankin Score
Change in Modified Rankin Score at discharge and at 90 days
Door to needle time
Categorization of alternate diagnosis for patients who did not have an ischemic stroke
Withdrawals
Unable to use data - inadequate data has been provided in the publication, specifically, the data set is inadequate to the point where
the sensitivity, specificity etc. cannot be calculated from the data set provided
Appendix 5. Quality Assessment Checklist (QUADAS-2)
Patient selection
Description
Describe the methods of patient selection reported in the paper.
Risk of bias
Was a consecutive or random sample of patients enrolled?
• ’Yes’ if consecutive or random sampling is explicitly stated.
• ’No’ if non-consecutive or convenience sampling is used.
• ’Unclear’ if the provided information is insufficient to make a judgment.
Was a case-control design avoided?
• ’Yes’ if all patients were recruited from the same population using a single set of inclusion and exclusion criteria.
• ’No’ if patients with and without the target condition were recruited from different populations and/or using different sets of
inclusion and exclusion criteria.
• ·’Unclear’ if the provided information is insufficient to decide .
Did the study avoid inappropriate exclusions?
(Exclusion of patients with a past medical history suggestive of an alternate diagnosis that can mimic a stroke such as a seizure).
(Exclusion of patients with an undifferentiated presentation that may have a stroke according to the intervention test).
(Exclusion of patients based on the absence of any cardinal risk factors for stroke (hypertension, smoker, diabetes, dyslipidemia, prior
TIA/stroke).
• ’Yes’ if all eligible patients suspected of stroke were included in the study.
• ’No’ if eligible patients suspected of stroke were excluded from the studies for reasons that might affect the accuracy of the index
test.
• ’Unclear’ if not possible to make a judgment based on the information provided in the study.
Prospective study design? (Were participants recruited prospectively for the purpose of the study?)
• ’Yes’ if participants recruited prospectively.
• ’No’ if study sample selected from a registry (retrospective recruitment).
• ’Unclear’ if the provided information is insufficient to make a judgment.
Concerns regarding applicability
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• ’Low’ if the study included unselected patients suspected of having a stroke at the first point of contact.
• ’High’ if otherwise.
• ’Unclear’ if the information provided in the paper is insufficient to make a decision.
Index test
Description
Describe the index test and how it was conducted and interpreted.
Risk of bias
Were the index test results interpreted without knowledge of the results of the reference standard?
• ’Yes’ or ’No’ if stated in the study
• ’Unclear’ if not stated
If a threshold was used, was it prespecified?
• ’Yes’ if the threshold used to make a referral decision was prespecified.
• ’No’ if ROC-optimized or other not prespecified cutoff was used.
• ’Unclear’ if the provided information is insufficient to decide.
Concerns regarding applicability
• ’Low’ if the index test was performed by prehospital staff in the context of first contact with a patient suspected of stroke.
• ’High’ if otherwise.
• ’Unclear’ if insufficient information is provided.
Reference standard
Description
Describe the reference standard and how it was conducted and interpreted.
Risk of bias
Is the reference standard likely to correctly classify the target condition?
• ’Yes’ if the final diagnosis was based on the results from history, physical examination and non-contrast computed tomography
(CT) head scan and/or any other imaging and was adjudicated independently by a neurologist.
• ’No’ if the above criteria were not met.
• ’Unclear’ if reported data is insufficient to decide.
Were the results from the reference standard interpreted without knowledge of the results from the index test?
• ’Yes’ or ’no’ if explicitly stated, ’unclear’ if not reported.
Concerns regarding applicability
• ’Low’ if the target condition as defined by the reference standard was stroke, without discrimination of type or severity.
• ’High’ if the target condition was a specific type of stroke (e.g. ischemic or hemorrhagic) or level of stroke severity.
• ’Unclear’ if insufficient information is provided.
Flow and timing
Description
Describe any patients who did not receive the index test(s), or reference standard, or both, or who were excluded from the 2x2 table.
Risk of bias
Was there an appropriate interval between index test(s) and reference standard?
• ’Yes’ - the blinded neurologist saw the patient and took a history and physical and interpreted the imaging within 14 days of the
implementation of the index test.
• ’No’ - the study clearly states that patients were not seen by the blinded neurologist within 14 days.
• ’Unclear’ - the time of diagnosis by the neurologist is not made available.
Did all patients receive a reference standard?
• ’Yes’ if all patients received a reference standard (seen by the blinded neurologist).
• ’No’ if a portion of the included patients did not receive a reference standard.
• ’Unclear’ if data is insufficient to decide.
Did all patients receive the same reference standard?
• ’Yes’ if all patients received the same reference standard.
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• ’No’ if the final diagnosis of stroke was based on different combination of tests.
• ’Unclear’ if there is no sufficient data to make a judgment.
Were all patients included in the analysis?
• ’Yes’ if all patients were included.
• ’No’ if patients who were enrolled in the study were excluded from the analysis.
• ’Unclear’ if insufficient data is available to decide.
Appendix 6. Results from the searches
Initial searches (January 2015):
MEDLINE in Ovid (1946 to January 2015), N = 2156
Embase in Ovid (1980 to January 2015), N = 6182
Cochrane Library (CDSR, DARE, CENTRAL, HTA, NHSEED searched January 2015), N = 143 refs
Total N = 8481
Update (January 2015 to January 2017):
MEDLINE in Ovid (1950 to January 2017), N = 554
Embase in Ovid (1980 to January 2017), N = 2447
Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1) in the Cochrane Library (searched January 2017), N = 237
Total N = 3238
Update (January 2017 to January 2018):
MEDLINE Ovid (1946 to 30 January 2018), N = 131
Embase Ovid (1974 to 30 January 2018), N = 1035
Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 12) and the Cochrane Database of Systematic Reviews
(CENTRAL; 2018, Issue 1) in the Cochrane Library (searched 30 January 2018), N = 54
Nothing new was found in HTA or DARE since previous search
Appendix 7. Summary of the reasons for full-text exclusion of studies
Exclusions of studies at full text screening
143 from the initial searches:
• 71 conference abstracts;
• 39 no new data (e.g. review) or inappropriate study design;
• 25 unsuitable index test;
• 4 unsuitable setting;
• 1 population;
• 2 unsuitable reference standard;
• 1 insufficient data.
29 from the update:
• 4 conference abstracts;
• 12 no new data (e.g. review) or inappropriate study design;
• 1 unsuitable target condition;
• 9 unsuitable index test;
• 2 unsuitable setting;
• 1 unsuitable reference standard.
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Appendix 8. Type of stroke missed by ROSIER (false negatives) as reported by the studies included
in the meta-analysis
Study Sample size Details of the type of stroke missed by the test as stated in the paper
Whiteley 2011 356 “Both the ROSIER and the FAST performed relatively poorly in identifying patients with posterior
circulations strokes (18/37, 49% FAST positive and 19/37, 51% ROSIER positive).” p. 1008
Lee 2015 312 TIA, thalamic infarction, posterior circulation stroke, middle cerebral artery infarction, intracranial
hemorrhage, table 5, p. 471
Jiang 2014 715 Not reported.
Nor 2005 160 “The false-negative group included posterior circulation infarction (n = 5) and lacunar infarction (n
= 2). The neurological signs in these cases were gait ataxia (n = 5), sensory deficits (n = 2), and one
each of ophthalmoplegia, quadriparesis, and loss of consciousness. Most (six) of these false-negative
cases had mild deficits (NIHSS < 3), and would not have been clear candidates for thrombolytic
therapy even if they had presented sufficiently early. The remaining patient had an NIHSS score of
24 and presented with drowsiness, gaze palsy, and quadriplegia.” p. 371
Jackson 2008 50 “Two patients with stroke were found to have a ROSIER score of 0, one was admitted unconscious
with a large primary intracerebral hemorrhage andwaswrongly scored and the second had a cerebellar
infarct with no weakness, speech or visual field defect.” p. 190
FAST: Face Arm Speech Time; n: number of participants; NIHSS: National Institutes of Health Stroke Scale; ROSIER: Recognition
of Stroke in the Emergency Room; TIA: transient ischemic attack.
Appendix 9. Additional comparative data reported by Purrucker 2015
Stroke scale Sensitivity (95% CI) Specificity (95% CI)
CPSS 0.83 (0.76 to 0.88) 0.69 (0.64 to 0.73)
FAST 0.85 (0.78 to 0.90) 0.68 (0.63 to 0.72)
LAPSS 1998 0.44 (0.36 to 0.52) 0.98 (0.96 to 0.99)
LAPSS 2000 0.49 (0.41 to 0.57) 0.97 (0.95 to 0.99)
MASS 0.63 (0.55 to 0.70) 0.94 (0.91 to 0.96)
MedPACS 0.71 (0.64 to 0.78) 0.92 (0.89 to 0.94)
ROSIER 0.80 (0.73 to 0.85) 0.79 (0.75 to 0.83)
The table is based on Table 3 in Purrucker 2015.
CI: confidence interval; FAST: Face Arm Speech Time; LAPSS: Los Angeles Prehospital Stroke Scale; MASS: Melbourne Ambulance
Stroke Scale; MedPACS: Medic Prehospital Assessment for Code Stroke; ROSIER: Recognition of Stroke in the Emergency Room.
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Appendix 10. Summary of comparative accuracy: comparison between included studies and
Purrucker 2015
Scales Included studies Purrucker 2015
Sensitivity Specificity Sensitivity Specificity
FAST vs ROSIER = = ? <
CPSS vs MASS = < > <
CPSS vs ROSIER ? < ? <
CPSS vs LAPSS > ? > <
CPSS vs MedPACS > < trend > trend <
MASS vs LAPSS > = trend > trend <
’Trend >’ or ’trend <’ means that the confidence intervals overlap but only marginally (see the table in Appendix 9), and there is a clear
trend towards one of the scales being more/less sensitive or specific. Discrepant results are given in bold.
CPSS: Cincinnati Prehospital Stroke Scale; FAST: Face Arm Speech Time; LAPSS: Los Angeles Prehospital Stroke Scale; MASS:
Melbourne Ambulance Stroke Scale; MedPACS: Medic Prehospital Assessment for Code Stroke; ROSIER: Recognition of Stroke in
the Emergency Room.
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All review authors participated in the selection of studies, data extraction, and methodologic quality assessment.
SY translated from Chinese.
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S O U R C E S O F S U P P O R T
Internal sources
• National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West
Peninsula (NIHR CLAHRC South West Peninsula), UK.
Zhivko Zhelev’s contribution to this research was supported by the NIHR Collaboration for Leadership in Applied Health Research
and Care South West Peninsula (NIHR CLAHRC South West Peninsula). The views expressed are those of the author(s) and not
necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• We included studies that compared multiple tests provided they met the rest of our inclusion criteria.
• In tailoring QUADAS-2, we added to the patient selection domain a signaling question regarding prospective/retrospective
design. The reason for adding this question is explained in the Methods. Upon advice from the Editors, we also added the question
“Were the index test results interpreted without knowledge of the results of the reference standard?” This latter question was initially
removed from the checklist as all answers would be ’Yes’ (the stroke scales are always used before the reference standard tests).
• The Cochrane information Specialists who conducted the electronic searches had no access to MEDION (
www.mediondatabase.nl) and, therefore, we did not search this database. Our previous experience suggests that searching this
database is unlikely to identify additional studies missed by the main database searches.
• In Appendix 9 and Appendix 10, we reported the results from Purrucker 2015. This study did not meet our inclusion criterion
for use of the scales on actual patients and, therefore, was excluded from the main analysis. However, it provides valuable information
on the comparative accuracy of multiple scales. Given the paucity of comparative data, we decided to report its results in appendices
and include it in a secondary analysis.
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